
<html lang="en"     class="pb-page"  data-request-id="7e748fbc-3f58-414b-92ab-ab825d7dbcbb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-21;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b01099"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design" /></meta><meta name="dc.Creator" content="Hai-Yun  Xiao" /></meta><meta name="dc.Creator" content="Scott H.  Watterson" /></meta><meta name="dc.Creator" content="Charles M.  Langevine" /></meta><meta name="dc.Creator" content="Anurag S.  Srivastava" /></meta><meta name="dc.Creator" content="Soo S.  Ko" /></meta><meta name="dc.Creator" content="Yanlei  Zhang" /></meta><meta name="dc.Creator" content="Robert J.  Cherney" /></meta><meta name="dc.Creator" content="Wei-Wei  Guo" /></meta><meta name="dc.Creator" content="John L.  Gilmore" /></meta><meta name="dc.Creator" content="James E.  Sheppeck, II" /></meta><meta name="dc.Creator" content="Dauh-Rurng  Wu" /></meta><meta name="dc.Creator" content="Peng  Li" /></meta><meta name="dc.Creator" content="Duraisamy  Ramasamy" /></meta><meta name="dc.Creator" content="Piramanayagam  Arunachalam" /></meta><meta name="dc.Creator" content="Arvind  Mathur" /></meta><meta name="dc.Creator" content="Tracy L.  Taylor" /></meta><meta name="dc.Creator" content="David J.  Shuster" /></meta><meta name="dc.Creator" content="Kim W.  McIntyre" /></meta><meta name="dc.Creator" content="Ding-Ren  Shen" /></meta><meta name="dc.Creator" content="Melissa  Yarde" /></meta><meta name="dc.Creator" content="Mary Ellen  Cvijic" /></meta><meta name="dc.Creator" content="Anthony M.  Marino" /></meta><meta name="dc.Creator" content="Praveen V.  Balimane" /></meta><meta name="dc.Creator" content="Zheng  Yang" /></meta><meta name="dc.Creator" content="Dana M.  Banas" /></meta><meta name="dc.Creator" content="Georgia  Cornelius" /></meta><meta name="dc.Creator" content="Celia J.  D’Arienzo" /></meta><meta name="dc.Creator" content="Bethanne M.  Warrack" /></meta><meta name="dc.Creator" content="Lois  Lehman-McKeeman" /></meta><meta name="dc.Creator" content="Luisa M.  Salter-Cid" /></meta><meta name="dc.Creator" content="Jenny  Xie" /></meta><meta name="dc.Creator" content="Joel C.  Barrish" /></meta><meta name="dc.Creator" content="Percy H.  Carter" /></meta><meta name="dc.Creator" content="Alaric J.  Dyckman" /></meta><meta name="dc.Creator" content="T. G. Murali  Dhar" /></meta><meta name="dc.Description" content="Fingolimod (1) is the first approved oral therapy for the treatment of relapsing remitting multiple sclerosis. While the phosphorylated metabolite of fingolimod was found to be a nonselective S1P r..." /></meta><meta name="Description" content="Fingolimod (1) is the first approved oral therapy for the treatment of relapsing remitting multiple sclerosis. While the phosphorylated metabolite of fingolimod was found to be a nonselective S1P r..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 20, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01099" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01099" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01099" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01099" /></link>
        
    
    

<title>Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01099" /></meta><meta property="og:title" content="Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0015.jpeg" /></meta><meta property="og:description" content="Fingolimod (1) is the first approved oral therapy for the treatment of relapsing remitting multiple sclerosis. While the phosphorylated metabolite of fingolimod was found to be a nonselective S1P receptor agonist, agonism specifically of S1P1 is responsible for the peripheral blood lymphopenia believed to be key to its efficacy. Identification of modulators that maintain activity on S1P1 while sparing activity on other S1P receptors could offer equivalent efficacy with reduced liabilities. We disclose in this paper a ligand-based drug design approach that led to the discovery of a series of potent tricyclic agonists of S1P1 with selectivity over S1P3 and were efficacious in a pharmacodynamic model of suppression of circulating lymphocytes. Compound 10 had the desired pharmacokinetic (PK) and pharmacodynamic (PD) profile and demonstrated maximal efficacy when administered orally in a rat adjuvant arthritis model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01099"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01099">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01099&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01099&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01099&amp;href=/doi/10.1021/acs.jmedchem.6b01099" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9837-9854</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01092" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01191" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Employing Ligand-Based Drug Design</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Yun++Xiao">Hai-Yun Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+H.++Watterson">Scott H. Watterson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+M.++Langevine">Charles M. Langevine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anurag+S.++Srivastava">Anurag S. Srivastava</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Soo+S.++Ko">Soo S. Ko</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanlei++Zhang">Yanlei Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Cherney">Robert J. Cherney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei-Wei++Guo">Wei-Wei Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+L.++Gilmore">John L. Gilmore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+E.++Sheppeck%2C++II">James E. Sheppeck, II</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dauh-Rurng++Wu">Dauh-Rurng Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peng++Li">Peng Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duraisamy++Ramasamy">Duraisamy Ramasamy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piramanayagam++Arunachalam">Piramanayagam Arunachalam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arvind++Mathur">Arvind Mathur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tracy+L.++Taylor">Tracy L. Taylor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Shuster">David J. Shuster</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kim+W.++McIntyre">Kim W. McIntyre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ding-Ren++Shen">Ding-Ren Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Yarde">Melissa Yarde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ellen++Cvijic">Mary Ellen Cvijic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+M.++Marino">Anthony M. Marino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Praveen+V.++Balimane">Praveen V. Balimane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Yang">Zheng Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dana+M.++Banas">Dana M. Banas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georgia++Cornelius">Georgia Cornelius</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia+J.++D%E2%80%99Arienzo">Celia J. D’Arienzo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bethanne+M.++Warrack">Bethanne M. Warrack</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lois++Lehman-McKeeman">Lois Lehman-McKeeman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luisa+M.++Salter-Cid">Luisa M. Salter-Cid</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Xie">Jenny Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Percy+H.++Carter">Percy H. Carter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alaric+J.++Dyckman">Alaric J. Dyckman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=T.+G.+Murali++Dhar">T. G. Murali Dhar</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">BMS Biocon Research Center, Bangalore 560099, India</span></div><div class="corresp-info"><strong>*</strong>Phone: 609-252-4158, E-mail: <a href="/cdn-cgi/l/email-protection#e08d9592818c89ce84888192a0828d93ce838f8d"><span class="__cf_email__" data-cfemail="95f8e0e7f4f9fcbbf1fdf4e7d5f7f8e6bbf6faf8">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01099&amp;href=/doi/10.1021%2Facs.jmedchem.6b01099" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9837–9854</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 11, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 July 2016</li><li><span class="item_label"><b>Published</b> online</span>20 October 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 November 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01099" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01099</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9837%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHai-Yun%2BXiao%252C%2BScott%2BH.%2BWatterson%252C%2BCharles%2BM.%2BLangevine%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D21%26contentID%3Dacs.jmedchem.6b01099%26title%3DIdentification%2Bof%2BTricyclic%2BAgonists%2Bof%2BSphingosine-1-phosphate%2BReceptor%2B1%2B%2528S1P1%2529%2BEmploying%2BLigand-Based%2BDrug%2BDesign%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9854%26publicationDate%3DNovember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01099"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1740</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01099" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hai-Yun&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;H. Watterson&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;M. Langevine&quot;},{&quot;first_name&quot;:&quot;Anurag&quot;,&quot;last_name&quot;:&quot;S. Srivastava&quot;},{&quot;first_name&quot;:&quot;Soo&quot;,&quot;last_name&quot;:&quot;S. Ko&quot;},{&quot;first_name&quot;:&quot;Yanlei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Cherney&quot;},{&quot;first_name&quot;:&quot;Wei-Wei&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;L. Gilmore&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;E. Sheppeck&quot;},{&quot;first_name&quot;:&quot;Dauh-Rurng&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Peng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Duraisamy&quot;,&quot;last_name&quot;:&quot;Ramasamy&quot;},{&quot;first_name&quot;:&quot;Piramanayagam&quot;,&quot;last_name&quot;:&quot;Arunachalam&quot;},{&quot;first_name&quot;:&quot;Arvind&quot;,&quot;last_name&quot;:&quot;Mathur&quot;},{&quot;first_name&quot;:&quot;Tracy&quot;,&quot;last_name&quot;:&quot;L. Taylor&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Shuster&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;W. McIntyre&quot;},{&quot;first_name&quot;:&quot;Ding-Ren&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Yarde&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ellen Cvijic&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;M. Marino&quot;},{&quot;first_name&quot;:&quot;Praveen&quot;,&quot;last_name&quot;:&quot;V. Balimane&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Dana&quot;,&quot;last_name&quot;:&quot;M. Banas&quot;},{&quot;first_name&quot;:&quot;Georgia&quot;,&quot;last_name&quot;:&quot;Cornelius&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;J. D’Arienzo&quot;},{&quot;first_name&quot;:&quot;Bethanne&quot;,&quot;last_name&quot;:&quot;M. Warrack&quot;},{&quot;first_name&quot;:&quot;Lois&quot;,&quot;last_name&quot;:&quot;Lehman-McKeeman&quot;},{&quot;first_name&quot;:&quot;Luisa&quot;,&quot;last_name&quot;:&quot;M. Salter-Cid&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;Percy&quot;,&quot;last_name&quot;:&quot;H. Carter&quot;},{&quot;first_name&quot;:&quot;Alaric&quot;,&quot;last_name&quot;:&quot;J. Dyckman&quot;},{&quot;first_name&quot;:&quot;T.&quot;,&quot;last_name&quot;:&quot;G. Murali Dhar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;9837-9854&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01099&quot;},&quot;abstract&quot;:&quot;Fingolimod (1) is the first approved oral therapy for the treatment of relapsing remitting multiple sclerosis. While the phosphorylated metabolite of fingolimod was found to be a nonselective S1P receptor agonist, agonism specifically of S1P1 is responsible for the peripheral blood lymphopenia believed to be key to its efficacy. Identification of modulators that maintain activity on S1P1 while sparing activity on other S1P receptors could offer equivalent efficacy with reduced liabilities. We disclose in this paper a ligand-based drug design approach that led to the discovery of a series of potent tricyclic agonists of S1P1 with selectivity over S1P3 and were efficacious in a pharmacodynamic model of suppression of circulating lymphocytes. Compound 10 had the desired pharmacokinetic (PK) and pharmacodynamic (PD) profile and demonstrated maximal efficacy when administered orally in a rat adjuvant arthritis model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01099&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01099" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01099&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01099" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01099&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01099" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01099&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01099&amp;href=/doi/10.1021/acs.jmedchem.6b01099" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01099" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01099" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01099%26sid%3Dliteratum%253Aachs%26pmid%3D27726358%26genre%3Darticle%26aulast%3DXiao%26date%3D2016%26atitle%3DIdentification%2Bof%2BTricyclic%2BAgonists%2Bof%2BSphingosine-1-phosphate%2BReceptor%2B1%2B%2528S1P1%2529%2BEmploying%2BLigand-Based%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D21%26spage%3D9837%26epage%3D9854%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291251" title="Sodium">Sodium</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/jmcmar.2016.59.issue-21/20161110/jmcmar.2016.59.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Fingolimod (<b>1</b>) is the first approved oral therapy for the treatment of relapsing remitting multiple sclerosis. While the phosphorylated metabolite of fingolimod was found to be a nonselective S1P receptor agonist, agonism specifically of S1P<sub>1</sub> is responsible for the peripheral blood lymphopenia believed to be key to its efficacy. Identification of modulators that maintain activity on S1P<sub>1</sub> while sparing activity on other S1P receptors could offer equivalent efficacy with reduced liabilities. We disclose in this paper a ligand-based drug design approach that led to the discovery of a series of potent tricyclic agonists of S1P<sub>1</sub> with selectivity over S1P<sub>3</sub> and were efficacious in a pharmacodynamic model of suppression of circulating lymphocytes. Compound <b>10</b> had the desired pharmacokinetic (PK) and pharmacodynamic (PD) profile and demonstrated maximal efficacy when administered orally in a rat adjuvant arthritis model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The G-protein coupled receptor (GPCR) S1P<sub>1</sub> (sphingosine-1-phosphate-subtype 1) has emerged as an attractive drug target in recent years. Activation of S1P<sub>1</sub> by synthetic agonists, but not by activation with the endogenous ligand S1P, leads to sustained internalization and degradation of cell surface receptors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This functional antagonism of the receptor results in immunosuppression through disruption of normal lymphocyte trafficking, with lymphocytes sequestered in lymph nodes and secondary lymphoid organs.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Extensive validation of this mechanism has been demonstrated across a range of preclinical models of chronic autoimmune disease.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The success of the nonselective S1P receptor agonist fingolimod (FTY720, <b>2</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), approved by the FDA in 2010 for the treatment of relapsing remitting multiple sclerosis (RRMS), has spurred interest in the clinical evaluation of it and additional S1P<sub>1</sub> agonists for a growing list of disorders (Crohn’s disease, ulcerative colitis, psoriasis, polymyositis, progressive MS, lupus).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Fingolimod is a pro-drug, requiring in vivo phosphorylation to form FTY720-P (<b>2-P</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which is a potent agonist of 4 of the 5 S1P receptors (S1P<sub>1,3,4,5</sub>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition to the pro-drug class of S1P<sub>1</sub> agonists, exemplified by fingolimod, direct-acting agonists that replace the amino-phosphonate group with moieties that mimic its interactions and thus do not require bioactivation have been reported by a number of research teams and are in clinical development.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13">(5-13)</a> The focus of research programs following fingolimod has primarily been aimed at identifying agonists with improved S1P family selectivity, specifically to avoid interaction with S1P<sub>3</sub>, which was believed to be associated with clinical side effects such as the transient reduction in heart rate (bradycardia). In rodent studies, fingolimod was unable to elicit heart rate reductions in S1P<sub>3</sub> knockout mice, whereas it did induce bradycardia in wild-type controls.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Furthermore, synthetic S1P<sub>1</sub>-selective agonists that lacked activity on S1P<sub>3</sub> did not induce bradycardia in rodents. Surprisingly, in human trials, multiple S1P<sub>3</sub>-sparing S1P<sub>1</sub> agonists have now been shown to offer no substantial advantage over fingolimod in regard to bradycardia.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In humans, as opposed to nonclinical species, regulation of heart rate appears to have a significant S1P<sub>1</sub> related component.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Nevertheless, as S1P<sub>3</sub> does not contribute to the desired efficacy, a drive for more selective S1P<sub>1</sub> agonists has remained a viable approach for research programs, including our own.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of S1P, fingolimod (FTY720), and its phosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We recently disclosed the identification of compound <b>3</b> as a potent functional antagonist of S1P<sub>1</sub> with selectivity over S1P<sub>3</sub> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The single-crystal X-ray structure of <b>3</b> indicated that the phenyl ring and the 1,2,4-oxadiazole ring are coplanar in orientation (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). This suggested that ring fusion of the oxadiazole ring with the 3-position of the phenyl ring would maintain planarity of the scaffold, thus leading to a novel series of tricyclic S1P<sub>1</sub> receptor modulators. However, in the absence of X-ray cocrystal structures of S1P<sub>1</sub> with functional antagonists, it was not clear if substituents at the 3-position of the phenyl ring would be tolerated by the receptor. Yan et al.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> disclosed a series S1P<sub>1</sub> receptor modulators with a methyl substituent at the 3-position of the phenyl ring (<b>4</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). These compounds were potent functional antagonists at S1P<sub>1</sub> with excellent selectivity over S1P<sub>3</sub>, suggesting that substituents at the 3-postion were tolerated by the receptor. These data gave us the impetus to follow-up on our ligand-based drug design hypothesis for the generation of novel S1P<sub>1</sub> modulators (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). As discussed below, this novel scaffold (<b>5</b>) allowed us to explore the structure–activity relationship (SAR) of the polar head piece, phenyl ring (A), central ring (B), heterocyclic ring (C), and the lipophilic tail piece as outlined in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of tricyclic modulators of S1P<sub>1</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a> outline the synthesis of representative examples of compounds with variations to the phenyl ring, central ring, heterocyclic ring, the lipophilic tail piece, and the polar head piece.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The key step in the synthesis of the bis-isoxazole <b>10</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) is the condensation of dilithiated 1-tetralone oxime with methyl 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylate.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> For optimal yields, LiTMP was the base of choice to affect this condensation; LDA or <i>n</i>-BuLi gave poor yields. In the case of the tricyclic chroman (<b>24</b>), the tetralone oxime route led to intractable mixtures of products during the condensation step. An alternative approach employing oxyamination of a β-diketone with hydroxylamine via an eneamine led to the desired product, albeit in low yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, see transformation <b>18</b> to <b>19</b>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The key step in the synthesis of the regioisomeric isoxazole tailpiece (<b>36</b>) was an intramolecular 1,3-dipolar cycloaddition of a nitrile oxide, which was generated in situ from the oxime precursor <b>32</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The synthesis of the thiazole (<b>47</b>, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) was accomplished in good yield via condensation of the acylamino ketone (<b>41</b>) with Lawesson’s reagent.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) Tf<sub>2</sub>O, Py, 0 °C to RT, 4 h, 94%, (2) tributyl(vinyl)stannane, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 100 °C, 14 h, 80%, (3) NH<sub>2</sub>OH·HCl, NaOAc, MeOH, 80 °C, 1.5 h, 70%; (b) (1) TMS-Cl, DIPEA, THF, 0 °C, (2) LiTMP, THF, methyl 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylate,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> −78 to 0 °C, (3) SOCl<sub>2</sub>, Py, PhMe, RT to 90 °C, 25% for 3 steps; (c) OsO<sub>4</sub>, NMO, THF, overnight then NaIO<sub>4</sub>, H<sub>2</sub>O, 30 min, 100%; (d) (1) <i>tert</i>-butyl azetidine-3-carboxylate, NaBH(OAc)<sub>3</sub>, Ti(OiPr)<sub>4</sub>, MeOH, DCE, 2 h, 79%, (2) TFA, 90%.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-chloropropanoic acid, CF<sub>3</sub>-SO<sub>3</sub>H, 80 °C, 75%; (b) 2 M aq NaOH, 5 °C–RT, 6 M aq H<sub>2</sub>SO<sub>4</sub>, 81%; (c) (CF<sub>3</sub>-SO<sub>2</sub>)<sub>2</sub>O, pyridine, 86%; (d) tributyl(vinyl)stannane, lithium chloride, Pd(PhP)<sub>4</sub>, dioxane, 100 °C, 80%; (e) OsO<sub>4</sub>, NMO, THF, 99%; (f) dimethoxypropane, (1<i>R</i>)-(−)-camphorsulfonic acid, 58%; (g) TiCl<sub>4</sub>, morpholine, toluene, 89%; (h) 3-phenyl-4-(trifluoromethyl)isoxazole-5-carbonyl fluoride,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Et<sub>3</sub>N, CH<sub>3</sub>CN:NH<sub>2</sub>OH-HCl, NaOAc, H<sub>2</sub>O, 45 °C, 17%; (i) SOCl<sub>2</sub>, pyridine, toluene, 62%; (j) TFA, 100%; (k) NaIO<sub>4</sub>, THF, H<sub>2</sub>O; (l) <i>tert</i>-butyl azetidine-3-carboxylate, acetic acid salt, AcOH, titantium(IV) isopropoxide, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 64%; (m) TFA, MeOH slurry crystallization, 99%.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) i-BuOCOCl, <i>N</i>-methylmorpholine, THF, NaBH<sub>4</sub>, THF–MeOH, 63%; (b) Dess–Martin reagent, CH<sub>2</sub>Cl<sub>2</sub>, 99%%; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, THF, 67%; (d) <i>n</i>-BuLi, THF, paraformaldehyde, 63%; (e) PBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 40–60%; (f) 4-bromo-2-hydroxybenzaldehyde, K<sub>2</sub>CO<sub>3</sub>, DMF, >85%; (g) NH<sub>2</sub>OH-HCl, Et<sub>3</sub>N, MeOH, 97%; (h) NaOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 73%; (i) tributyl(vinyl)stannane, lithium chloride, (PhP)<sub>4</sub>Pd, dioxane, 100 °C, 67%; (j) OsO<sub>4</sub>, NMO, THF, NaIO<sub>4</sub>, THF, H<sub>2</sub>O, 95%; (k) <i>tert</i>-butyl azetidine-3-carboxylate, acetic acid salt, AcOH, titantium(IV) isopropoxide, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 58%; (ll) TFA, neutralization, MeOH, slurry crystallization, 65%.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Isomeric Tricyclic S1P<sub>1</sub> Modulator <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, pTsOH, 60 °C, 11 min; (b) NaN<sub>3</sub>, acetone, water, 3 h rt, 69% over two steps; (c) Pd/C, 2 N HCl, MeOH, 50 psi H<sub>2</sub>, rt 4 h, 74%; (d) (1) 3-phenyl-4-trifluoromethyl)isoxazole-5-carboxylic acid,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> oxalyl chloride, DMF, DCM, 0 °C, (2) DMAP, Hunig’s base, DCM, rt overnight, 40%; (e) Lawesson’s reagent, THF, 30 min, 120 °C μ-wave, 60%; (f) BBr<sub>3</sub>, DCM, 6 h, rt, 100%; (g) triflic anhydride, pyridine, 0 °C, 89%; (h) tributyl(vinyl)stannane, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 100 °C, overnight; (i) OsO<sub>4</sub>, NMO, THF, 3 h, rt then NaIO<sub>4</sub>, H<sub>2</sub>O, 90 min, 47% over two steps; (j) (1) azetidine-3-carboxylic acid, AcOH, MeOH, 1,2-dichloroethane, 1 h, 80 °C, (2) NaCNBH<sub>3</sub>, rt, 1 h, 25%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds were evaluated in a functional GTPγS assay for both human S1P<sub>1</sub> and S1P<sub>3</sub> receptor agonism. Compounds with good S1P<sub>1</sub> potency, selectivity over S1P<sub>3</sub>, and acceptable profiles in liability assays (metabolic stability, CYP inhibition, etc.) were initially evaluated in a rat pharmacokinetic/pharmacodynamic (PK/PD) model where rats were dosed orally with the compound. Blood was drawn at the 4 and 24 h time points to measure both circulating lymphocytes relative to control and plasma concentration of each compound. Compounds which showed reduction in circulating lymphocytes at low doses were then evaluated in PK studies and then progressed to chronic efficacy models such as the rat adjuvant arthritis model. The following tables summarize SAR related to the lipophilic tail piece (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), central ring B (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), heterocyclic ring C (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), phenyl ring A (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) as well as the PK/PD properties of these compounds.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Lipophilic Tail Piece SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro activity</th><th class="rowsep1 colsep0" colspan="5" align="center">rat blood lymphocyte reduction assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>1</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>3</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub>/S1P<sub>1</sub> sel</th><th class="colsep0 rowsep0" align="center">reduction at 4 h (%)(1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 4 h (nM)</th><th class="colsep0 rowsep0" align="center">reduction at 24 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 24 h (nM)</th><th class="colsep0 rowsep0" align="center">conc 4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">0.47 ± 0.25</td><td class="colsep0 rowsep0" align="center">1600 ± 320</td><td class="colsep0 rowsep0" align="center">3400×</td><td class="colsep0 rowsep0" align="center">78</td><td class="colsep0 rowsep0" align="center">2100</td><td class="colsep0 rowsep0" align="center">91</td><td class="colsep0 rowsep0" align="center">700</td><td class="colsep0 rowsep0" align="center">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">0.59 ± 0.19</td><td class="colsep0 rowsep0" align="center">4400 ± 330</td><td class="colsep0 rowsep0" align="center">7500×</td><td class="colsep0 rowsep0" align="center">86</td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center">85</td><td class="colsep0 rowsep0" align="center">27</td><td class="colsep0 rowsep0" align="center">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">83 (0.3)</td><td class="colsep0 rowsep0" align="center">55</td><td class="colsep0 rowsep0" align="center">80 (0.3)</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">0.48 ± 0.27</td><td class="colsep0 rowsep0" align="center">1900 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">4000×</td><td class="colsep0 rowsep0" align="center">83</td><td class="colsep0 rowsep0" align="center">160</td><td class="colsep0 rowsep0" align="center">87</td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="center">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">0.58 ± 0.16</td><td class="colsep0 rowsep0" align="center">4600 ± 2900</td><td class="colsep0 rowsep0" align="center">7900×</td><td class="colsep0 rowsep0" align="center">74</td><td class="colsep0 rowsep0" align="center">190</td><td class="colsep0 rowsep0" align="center">69</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="center">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">0.33 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">1400 ± 870</td><td class="colsep0 rowsep0" align="center">4200×</td><td class="colsep0 rowsep0" align="center">82 (0.4)</td><td class="colsep0 rowsep0" align="center">150</td><td class="colsep0 rowsep0" align="center">85 (0.4)</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="center">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">1.0 ± 0.86</td><td class="colsep0 rowsep0" align="center">1300<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1300×</td><td class="colsep0 rowsep0" align="center">82 (0.5)</td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center">69 (0.5)</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="center">1.5<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">>3100<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">>2100×</td><td class="colsep0 rowsep0" align="center">86</td><td class="colsep0 rowsep0" align="center">520</td><td class="colsep0 rowsep0" align="center">80</td><td class="colsep0 rowsep0" align="center">61</td><td class="colsep0 rowsep0" align="center">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="center">1.3<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1,300<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1000×</td><td class="colsep0 rowsep0" align="center">85</td><td class="colsep0 rowsep0" align="center">190</td><td class="colsep0 rowsep0" align="center">34</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="center">1.5 ± 1.5</td><td class="colsep0 rowsep0" align="center">26,000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">17000×</td><td class="colsep0 rowsep0" align="center">57</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center">4.6 ± 2.6</td><td class="colsep0 rowsep0" align="center">>63000 ± 25000</td><td class="colsep0 rowsep0" align="center">>14000×</td><td class="colsep0 rowsep0" align="center">–5</td><td class="colsep0 rowsep0" align="center"><LLQ</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center"><LLQ</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="center">24<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">11000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">460×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="center">1.3 ± 1.0</td><td class="colsep0 rowsep0" align="center">2800<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">2200×</td><td class="colsep0 rowsep0" align="center">74</td><td class="colsep0 rowsep0" align="center">110</td><td class="colsep0 rowsep0" align="center">76</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="center">0.98 ± 0.29</td><td class="colsep0 rowsep0" align="center">2100 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">2100×</td><td class="colsep0 rowsep0" align="center">35 (0.5)</td><td class="colsep0 rowsep0" align="center">68</td><td class="colsep0 rowsep0" align="center">32 (0.5)</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="center">310 ± 32</td><td class="colsep0 rowsep0" align="center">>63000 ± 30000</td><td class="colsep0 rowsep0" align="center">>200×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="center">1.6 ± 1.4</td><td class="colsep0 rowsep0" align="center">14000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">8800×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">EC<sub>50</sub> values are shown as a single determination. ND = not determined.</p></div></div></div><div class="NLM_p">As expected, on the basis of our earlier effort,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> lipophilic groups are well tolerated in this region of the receptor, leading to potent functional antagonists of S1P<sub>1</sub>. Within this group, however, both isomeric isoxazoles (<b>10</b> and <b>48</b>) and isothiazoles (<b>49</b> and <b>50</b>) exhibited picomolar potencies for S1P<sub>1</sub> in the GTPγS assay with good selectivity against S1P<sub>3</sub>. It is also interesting to note the SAR trends in the five-membered heteroaryl vs the phenyl analogues, for example, a CF<sub>3</sub> group on the five-membered heteroaryl ring, which is adjacent to the carbon atom anchoring the tricyclic group (R, in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), led to very potent functional antagonism at S1P<sub>1</sub>. In the case of the phenyl analogues, however, ortho substitution of the CF<sub>3</sub> group to the R group led to a relative loss in potency at S1P<sub>1</sub> in the functional assay (compare compound <b>52</b>, <b>57</b>, and <b>54</b> with <b>56</b>). Potency is regained when the CF<sub>3</sub> group is moved to the meta position in relation to the R group (compare <b>56</b> and <b>54</b>). It is also important to note that lipophilic moieties at the para position of the phenyl ring are critical in imparting functional potency at S1P<sub>1</sub>; the data for <b>59</b> is consistent with this SAR. Although subtle SAR trends described above are difficult to explain from a functional potency perspective, it is quite possible that optimal occupancy of the lipophilic pocket and the dihedral angle between the R group and the lipophilic tail piece may be important factors contributing to the modest potency differences observed in this region of the molecule. Because a number of compounds in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> showed excellent functional potency for S1P<sub>1</sub> while maintaining selectivity for S1P<sub>3,</sub> they were advanced to the rat blood lymphocyte reduction (BLR) pharmacokinetic/pharmacodynamic (PK/PD) model. Compounds with the isoxazole and isothiazole tail pieces showed sustained PD effects at 24 h at low plasma concentrations: see for example, data for <b>50</b>, <b>48</b>, and <b>10</b> in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. Because we had a good understanding of the liability profile of the isoxazoles compared to the isothiazoles based on our earlier work,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the isoxazoles (<b>48</b> and <b>10</b>) were determined to be the optimized lipophilic tail pieces for exploring SAR of the rest of the tricyclic scaffold.</div><div class="NLM_p"><a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> summarizes SAR of the central ring B. Of the carbocyclic analogues examined, the six membered ring (<b>10</b>, <b>48</b>) was optimal; the five-membered analogue (<b>61</b>) was approximately an order of magnitude less potent in the S1P<sub>1</sub> GTPγS assay. Comparing the six- and seven-membered analogues (<b>62</b> vs <b>63</b>), the six membered analogue was significantly more potent. This data was also consistent with the data for the seven-membered oxepane analogue <b>65</b>. The significant loss in potency for the seven-membered analogues compared to the five- and six-membered compounds supports our initial hypothesis about the importance of maintaining planarity between the phenyl group (which anchors the polar headpiece) and the central heterocyclic ring for optimal potency and selectivity for the S1P<sub>1</sub> receptor. Of the heterocyclic rings examined, the pyran analogues (<b>24</b> and <b>36</b>) were equipotent to the carbocyclic analogues (<b>10</b> and <b>48</b>) in the S1P<sub>1</sub> GTPγS assay. Because both <b>24</b> and <b>36</b> were about equipotent in the S1P<sub>1</sub> GTPγS assay, we tested them in the rat BLR assay for further progression. As outlined in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, both analogues were efficacious in reducing lymphocyte count at very low doses, and these reductions were similar to what was observed with the carbocyclic analogue <b>10</b>. We decided to use the carbocyclic analogue <b>10</b> for further analoguing because the synthetic feasibility of exploring SAR appeared to be easier with this compound compared to pyrans <b>24</b> and <b>36</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the Central Ring, B</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro activity</th><th class="rowsep1 colsep0" colspan="5" align="center">rat blood lymphocyte reduction assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>1</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>3</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub>/S1P<sub>1</sub> sel</th><th class="colsep0 rowsep0" align="center">reduction at 4 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 4 h (nM)</th><th class="colsep0 rowsep0" align="center">reduction at 24 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 24 h (nM)</th><th class="colsep0 rowsep0" align="center" char=".">4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">0.59 ± 0.19</td><td class="colsep0 rowsep0" align="center">4400 ± 330</td><td class="colsep0 rowsep0" align="center">7500×</td><td class="colsep0 rowsep0" align="center">83 (0.3)</td><td class="colsep0 rowsep0" align="center">55</td><td class="colsep0 rowsep0" align="center">80 (0.3)</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="center">6.8 ± 1.4</td><td class="colsep0 rowsep0" align="center">32000<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">4700×</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center"><LLQ</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="center">1.3 ± 0.37</td><td class="colsep0 rowsep0" align="center">4400<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">3400×</td><td class="colsep0 rowsep0" align="center">81</td><td class="colsep0 rowsep0" align="center">200</td><td class="colsep0 rowsep0" align="center">85</td><td class="colsep0 rowsep0" align="center">46</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">66 (0.3)</td><td class="colsep0 rowsep0" align="center">34</td><td class="colsep0 rowsep0" align="center">79 (0.3)</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="center">31 ± 23</td><td class="colsep0 rowsep0" align="center">12000 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">390×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="center">0.25 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">>31000 ± 15000</td><td class="colsep0 rowsep0" align="center">>120000×</td><td class="colsep0 rowsep0" align="center">82 (0.5)</td><td class="colsep0 rowsep0" align="center">330</td><td class="colsep0 rowsep0" align="center">89 (0.5)</td><td class="colsep0 rowsep0" align="center">56</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="center">0.27 ± 0.18</td><td class="colsep0 rowsep0" align="center">1200 ± 1,300</td><td class="colsep0 rowsep0" align="center">4400×</td><td class="colsep0 rowsep0" align="center">87 (0.5)</td><td class="colsep0 rowsep0" align="center">230</td><td class="colsep0 rowsep0" align="center">93 (0.5)</td><td class="colsep0 rowsep0" align="center">46</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="center">1.6 ± 0.32</td><td class="colsep0 rowsep0" align="center">>63000 ± 31000</td><td class="colsep0 rowsep0" align="center">>39000×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="center">33<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1600<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">48×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">EC<sub>50</sub> values are shown as a single determination; ND = not determined.</p></div></div></div><div class="NLM_p"><a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> summarizes the SAR of the heterocyclic ring C, (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). It is clear from <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> that of the various heterocyclic rings examined, the [1,2-<i>c</i>]isoxazole (<b>10</b>) is the most potent in the S1P<sub>1</sub> GTPγS assay. It is of interest to note that the isomeric [2,1-<i>d</i>]oxazole (<b>69</b>) is an order of magnitude less potent vs S1P<sub>1</sub> in the GTPγS assay compared to compound <b>10</b>. Additionally, in the rat BLR PK/PD assay compound <b>69</b> was significantly less efficacious in reducing lymphocyte counts through 24 h compared to the isoxazole (<b>10</b>). On the contrary, the thiazole analogue <b>47</b>, which is similar in potency to <b>69</b> in the S1P<sub>1</sub> GTPγS assay, was highly efficacious in reducing lymphocyte counts in the rat BLR assay. This is likely due to the higher plasma concentration of <b>47</b> compared to <b>69</b> at the 24 h time point.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of the Heterocyclic Ring, C</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro activity</th><th class="rowsep1 colsep0" colspan="5" align="center">rat blood lymphocyte reduction assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>1</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>3</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub>/S1P<sub>1</sub> sel</th><th class="colsep0 rowsep0" align="center">reduction at 4 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 4 h (nM)</th><th class="colsep0 rowsep0" align="center">reduction at 24 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 24 h (nM)</th><th class="colsep0 rowsep0" align="center" char=".">4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">0.59 ± 0.19</td><td class="colsep0 rowsep0" align="center">4400 ± 330</td><td class="colsep0 rowsep0" align="center">7500×</td><td class="colsep0 rowsep0" align="center">83 (0.3)</td><td class="colsep0 rowsep0" align="center">55</td><td class="colsep0 rowsep0" align="center">80 (0.3)</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="center">190 ± 23</td><td class="colsep0 rowsep0" align="center">>63000 ± 30000</td><td class="colsep0 rowsep0" align="center">>330×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="center">380 ± 150</td><td class="colsep0 rowsep0" align="center">>63000 ± 30000</td><td class="colsep0 rowsep0" align="center">>170×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="center">21 ± 16</td><td class="colsep0 rowsep0" align="center">>63000 ± 35000</td><td class="colsep0 rowsep0" align="center">>3000×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="center">5.5 ± 3.6</td><td class="colsep0 rowsep0" align="center">920<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">170×</td><td class="colsep0 rowsep0" align="center">62</td><td class="colsep0 rowsep0" align="center">110</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">2.4 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">12000<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">5000×</td><td class="colsep0 rowsep0" align="center">80</td><td class="colsep0 rowsep0" align="center">230</td><td class="colsep0 rowsep0" align="center">85</td><td class="colsep0 rowsep0" align="center">84</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">EC<sub>50</sub> values are shown as a single determination; ND = not determined.</p></div></div></div><div class="NLM_p">Although we did not do exhaustive SAR studies on the aryl ring (A, in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), the limited SAR work suggested that the phenyl analogue (<b>10</b>) provided the best balance of S1P<sub>1</sub> potency vs selectivity for S1P<sub>3</sub> in the GTPγS assay (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Ring A</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0011.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro activity</th><th class="rowsep1 colsep0" colspan="5" align="center">rat blood lymphocyte reduction assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>1</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>3</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub>/S1P<sub>1</sub> sel</th><th class="colsep0 rowsep0" align="center">reduction at 4 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center" char=".">plasma conc at 4 h (nM)</th><th class="colsep0 rowsep0" align="center">reduction at 24 (%) h (1.0 mpk)</th><th class="colsep0 rowsep0" align="center" char=".">plasma conc at 24 h (nM)</th><th class="colsep0 rowsep0" align="center" char=".">4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">0.59 ± 0.19</td><td class="colsep0 rowsep0" align="center">4400 ± 330</td><td class="colsep0 rowsep0" align="center">7500×</td><td class="colsep0 rowsep0" align="center">83 (0.3)</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="center">80 (0.3)</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="center">0.87<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1200<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1400×</td><td class="colsep0 rowsep0" align="center">85</td><td class="colsep0 rowsep0" align="char" char=".">190</td><td class="colsep0 rowsep0" align="center">34</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="center">1.6 ± 0.32</td><td class="colsep0 rowsep0" align="center">15000<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">9400×</td><td class="colsep0 rowsep0" align="center">74 (0.5)</td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="center">79 (0.5)</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="center">17<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">>63000 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">>3700×</td><td class="colsep0 rowsep0" align="center">76</td><td class="colsep0 rowsep0" align="char" char=".">460</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">EC<sub>50</sub> values are shown as a single determination; ND = not determined.</p></div></div></div><div class="NLM_p">Because we have shown that the azetidine carboxylic acid head piece can be replaced by an ethanolamine group,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> we decided to explore this SAR along with other polar moieties in the tricylic chemotype (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of Polar Head Piece</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0012.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro activity</th><th class="rowsep1 colsep0" colspan="5" align="center">rat blood lymphocyte reduction assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>1</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>3</sub> GTPγS EC<sub>50</sub> nM<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub>/S1P<sub>1</sub> sel</th><th class="colsep0 rowsep0" align="center">reduction at 4 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 4 h (nM)</th><th class="colsep0 rowsep0" align="center">reduction at 24 h (%) (1.0 mpk)</th><th class="colsep0 rowsep0" align="center">plasma conc at 24 h (nM)</th><th class="colsep0 rowsep0" align="center" char=".">4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">0.59 ± 0.19</td><td class="colsep0 rowsep0" align="center">4400 ± 330</td><td class="colsep0 rowsep0" align="center">7500×</td><td class="colsep0 rowsep0" align="center">83 (0.3)</td><td class="colsep0 rowsep0" align="center">55</td><td class="colsep0 rowsep0" align="center">80 (0.3)</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="center">4.0 ± 1.9</td><td class="colsep0 rowsep0" align="center">7400<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1900×</td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="center">190</td><td class="colsep0 rowsep0" align="center">72</td><td class="colsep0 rowsep0" align="center">160</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="center">0.33 ± 0.20</td><td class="colsep0 rowsep0" align="center">1700 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">5200×</td><td class="colsep0 rowsep0" align="center">81</td><td class="colsep0 rowsep0" align="center">280</td><td class="colsep0 rowsep0" align="center">87</td><td class="colsep0 rowsep0" align="center">77</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">70 (0.3)</td><td class="colsep0 rowsep0" align="center">93</td><td class="colsep0 rowsep0" align="center">78 (0.3)</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="center">0.21 ± 0.045</td><td class="colsep0 rowsep0" align="center">13000 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="center">62000×</td><td class="colsep0 rowsep0" align="center">76</td><td class="colsep0 rowsep0" align="center">140</td><td class="colsep0 rowsep0" align="center">76</td><td class="colsep0 rowsep0" align="center">49</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="center">26 ± 7.8</td><td class="colsep0 rowsep0" align="center">16000<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">620×</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="center">140</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="center">200 ± 89</td><td class="colsep0 rowsep0" align="center">18000<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">90×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="center">1.6 ± 0.58</td><td class="colsep0 rowsep0" align="center">6200<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">3900×</td><td class="colsep0 rowsep0" align="center">50 (0.5)</td><td class="colsep0 rowsep0" align="center">190</td><td class="colsep0 rowsep0" align="center">43 (0.5)</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="center">51 ± 9.0</td><td class="colsep0 rowsep0" align="center">23000<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">450×</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">EC<sub>50</sub> values are shown as a single determination. ND = not determined.</p></div></div></div><div class="NLM_p">As is evident from <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, ethanolamines such as <b>74</b> and <b>75</b> and α-hydroxy amides such as <b>78</b> showed potencies comparable to compound <b>10</b> in the S1P<sub>1</sub> GTPγS assay while showing good selectivity for S1P<sub>3</sub>. It is interesting to note that chirality at the carbon anchoring the hydroxy group is important in determining potency and selectivity for S1P<sub>1</sub> in both the ethanolamine and the α-hydroxy amide series (the absolute configuration of the isomers <b>73</b>–<b>78</b> was not established in this series).</div><div class="NLM_p">It is clear from the discussion above, that a number of compounds show excellent lymphopenia at low doses in the rat BLR assay. However, compound <b>10</b> remained one of the lead compounds in terms of showing a sustained PD response at very low doses (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), with an ED<sub>50</sub> of 0.05 mg/kg (EC<sub>50</sub> = 2.5 ± 0.8 nM) in addition to displaying an excellent liability profile (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Moreover, the PK profile of the compound across species (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>) was very promising (low clearance, moderate to high bioavailability, and volumes of distribution) and the compound was advanced to the rat adjuvant arthritis (AA) model, a preclinical model of rheumatoid arthritis. The rationale for testing compound <b>10</b> in a rat AA model is as follows. While the current market approval for Gilenya, an S1P<sub>1</sub> agonist, is for RRMS, S1P<sub>1</sub> agonists have been or are currently being clinically evaluated for a wide range of autoimmune disorders (psoriasis, ulcerative colitis, Crohn’s disease, organ transplant, lupus). At the time of these investigations, arthritis was of primary interest for this program.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat lymphocyte reduction of compound <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Partial in Vitro Profiling Data for Compound <b>10</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>1</sub> binding (IC<sub>50</sub>) (nM)</td><td class="colsep0 rowsep0" align="left">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>1</sub> GTPγS EC<sub>50</sub> (<i>Y</i><sub>max</sub>) (nM)</td><td class="colsep0 rowsep0" align="left">0.59 (95%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>1</sub> cAMP EC<sub>50</sub> (<i>Y</i><sub>max</sub>) (nM)</td><td class="colsep0 rowsep0" align="left">0.032 (93%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>3</sub>/S1P<sub>1</sub> selectivity</td><td class="colsep0 rowsep0" align="left">7500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>4</sub>/S1P<sub>1</sub> selectivity</td><td class="colsep0 rowsep0" align="left">2.4×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</td><td class="colsep0 rowsep0" align="left">2.4×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat S1P<sub>1</sub> GTPγS (EC<sub>50</sub>) (nM)</td><td class="colsep0 rowsep0" align="left">0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat S1P<sub>3</sub>/S1P<sub>1</sub> selectivity</td><td class="colsep0 rowsep0" align="left">6100×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein binding (bound)</td><td class="colsep0 rowsep0" align="left">99.6% human</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.3% mouse</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.6% rat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.5% dog</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.5% monkey</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG (patch clamp)</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 2 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sup>+</sup> (patch clamp)</td><td class="colsep0 rowsep0" align="left">12% @ 10 μM (1 and 4 Hz)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ca<sup>+</sup> (patch clamp)</td><td class="colsep0 rowsep0" align="left">11% @ 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PXR TransAct, EC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> inhibition (IC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="left">>40 μM 1A2, 2B6, 2C9, 2C19, 2D6, 3A4-BZR = 14 μM 2C8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">PAMPA permeability (nm/s)</td><td class="colsep0 rowsep0" align="left">280 @ pH 7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">260 @ pH 5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">met stab, <i>T</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">>120 min (h, m, r, d, mk)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">CYP = cytochrome P450.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Parameters for Compound <b>10</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">mouse<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cyno<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">dog<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po dose (mg/kg)</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv dose (mg/kg)</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="center">3.6</td><td class="colsep0 rowsep0" align="center">0.14</td><td class="colsep0 rowsep0" align="center">0.41</td><td class="colsep0 rowsep0" align="center">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μM·h) PO</td><td class="colsep0 rowsep0" align="center">30.3</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">3.4</td><td class="colsep0 rowsep0" align="center">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">7.9</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">23.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">8.5</td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="center">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="center">2.2</td><td class="colsep0 rowsep0" align="center">4.8</td><td class="colsep0 rowsep0" align="center">3.6</td><td class="colsep0 rowsep0" align="center">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub> (%)</td><td class="colsep0 rowsep0" align="center">80</td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="center">80</td><td class="colsep0 rowsep0" align="center">95</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Average of three animals.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Cynomologus monkey.</p></div></div></div><div class="NLM_p">Arthritis was induced in male Lewis rats by a subcutaneous injection of complete Freund’s adjuvant at the base of the tail. Compound <b>10</b> was dosed orally (PO), once a day (QD), for 21 days at 0.03, 0.1, and 1.0 mg/kg. Dexamethasone served as the positive control in the study and was dosed at 0.1 mg/kg PO/QD. Paw volumes (day 7 to day 21) were measured using water displacement plethysmometry. As is evident from <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, a dose of 0.03 mg/kg had little impact on disease development. However, a dose of 0.1 mg/kg provided >50% suppression of paw swelling, and the higher dose of 1 mg/kg resulted in robust inhibition equivalent to the positive control dexamethasone. On the basis of the suppression of paw swelling observed in this study, the ED<sub>50</sub> for compound <b>10</b> was determined to be 0.09 mg/kg (EC<sub>50</sub> = 24 nM), which is comparable to other S1P<sub>1</sub> modulators disclosed in the literature.<a onclick="showRef(event, 'ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref23">(16, 23)</a></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Rat adjuvant arthritis study of compound <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a series of tricyclic S1P<sub>1</sub> receptor agonists with selectivity over S1P<sub>3</sub> have been identified employing a ligand-based drug design approach. SAR in this series suggested that (a) a number of lipophilic tail pieces are tolerated, (b) the azetidine carboxylic acid (<b>10</b>) and the hydroxy nipecotic acid (<b>74</b> and <b>75</b>) are optimal head pieces, (c) six-membered carbocylic and pyran rings are optimal central rings, and (d) [1,2-<i>c</i>]isoxazole is the preferred heteroaromatic ring. On the basis of the extensive SAR carried out, compound <b>10</b> was identified as having the optimal properties in terms of potency for S1P<sub>1</sub>, selectivity vs S1P<sub>3</sub> with an excellent liability profile. This compound showed sustained pharmacodynamic effects in a rat blood lymphocyte reduction assay and efficacy in a rat adjuvant arthritis model, with an ED<sub>50</sub> comparable to reported S1P<sub>1</sub> modulators. Based on this favorable profile, compound <b>10</b> was further evaluated for suitability as a clinical development candidate.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All commercially available chemicals and solvents were used without further purification. Reactions were performed under an atmosphere of nitrogen. All new compounds gave satisfactory <sup>1</sup>H NMR, LC/MS, and/or HRMS, and mass spectrometry results. <sup>1</sup>H NMR spectra were obtained on a Bruker 400 MHz or a JEOL 500 MHz NMR spectrometer using the residual TMS signal of deuterated NMR solvent as internal reference. Electrospray ionization (ESI) mass spectra were obtained on a Waters ZQ single quadrupole mass spectrometer. All MS measurements were made on open access systems. The purity of tested compounds determined by analytical HPLC was >95%. HPLC methods are listed below:</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Method A</h3><div class="NLM_p last">A linear gradient using 5% acetonitrile, 95% water, and 0.05% TFA (solvent A) and 95% acetonitrile, 5% water, and 0.05% TFA (solvent B); <i>t</i> = 0 min, 10% B, <i>t</i> = 15 min, 100% B (20 min) was employed on a SunFire C18 3.5 μ 3.0 mm × 150 mm column. Flow rate was 1.0 mL/min, and UV detection was set to 220/254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Method B</h3><div class="NLM_p last">A linear gradient using 5% acetonitrile, 95% water, and 0.05% TFA (solvent A) and 95% acetonitrile, 5% water, and 0.05% TFA (solvent B); <i>t</i> = 0 min, 10% B, <i>t</i> = 15 min, 100% B (20 min) was employed on a XBridge Ph 3.5 μ 3.0 mm × 150 mm column. Flow rate was 1.0 mL/min, and UV detection was set to 220/254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Method C</h3><div class="NLM_p last">A linear gradient using 10% methanol, 90% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent A) and 90% methanol, 10% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent B); <i>t</i> = 0 min, 0% B, <i>t</i> = 4 min, 100% B (5 min) was employed on a YMC S5 CombiScreen 4.6 mm × 50 mm column. Flow rate was 4.0 mL/min, and UV detection was set to 220 or 254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Method D</h3><div class="NLM_p last">A linear gradient using 10% methanol, 90% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent A) and 90% methanol, 10% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent B); <i>t</i> = 0 min, 0% B, <i>t</i> = 4 min, 100% B (5 min) was employed on a Chromolith SpeedROD 4.6 mm × 50 mm column. Flow rate was 4.0 mL/min, and UV detection was set to 220 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 6-Vinyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one oxime (<b>7</b>)</h3><div class="NLM_p">To a solution of 6-hydroxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one (2 g, 12.33 mmol) in anhydrous pyridine (10 mL) was added trifluoromethanesulfonic anhydride (2.5 mL, 14.80 mmol) at 0 °C over a period of 5 min. The reaction mixture was allowed to come to room temperature and stirred at room temperature for 4 h. The reaction mixture was concentrated under reduced pressure. The resulting brownish-red residue was partitioned between ether (60 mL) and water (30 mL). The ether layer was sequentially washed with 1N hydrochloric acid (20 mL), satd aq NaHCO<sub>3</sub> (20 mL), and brine (20 mL), dried over sodium sulfate, concentrated, and purified by silica gel column chromatography using hexane/ethyl acetate to yield 5-oxo-5,6,7,8-tetrahydronaphthalen-2-yl trifluoromethanesulfonate (3.4 g, 11.55 mmol, 94% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.14 (1 H, d, <i>J</i> = 8.4 Hz), 7.17–7.24 (2 H, m), 3.02 (2 H, t, <i>J</i> = 6.1 Hz), 2.69 (2 H, t, <i>J</i> = 6.5 Hz), 2.15–2.22 (2 H, m).</div><div class="NLM_p">To a solution of 5-oxo-5,6,7,8-tetrahydronaphthalen-2-yl-trifluoromethanesulfonate (3.4 g, 11.55 mmol) in anhydrous dioxane was sequentially added tributyl(vinyl)stannane (3.73 mL, 12.71 mmol), lithium chloride (1.470 g, 34.7 mmol), and tetrakis(triphenylphosphine)palladium(0) (1.335 g, 1.155 mmol). The reaction mixture was purged with nitrogen gas for 5 min and heated at 100 °C for 14 h. The reaction mixture was cooled to room temperature and filtered. The yellow residue was washed with ethyl acetate (3 × 20 mL). The filtrate was concentrated under reduced pressure. To the red oil was added ether (50 mL), and the contents were stirred at room temperature for 15 min. The contents were filtered, and the resulting brick-red residue was washed with ether (3 × 20 mL). The filtrate was concentrated under reduced pressure, and the resulting red oil was purified by silica gel column chromatography using hexane/ethyl acetate to yield 6-vinyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one (1.6 g, 9.29 mmol, 80% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.00 (d, <i>J</i> = 8.14 Hz, 1 H), 7.36 (dd, <i>J</i> = 8.14, 1.10 Hz, 1 H), 7.26 (s, 1 H), 6.72 (dd, <i>J</i> = 17.61, 11.00 Hz, 1 H), 5.87 (dd, <i>J</i> = 17.61, 0.66 Hz, 1 H), 5.37–5.41 (m, 1 H), 2.96 (t, <i>J</i> = 6.05 Hz, 2 H), 2.63–2.67 (m, 2 H), 2.10–2.17 (m, 2 H).</div><div class="NLM_p last">To 6-vinyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one (1.6 g, 9.29 mmol) in methanol (10 mL) was sequentially added hydroxylamine hydrochloride (0.775 g, 11.15 mmol) and sodium acetate (0.915 g, 11.15 mmol). The reaction mixture was heated at 80 °C (oil bath temp) for 1.5 h. The reaction mixture was concentrated under reduced pressure, and to the residue was added water (30 mL). The contents were triturated and filtered. The solid material was washed with water (2 × 20 mL) and dried overnight to yield 6-vinyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one oxime (1.2 g, 6.41 mmol, 69.0% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.23 (br s, 1 H), 7.85 (d, <i>J</i> = 8.14 Hz, 1 H), 7.28 (s, 1 H), 7.18 (s, 1 H), 6.69 (dd, <i>J</i> = 17.61, 10.78 Hz, 1 H), 5.78 (dd, <i>J</i> = 17.61, 0.88 Hz, 1 H), 5.23–5.32 (m, 1 H), 2.71–2.87 (m, 4 H), 1.81–1.94 (m, 2 H).</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-7-vinyl-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazole (<b>8</b>)</h3><div class="NLM_p">Preparation of LiTMP: To a stirred solution of 2,2,6,6-tetramethylpiperidine (10.88 mL, 64.5 mmol) in anhydrous THF (25 mL) was added <i>n</i>-BuLi (25.8 mL, 64.5 mmol) (2.5 M in hexanes) dropwise at 0 °C under nitrogen. The pale-yellow solution was then stirred at the same temperature for 20 min.</div><div class="NLM_p">To a stirred solution of 6-vinyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one oxime (<b>7</b>, 4.03 g, 21.50 mmol) and diisopropylethylamine (6.83 mL, 39.1 mmol) in anhydrous THF (50 mL) was added TMS-Cl (2.75 mL, 21.50 mmol) dropwise at 0 °C under nitrogen. The mixture was stirred at 0 °C for 30 min. The previously prepared LiTMP solution was added dropwise at −78 °C under nitrogen. After the mixture was stirred at the same temperature for 30 min, a solution of methyl 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylate<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (5.3 g, 19.54 mmol) in anhydrous THF (10 mL) was added dropwise at −78 °C. The solution was stirred at −78 °C for 30 min and then warmed to 0 °C over 30 min. The reaction was quenched with saturated aqueous ammonium chloride solution (25 mL) and water (20 mL). EtOAc (50 mL) was added and contents stirred at room temperature for 30 min and filtered through a pad of Celite. The filtrate was separated. The aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic solutions were washed with brine (50 mL), dried over sodium sulfate, and concentrated to give a liquid. Flash chromatography purification (330 g silica gel column, 15–30% ethyl acetate in hexanes) afforded 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-7-vinyl-3,3a,4,5-tetrahydronaphtho[1,2-<i>c</i>]isoxazol-3-ol (5 g, 11.73 mmol, 60.0% yield). The compound had an HPLC retention time = 3.74 min (condition C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>18</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 427.13, found 426.9.</div><div class="NLM_p last">The 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-7-vinyl-3,3a,4,5-tetrahydronaphtho[1,2-<i>c</i>]isoxazol-3-ol (5 g, 11.73 mmol) was mixed with thionyl chloride (1.712 mL, 23.45 mmol) and anhydrous toluene (80 mL). Pyridine (0.190 mL, 2.345 mmol) was then added dropwise. The mixture was stirred under nitrogen at room temperature for 30 min and 90 °C for 15 min. The mixture was concentrated under reduced pressure. The residue was mixed with saturated aqueous sodium bicarbonate solution (50 mL) and extracted with dichloromethane (100 mL, 2 × 50 mL). The combined dichloromethane extracts were dried over sodium sulfate, filtered through a pad of silica gel, and concentrated under reduced pressure. Flash chromatography purification (220g silica gel column, 25 → 60% dichloromethane in hexanes) and trituration with methanol gave 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-7-vinyl-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazole (1.96 g, 4.80 mmol, 40.9% yield). The compound had an HPLC retention time = 4.28 min (condition C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>16</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 409.12, found 408.9.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho [1,2-<i>c</i>]isoxazole-7-carbaldehyde (<b>9</b>)</h3><div class="NLM_p last">To a stirred mixture of 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-7-vinyl-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazole (1.96 g, 4.80 mmol) and THF (20 mL) were added NMO (50% in water, 1.493 mL, 7.20 mmol) and osmium tetroxide (4% in water, 1.173 mL, 0.192 mmol) at room temperature. The mixture was vigorously stirred at room temperature overnight. A solution of sodium periodate (1.540 g, 7.20 mmol) in water (10 mL) was added. The mixture was stirred at room temperature under nitrogen for 30 min. Water (20 mL) was then added. The solid was filtered, washed with water (2 × 5 mL) and ethanol (2 mL), and dried to give 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazole-7-carbaldehyde (1.92 g, 4.68 mmol, 98%). The compound had an HPLC retention time = 3.95 min (condition C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>14</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 411.10, found 410.9.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-((3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>10</b>)</h3><div class="NLM_p">To a stirred solution of 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazole-7-carbaldehyde (2.1 g, 5.12 mmol), <i>tert</i>-butyl azetidine-3-carboxylate, AcOH (1.668 g, 7.68 mmol), and acetic acid (0.586 mL, 10.24 mmol) in anhydrous MeOH (10 mL) and anhydrous 1,2-dichloroethane (30 mL) was added titanium(IV) isopropoxide (3.05 mL, 10.24 mmol) dropwise at room temperature under nitrogen. The solution was stirred at room temperature for 1 h before sodium triacetoxyborohydride (4.34 g, 20.47 mmol) was added in 10 portions over 3.5 h. The mixture was stirred at room temperature for 2 h. Saturated sodium bicarbonate (70 mL) was added slowly to make the reaction mixture basic. Celite was added, and the contents were stirred at room temperature for 30 min and then filtered through a pad of Celite. The aqueous filtrate was separated and extracted with dichloromethane (3 × 20 mL). The combined organic solutions were dried (sodium sulfate) and concentrated. Flash chromatography purification (120g silica gel column, 25 → 70% ethyl acetate in hexanes) afforded <i>tert</i>-butyl 1-((3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl) azetidine-3-carboxylate (2.24 g, 4.06 mmol, 79% yield). The compound had an HPLC retention time =3.40 min (condition C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>29</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 552.21, found 552.1.</div><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 1-((3-(3-phenyl-4-(trifluoromethyl) isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylate (2.24 g, 4.06 mmol) in dichloromethane (4 mL) was added TFA (4 mL) slowly at room temperature. The reaction mixture was stirred at room temperature for 2 h. The mixture was concentrated to remove dichloromethane, and TFA (6 mL) was added. The mixture was stirred at room temperature until the starting material disappeared. Dichloroethane (6 mL) was added, and the reaction mixture was concentrated under reduced pressure. The residue was mixed with water (10 mL), made basic (pH ∼ 8) with 1 N aqueous NaOH, and acidified with 1N aqueous HCl to pH ∼ 5. The mixture was sonicated for 30 min. The solid was filtered and washed with water (4 × 10 mL). The residue was mixed with methanol (40 mL), sonicated for 30 min, filtered, washed with methanol (3 × 10 mL), and dried to give 1-((3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl) azetidine-3-carboxylic acid. HPLC <i>t</i><sub>r</sub> = 7.62 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 496.15, found 496.0. <sup>1</sup>H NMR (500 MHz, DMSO) δ ppm 7.85 (1 H, d, <i>J</i> = 7.90 Hz), 7.64–7.68 (2 H, m), 7.57–7.65 (3 H, m), 7.37 (1 H, s), 7.33 (1 H, d), 3.60 (2 H, s), 3.42 (2 H, br s), 3.23 (3 H, br s), 3.10 (2 H, d, <i>J</i> = 6.41 Hz), 3.05 (2 H, d, <i>J</i> = 6.41 Hz).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-Chloro-1-(2,4-dihydroxyphenyl)propan-1-one (<b>12</b>)</h3><div class="NLM_p last">To a stirred mixture of resorcinol (10 g, 91 mmol) and 3-chloropropanoic acid (9.95 g, 92 mmol) was added trifluoromethanesulfonic acid (50 g, 333 mmol) in one portion. The solution was heated at 80 °C for 30 min, cooled to room temperature over 15 min, and poured into dichloromethane (200 mL). The resulting solution was slowly poured into water (200 mL), and the layers were separated. The aqueous layer was extracted with dichloromethane (2 × 100 mL). The combined organic solutions were dried over anhydrous sodium sulfate and filtered. Concentration under reduced pressure afforded 3-chloro-1-(2,4-dihydroxyphenyl)propan-1-one (13.62 g, 67.9 mmol, 74.8% yield) as an orange semisolid. The compound was used without any further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 12.39 (1H, s), 7.56 (1H, d, <i>J</i> = 8.58 Hz), 7.19 (1H, s), 6.17–6.49 (1H, m), 5.23 (1H, s), 3.78–4.01 (2H, m), and 3.34 (2H, t, <i>J</i> = 6.71 Hz).</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 7-Hydroxychroman-4-one (<b>13</b>)</h3><div class="NLM_p last">To a stirred 2 M solution of sodium hydroxide (500 mL, 1000 mmol) at 5 °C was added 3-chloro-1-(2,4-dihydroxyphenyl)propan-1-one (13.6 g, 67.9 mmol) in one portion. The solution was warmed to room temperature over 2 h, recooled to 5 °C, and the pH was adjusted to ∼2 with 6 M aqueous sulfuric acid (∼50 mL). The orange precipitate formed was collected by vacuum filtration and dried under reduced pressure. The filtrate was extracted with ethyl acetate (3 × 100 mL), washed with brine, and dried over anhydrous sodium sulfate. Concentration under reduced pressure gave an orange solid. The two recovered solids were combined to give 7-hydroxychroman-4-one (9.0 g, 54.8 mmol, 81% yield). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>8</sub>O<sub>3</sub> [M + H]<sup>+</sup> 165.1, found 165.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.77 (1H, d, <i>J</i> = 8.58 Hz), 6.45 (1H, dd, <i>J</i> = 8.69, 2.31 Hz), 6.33 (1H, d, <i>J</i> = 2.42 Hz), 5.62 (1H, br s), 4.33–4.66 (2H, m), and 2.58–2.90 (2H, m).</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-Oxochroman-7-yl trifluoromethanesulfonate (<b>14</b>)</h3><div class="NLM_p last">To a solution of 7-hydroxychroman-4-one (2.024 g, 12.3 mmol) in pyridine (10 mL) at 0 °C was added trifluoromethanesulfonic anhydride (2.500 mL, 14.8 mmol) over 5 min. The ice-bath was removed, and the reaction mixture was stirred at room temperature for 2.5 h. Pyridine was removed under reduced pressure, and the residue was diluted with ether (70 mL) and washed with water (30 mL). The organic layer was collected, and the aqueous layer was back-extracted with ether (25 mL). The combined organic layers were washed with 1N aqueous hydrochloric acid, 1N aqueous sodium hydroxide, and brine, and dried over anhydrous sodium sulfate. Ether was removed under reduced pressure, and the crude product was purified by silica gel flash chromatography using a mixture of ethyl acetate in hexane (5–15–20%) to afford 4-oxochroman-7-yl trifluoromethanesulfonate (3.13 g, 10.6 mmol, 86% yield) as a yellow oil. HPLC <i>t</i><sub>r</sub> = 2.40 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>7</sub>F<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 297.0, found 297.2.</div></div><div id="sec5_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 7-Vinylchroman-4-one (<b>15</b>)</h3><div class="NLM_p last">To a solution of 4-oxochroman-7-yl trifluoromethanesulfonate (2.00 g, 6.75 mmol) in dioxane (10 mL) in a sealed tube was added sequentially tributyl(vinyl)stannane (2.18 mL, 7.43 mmol) and lithium chloride (0.859 g, 20.3 mmol). The mixture was degassed under reduced pressure and charged with nitrogen (2×). To the mixture was added tetrakis(triphenylphosphine)palladium(0) (0.780 g, 0.675 mmol) and the contents stirred under a strong stream of nitrogen for 5 min. The reaction mixture was sealed, immersed in an oil bath at 100 °C, and stirred overnight. The reaction mixture was cooled to room temperature and filtered under reduced pressure. The solid was washed with ethyl acetate (4 × 50 mL), and the filtrate was concentrated. The crude product mixture was diluted with ether (∼100 mL), sonicated for several minutes, and filtered (the cake was rinsed with ether). The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel flash chromatography using a mixture of ethyl acetate in hexane (5–12–15%) to give 7-vinylchroman-4-one (0.938 g, 5.38 mmol, 80% yield) as a yellow oil. HPLC <i>t</i><sub>r</sub> = 1.93 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>10</sub>O<sub>2</sub> [M + H]<sup>+</sup> 175.1, found 174.9. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.87 (d, <i>J</i> = 8.14 Hz, 1H), 7.09 (dd, <i>J</i> = 8.25, 1.43 Hz, 1H), 6.98 (d, <i>J</i> = 1.54 Hz, 1H), 6.69 (dd, <i>J</i> = 17.61, 11.00 Hz, 1H), 5.88 (d, <i>J</i> = 17.61 Hz, 1H), 5.42 (d, <i>J</i> = 10.78 Hz, 1H), 4.52–4.58 (m, 2H), and 2.78–2.85 (m, 2H).</div></div><div id="sec5_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 7-(1,2-Dihydroxyethyl)chroman-4-one (<b>16</b>)</h3><div class="NLM_p last">To a mixture of 7-vinylchroman-4-one (0.801 g, 4.60 mmol) and a 50% solution of NMO in water (0.953 mL, 4.60 mmol) in tetrahydrofuran (11 mL) at room temperature was added a 4% aqueous solution of osmium tetroxide in water (1.44 mL, 0.184 mmol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was diluted with dichloromethane (200 mL) and washed with water (40 mL). The organic layer was collected and was washed with brine (40 mL). The combined aqueous layers were extracted with dichloromethane (200 mL), and the combined organic layers were dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 7-(1,2-dihydroxyethyl)chroman-4-one (0.950 g, 4.56 mmol, 99% yield) as a dark-yellow oil. HPLC <i>t</i><sub>r</sub> = 0.587 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>12</sub>O<sub>4</sub> [M + H]<sup>+</sup> 209.1, found 209.0.</div></div><div id="sec5_4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 7-(2,2-Dimethyl-1,3-dioxolan-4-yl)chroman-4-one (<b>17</b>)</h3><div class="NLM_p last">To a mixture of 7-(1,2-dihydroxyethyl)chroman-4-one (0.950 g, 4.56 mmol) and 2,2-dimethoxypropane (1.68 mL, 13.7 mmol) in acetone (20 mL) at room temperature was added (1<i>R</i>)-(−)-camphorsulfonic acid (0.212 g, 0.913 mmol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was quenched with a saturated aqueous solution of sodium bicarbonate and concentrated under reduced pressure. The aqueous residue was diluted with ethyl acetate and washed with a saturated aqueous solution of sodium bicarbonate and brine. The organic layer was collected, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over anhydrous sodium sulfate and concentrated to give the crude product as a dark oil, which was purified by flash silica gel chromatography using a 20% mixture of ethyl acetate and hexane to afford 7-(2,2-dimethyl-1,3-dioxolan-4-yl)chroman-4-one (0.657 g, 2.65 mmol, 58% yield) as a clear, colorless oil. HPLC <i>t</i><sub>r</sub> = 2.14 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>O<sub>4</sub> [M + H]<sup>+</sup> 249.1, found 248.9.</div></div><div id="sec5_4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(7-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2<i>H</i>-chromen-4-yl)morpholine (<b>18</b>)</h3><div class="NLM_p last">To a mixture of 7-(2,2-dimethyl-1,3-dioxolan-4-yl)chroman-4-one (0.657 g, 2.65 mmol) and morpholine (1.15 mL, 13.2 mmol) in toluene (12 mL) at 0 °C was added a 1.0 M solution of titanium(IV) chloride in toluene (1.46 mL, 1.46 mmol) dropwise. The ice-bath was removed, and the orange, heterogeneous reaction mixture was stirred at room temperature overnight. The heterogeneous, orange reaction mixture was filtered through a pad of Celite and rinsed with toluene (3 × 20 mL). The pale-yellow filtrate was concentrated under reduced pressure to give 4-(7-(2,2-dimethyl-1,3-dioxolan-4-yl)-2<i>H</i>-chromen-4-yl)morpholine (0.751 g, 2.37 mmol, 89% yield) as a yellow oil.</div></div><div id="sec5_4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 7-(2,2-Dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-3a,4-dihydro-3<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-ol (<b>19</b>)</h3><div class="NLM_p last">To a homogeneous solution of 4-(7-(2,2-dimethyl-1,3-dioxolan-4-yl)-2<i>H</i>-chromen-4-yl)morpholine (0.266 g, 0.838 mmol) and triethylamine (0.232 mL, 1.68 mmol) in anhydrous acetonitrile (3.0 mL) at 0 °C was added a solution of 3-phenyl-4-(trifluoromethyl)isoxazole-5-carbonyl fluoride<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (0.217 g, 0.838 mmol) in acetonitrile (1.0 mL). The reaction mixture was stirred at 0 °C for 30 min and then at room temperature for 60 min. A homogeneous solution of hydroxylamine hydrochloride (0.233 g, 3.35 mmol) and sodium acetate (0.275 g, 3.35 mmol) in water (0.544 mL, 30.2 mmol) was added, and the reaction mixture was heated at 45 °C for 60 min. The reaction mixture was diluted with dichloromethane, washed with water, and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography using a mixture of ethyl acetate in hexane (5–12–20%) afforded 240 mg of the product mixture. The product was further purified by reverse phase preparative HPLC (2 × 120 mg) to give, after neutralization, 7-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-3a,4-dihydro-3<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-ol (0.070 g, 0.139 mmol, 17% yield). HPLC <i>t</i><sub>r</sub> = 3.08 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>21</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup> 503.1, found 502.9.</div></div><div id="sec5_4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 7-(2,2-Dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (<b>20</b>)</h3><div class="NLM_p last">(<i>This</i> reaction <i>was run twice</i>.) To a stirred suspension of 7-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-3a,4-dihydro-3<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-ol (0.035 g, 0.070 mmol) in anhydrous toluene (1.0 mL) at room temperature was added pyridine (0.012 mL, 0.153 mmol) followed by thionyl chloride (8.64 μL, 0.118 mmol). The reaction mixture was stirred at room temperature for 15 min and then at 80 °C for 15 min. The reaction mixture was cooled to room temperature and concentrated. The solid residue was diluted with dichloromethane, washed with a saturated aqueous solution of sodium bicarbonate, and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded a yellow film. The combined crude products were triturated with methanol with sonication. The solid was collected to provide 7-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (0.042 g, 0.087 mmol, 62% yield). HPLC <i>t</i><sub>r</sub> = 3.63 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup> 485.1, found 484.9.</div></div><div id="sec5_4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)ethane-1,2-diol (<b>21</b>)</h3><div class="NLM_p last">A solution of 7-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)-isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (0.042 g, 0.087 mmol) in trifluoroacetic acid (1.00 mL, 13.0 mmol) was left standing at room temperature for 45 min. The trifluoroacetic acid was removed under reduced pressure, and the residue was diluted with dichloromethane, washed with a saturated aqueous solution of sodium bicarbonate, and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 1-(3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)ethane-1,2-diol (0.039 g, 0.088 mmol, 100% yield). HPLC <i>t</i><sub>r</sub> = 3.00 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup> 445.1, found 444.9.</div></div><div id="sec5_4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-7-carbaldehyde (<b>22</b>)</h3><div class="NLM_p last">To a homogeneous solution of 1-(3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)ethane-1,2-diol (0.039 g, 0.088 mmol) in a mixture of tetrahydrofuran (1.0 mL) and water (0.065 mL) at room temperature was added sodium periodate (0.028 g, 0.132 mmol). The reaction mixture was stirred for 30 min. The solvent was removed under reduced pressure, and the residue was diluted with dichloromethane, washed with water, and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 36 mg of a ∼1:1 mixture of 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-7-carbaldehyde and 7-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole as a yellow oil. The product was used in the next step without any further purification. HPLC <i>t</i><sub>r</sub> = 3.35 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 413.1, found 412.9.</div></div><div id="sec5_4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>tert</i>-Butyl 1-((3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylate (<b>23</b>)</h3><div class="NLM_p last">To the mixture of 3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-7-carbaldehyde (0.036 g, 0.087 mmol) and 7-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole from the previous reaction in methanol (0.333 mL) and dichloromethane (1.0 mL) at room temperature was added the <i>tert</i>-butyl azetidine-3-carboxylate, acetic acid salt (0.028 g, 0.131 mmol), acetic acid (10.00 μL, 0.175 mmol), and titanium(IV) isopropoxide (0.051 mL, 0.175 mmol) dropwise. The resulting homogeneous reaction mixture was stirred for 60 min. To the reaction mixture was added sodium triacetoxyborohydride (0.056 g, 0.262 mmol) in one portion, and the reaction mixture was stirred at room temperature for 30 min. The reaction was quenched with a saturated aqueous solution of sodium bicarbonate until the pH was slightly basic (∼5 mL). The resulting emulsion was extracted with dichloromethane (3×), and the organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to give a pale-yellow solid. The crude product was purified by flash silica gel chromatography using a mixture of ethyl acetate in hexane (20–35–50%) to afford <i>tert</i>-butyl 1-((3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylate (0.031g, 0.056 mmol, 64% yield). HPLC <i>t</i><sub>r</sub> = 3.01 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>26</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 554.1, found 553.9.</div></div><div id="sec5_4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-((3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>24</b>)</h3><div class="NLM_p last">A mixture of <i>tert</i>-butyl 1-((3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylate (0.031 g, 0.056 mmol) and trifluoroacetic acid (2.58 mL, 33.5 mmol) was left standing at room temperature for 45 min. The trifluoroacetic acid was removed under reduced pressure, and the residue was suspended in water, the pH was adjusted to 5 with sonication, and the resulting suspension was stirred for 1 h. The pH remained at 5, so the solid was collected by vacuum filtration, washed with water, and dried under reduced pressure to give a quantitative yield of the product. The compound was suspended in methanol and sonicated for 15 min. The product was collected by vacuum filtration, washed with methanol, and dried under reduced pressure to provide 1-((3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic acid (0.029 g, 0.058 mmol, 100% yield). HPLC <i>t</i><sub>r</sub> = 7.51 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 498.1, found 498.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.79 (d, <i>J</i> = 7.77 Hz, 1H), 7.59–7.69 (m, 5H), 7.09 (d, <i>J</i> = 7.77 Hz, 1H), 7.04 (s, 1H), 5.61 (s, 2H), 3.58 (s, 2H), and 3.20–3.46 (m, 5H).</div></div><div id="sec5_4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)methanol (<b>26</b>)</h3><div class="NLM_p last">To a solution of 5-phenyl-4-(trifluoromethyl)isoxazole-3-carboxylic acid (6.0 g, 23.33 mmol) in tetrahydrofuran (40 mL) at 0 °C was added <i>N</i>-methylmorpholine (3.85 mL, 35.0 mmol) followed by isobutyl chloroformate (4.60 mL, 35.0 mmol) via syringe over 5 min. The resulting suspension was stirred at 0 °C for 15 min. The suspension was then added to a suspension of sodium borohydride (1.589 g, 42.0 mmol) in tetrahydrofuran (80 mL) and methanol (24 mL) at −78 °C via a 10 mL pipet. During the addition, frothing was observed. The reaction mixture was stirred for 3 h. The reaction mixture was slowly warmed to ∼ −20 °C and quenched with a 1:9 mixture of acetic acid in water (40 mL). The reaction mixture was then stirred at room temperature for 60 min. The solvent was removed under reduced pressure, and the residue was diluted with ethyl acetate (240 mL), washed with water (40 mL), washed with a saturated aqueous solution of sodium bicarbonate (2 × 40 mL), and washed with brine (40 mL). The organic layer was collected, the aqueous layers were back-extracted with ethyl acetate (200 mL), and the combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification by flash silica gel chromatography using a mixture of ethyl acetate in hexane (5–12–20%) afforded (5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)methanol (3.22 g, 13.24 mmol, 56.8% yield) as a clear, colorless oil. HPLC <i>t</i><sub>r</sub> = 1.93 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>8</sub>F<sub>3</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 244.2, found 244.0.</div></div><div id="sec5_4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-Phenyl-4-(trifluoromethyl)isoxazole-3-carbaldehyde (<b>27</b>)</h3><div class="NLM_p last">To a mixture of (5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)methanol (3.19 g, 13.12 mmol) in dichloromethane (40 mL) at 0 °C was added Dess–Martin periodinane (6.12 g, 14.43 mmol). The reaction mixture was stirred at 0 °C for 10 min and then at room temperature for 1.5 h. By HPLC, the reaction was complete. A 1:1 mixture of saturated aqueous sodium thiosulfate and saturated aqueous bicarbonate (75 mL) was added slowly. The organic layer was collected, and the aqueous layer was extracted with dichloromethane (2 × 100 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered through a pad of Celite, and concentrated under reduced pressure to give a quantitative yield of 5-phenyl-4-(trifluoromethyl)isoxazole-3-carbaldehyde as a clear, colorless oil. HPLC <i>t</i><sub>r</sub> = 2.05 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>6</sub>F<sub>3</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 242.0, found 242.0.</div></div><div id="sec5_4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-(2,2-Dibromovinyl)-5-phenyl-4-(trifluoromethyl)isoxazole (<b>28</b>)</h3><div class="NLM_p last">To a solution of carbontetrabromide (12.24 g, 36.9 mmol) in dichloromethane (10 mL) at 0 °C was added a solution of triphenylphosphine (4.84 g, 18.5 mmol) in dichloromethane (10 mL), and the resulting mixture was stirred at 0 °C for 5 min. A solution of 5-phenyl-4-(trifluoromethyl)isoxazole-3-carbaldehyde (<b>27</b>, 1.59 g, 4.62 mmol) in dichloromethane (10 mL) was added via syringe, and the reaction mixture was stirred at 0 °C for 20 min. The reaction mixture was diluted with dichloromethane and washed with water. A white precipitate formed and was removed by vacuum filtrating. The filtrate was washed with a saturated aqueous solution of sodium bicarbonate, washed with a saturated aqueous solution of ammonium chloride, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by flash silica gel chromatography using a mixture of ethyl acetate in hexane (1–3%) to give 3-(2,2-dibromovinyl)-5-phenyl-4-(trifluoromethyl)isoxazole (1.21 g, 3.05 mmol, 66.0% yield). HPLC <i>t</i><sub>r</sub> = 3.10 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>6</sub>Br<sub>2</sub>F<sub>3</sub>NO [M + H]<sup>+</sup> 395.9, found 395.9 and 397.9. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 7.43 (s, 1H), 7.52–7.56 (m, 2H), 7.56–7.61 (m, 1H), and 7.74 (d, <i>J</i> = 7.49 Hz, 2H).</div></div><div id="sec5_4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-yn-1-ol (<b>29</b>)</h3><div class="NLM_p last">To a solution of 3-(2,2-dibromovinyl)-5-phenyl-4-(trifluoromethyl)isoxazole (0.496 g, 1.19 mmol) in tetrahydrofuran (6.0 mL) at −78 °C was slowly added a 2.5 M solution of butyl lithium in hexane (1.05 mL, 2.61 mmol). The reaction mixture was stirred at −78 °C for 25 min and then warmed to room temperature. Once at room temperature, paraformaldehyde (0.713 g, 23.74 mmol) was added, and the reaction mixture was stirred for 5 min. The mixture was diluted with ether, washed with water (2×), and washed with brine. The combined aqueous layers were extracted with ether, and the combined organics layers were dried over anhydrous sodium sulfate and concentrated. The residue was purified by flash silica gel chromatography using a mixture of ethyl acetate in hexane (1–5–20%) to give 3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-yn-1-ol (0.199 g, 0.745 mmol, 63% yield). HPLC <i>t</i><sub>r</sub> = 2.39 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>8</sub>F<sub>3</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 268.1, found 268.2.</div></div><div id="sec5_4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-(3-Bromoprop-1-ynyl)-5-phenyl-4-(trifluoromethyl)isoxazole (<b>30</b>)</h3><div class="NLM_p last">To a solution of 3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-yn-1-ol (0.465 g, 1.740 mmol) in dichloromethane (9.0 mL) at 0 °C was added a 1.0 M solution of tribromophosphine in dichloromethane (2.09 mL, 2.09 mmol). After 5 min, the ice-bath was removed and the reaction mixture was stirred at room temperature overnight. Additional tribromophosphine (1.0 M in dichloromethane) (2.09 mL, 2.09 mmol) was added, and the reaction mixture was stirred at room temperature for 4.5 h. Additional tribromophosphine (1.0 M in dichloromethane) (2.09 mL, 2.09 mmol) was added, and the reaction mixture was stirred at room temperature over the weekend. The reaction mixture was diluted with dichloromethane, washed with a saturated aqueous solution of sodium bicarbonate, and dried over anhydrous sodium sulfate. Concentration under reduced pressure provided the crude product, which was loaded with a minimum amount of dichloromethane on a fritted funnel containing a layer of Celite topped with a layer of silica gel. The plug column was eluted with a mixture of ethyl acetate and hexane (1–3%) to give 3-(3-bromoprop-1-ynyl)-5-phenyl-4-(trifluoromethyl)isoxazole (0.219 g, 0.663 mmol, 38% yield) as a clear, colorless oil. HPLC <i>t</i><sub>r</sub> = 2.95 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>7</sub>BrF<sub>3</sub>NO [M + H]<sup>+</sup> 329.9, found 329.9 and 331.9.</div></div><div id="sec5_4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-Bromo-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-ynyloxy)benzaldehyde (<b>31</b>)</h3><div class="NLM_p last">To a mixture of 3-(3-bromoprop-1-ynyl)-5-phenyl-4-(trifluoromethyl)isoxazole (0.219 g, 0.663 mmol) and 4-bromo-2-hydroxybenzaldehyde (0.133 g, 0.663 mmol) in dimethylformamide (2.0 mL) at room temperature was added potassium carbonate (0.115 g, 0.829 mmol). The reaction mixture was stirred at room temperature for 3 h, diluted with ethyl acetate (75 mL), washed with a 10% aqueous solution of lithium chloride (2 × 25 mL), and washed with brine (25 mL). The organic layer was collected, and the combined aqueous phases were extracted with ethyl acetate (2 × 25 mL). The combined organic layers were dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded a tan solid which was triturated with methanol with sonication to give 4-bromo-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-ynyloxy)benzaldehyde (0.223 g, 0.495 mmol, 75% yield). HPLC <i>t</i><sub>r</sub> = 3.28 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>11</sub>BrF<sub>3</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 450.0, found 449.9 and 451.92. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 5.12 (s, 2H), 7.28 (d, <i>J</i> = 8.32 Hz, 1H), 7.34 (d, <i>J</i> = 1.66 Hz, 1H), 7.51–7.55 (m, 2H), 7.56–7.61 (m, 1H), 7.72 (d, <i>J</i> = 7.21 Hz, 2H), 7.75 (d, <i>J</i> = 8.32 Hz, 1H), and 10.44 (s, 1H).</div></div><div id="sec5_4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>E</i>)-4-Bromo-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-ynyloxy)benzaldehyde Oxime (<b>32</b>)</h3><div class="NLM_p last">A mixture of 4-bromo-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-ynyloxy)benzaldehyde (0.050 g, 0.111 mmol), hydroxylamine hydrochloride (9.26 mg, 0.133 mmol), and sodium acetate (0.018 g, 0.222 mmol) in methanol (2.0 mL) was heated at reflux for 30 min. The solvent was removed under reduce pressure, and the residue was diluted with dichloromethane, washed with water, and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded (<i>E</i>)-4-bromo-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-ynyloxy)benzaldehyde oxime (0.050 g, 0.107 mmol, 97% yield). HPLC <i>t</i><sub>r</sub> = 3.26 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>12</sub>BrF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 465.0, found 464.8 and 466.8.</div></div><div id="sec5_4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 7-Bromo-3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (<b>33</b>)</h3><div class="NLM_p last">To a mixture of sodium hypochlorite (23 mL), triethylamine (0.021 mL, 0.155 mmol), and dichloromethane (1.0 mL) at 0 °C was added dropwise a solution of (<i>E</i>)-4-bromo-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)prop-2-ynyloxy)benzaldehyde oxime (0.036 g, 0.077 mmol) in dichloromethane (3 mL). The reaction mixture was stirred at 0 °C for 30 min and then at room temperature for 1.5 h. The reaction mixture was diluted with dichloromethane, and the organic layer was collected. The aqueous layer was extracted with dichloromethane (2×), and the combined organic layers were washed with brine and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by trituration with methanol with sonication afforded 7-bromo-3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (0.026 g, 0.056 mmol, 73% yield). HPLC <i>t</i><sub>r</sub> = 3.91 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>10</sub>BrF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 463.0, found 462.9 and 464.9. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 7.78 (d, <i>J</i> = 8.05 Hz, 1H), 7.73 (d, <i>J</i> = 7.49 Hz, 2H), 7.60–7.65 (m, 1H), 7.55–7.59 (m, 2H), 7.23–7.27 (m, 2H), and 5.49 (s, 2H).</div></div><div id="sec5_4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-7-carbaldehyde (<b>34</b>)</h3><div class="NLM_p">To a heterogeneous solution of 7-bromo-3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (0.105 g, 0.227 mmol) in dioxane (2.0 mL) in a sealed tube was added sequentially tributyl(vinyl)stannane (0.073 mL, 0.249 mmol) and lithium chloride (0.029 g, 0.680 mmol). The mixture was degassed under reduced pressure and charged with nitrogen (3×). To the mixture was added tetrakis(triphenylphosphine)palladium(0) (0.026 g, 0.023 mmol), and the mixture was stirred under a strong stream of nitrogen for 5 min. The reaction mixture was sealed, immersed in an oil bath at 100 °C, and stirred overnight. The reaction mixture was concentrated under reduced pressure, and the residue was diluted with dichloromethane (10 mL), filtered through a pad of Celite, and rinsed with dichloromethane (10 mL). The filtrate was concentrated, and the residue was purified by flash silica gel chromatography using a 5% mixture of ethyl acetate in hexane to give 3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-7-vinyl-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (0.062 g, 0.151 mmol, 67% yield). HPLC <i>t</i><sub>r</sub> = 3.84 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 411.1, found 411.0.</div><div class="NLM_p last">To a mixture of 3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-7-vinyl-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole (0.060 g, 0.146 mmol) and a 50% aqueous solution of NMO (0.030 mL, 0.146 mmol) at room temperature was added a 4% aqueous solution of osmium tetroxide (0.046 mL, 5.85 μmol). The reaction mixture was stirred at room temperature for 5 h. The intermediate diol had an HPLC retention time = 3.09 min and an [M + H]<sup>+</sup> = 445. Sodium periodate (0.047 g, 0.219 mmol) was added to the homogeneous mixture followed by water (0.10 mL), and the reaction was stirred for 60 min at room temperature. Concentration under reduced pressure afforded a tan solid residue that was then diluted with ethyl acetate (40 mL), washed with the water (10 mL), and washed with brine (10 mL). The organic layer was collected, and the aqueous layer was washed with ethyl acetate (40 mL). The combined organic layers were dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-7-carbaldehyde (0.057 g, 0.138 mmol, 95% yield). HPLC <i>t</i><sub>r</sub> = 3.49 min (method D).</div></div><div id="sec5_4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl 1-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylate (<b>35</b>)</h3><div class="NLM_p last">To a mixture of 3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-7-carbaldehyde (0.057 g, 0.138 mmol), <i>tert</i>-butyl azetidine-3-carboxylate, acetic acid salt (0.045 g, 0.207 mmol), and acetic acid (0.016 mL, 0.276 mmol) in methanol (3.0 mL) and dichloroethane (0.900 mL) at room temperature was added titanium(IV) isopropoxide (0.081 mL, 0.276 mmol) dropwise. The resulting homogeneous reaction mixture was stirred for 90 min. To the reaction mixture was added sodium triacetoxyborohydride (0.088 g, 0.415 mmol) in one portion, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was quenched with a saturated aqueous solution of sodium bicarbonate until the pH was slightly basic (∼5 mL). The resulting emulsion was extracted with dichloromethane (3×). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to give a pale-yellow solid. The crude product was purified by flash silica gel chromatography using a mixture of ethyl acetate in hexane (20–35–50%) to afford <i>tert</i>-butyl 1-((3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylate (0.044 g, 0.079 mmol, 58% yield). HPLC <i>t</i><sub>r</sub> = 3.06 min (method D). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>26</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 554.2, found 554.2.</div></div><div id="sec5_4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>36</b>)</h3><div class="NLM_p last">A mixture of <i>tert</i>-butyl 1-((3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylate (0.044 g, 0.079 mmol) and trifluoroacetic acid (3.00 mL, 39.0 mmol) was left standing at room temperature for 60 min. The trifluoroacetic acid was removed under reduced pressure, and the residue was suspended in water, the pH was adjusted to ∼5 using 1N NaOH with sonication, and the resulting suspension was stirred overnight. The pH remained at 5, so the solid was collected by vacuum filtration, washed with water, and dried under reduced pressure to give a quantitative yield of the product. The compound was suspended in methanol and sonicated for 15 min and then stirred overnight. The product was collected by vacuum filtration, washed with methanol, and dried under reduced pressure to provide 1-((3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic acid (0.026 g, 0.052 mmol, 65% yield). HPLC <i>t</i><sub>r</sub> = 8.92 min (method B). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 498.1, found 498.1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.78 (dd, <i>J</i> = 7.21, 5.83 Hz, 3H), 7.70–7.75 (m, 1H), 7.64–7.70 (m, 2H), 7.08 (d, <i>J</i> = 7.77 Hz, 1H), 7.03 (s, 1H), 5.51 (s, 2H), 3.58 (s, 2 H), 3.42 (br s, 2H), and 3.22 (br s, 3H).</div></div><div id="sec5_4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Bromo-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one (<b>38</b>)</h3><div class="NLM_p last">6-Methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one (1 g, 5.67 mmol), NBS (1.010 g, 5.67 mmol), and pTsOH (0.108 g, 0.567 mmol) were ground in a porcelain mortar and the mixture was heated at 60 °C for 11 min in a scintillation vial with stirring. The reaction was carried out in four separate vials with the same scale (total 4 × 1 g of 6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one). After cooling, the contents of the four vials were combined and dissolved in 80 mL of dichloromethane. The solution was washed in sequence with saturated sodium bicarbonate (2×) and water and then dried over magnesium sulfate. The reaction mixture was concentrated under reduced pressure to yield 2-bromo-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one as an oily residue. The crude product was used for next reaction without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.07 (d, <i>J</i> = 8.8 Hz, 1H), 6.88 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 6.73 (d, <i>J</i> = 2.4 Hz, 1H), 4.70 (t, <i>J</i> = 4.2 Hz, 1H), 3.88 (s, 3H), 3.35–3.25 (m, 1H), 2.87 (dt, <i>J</i> = 16.9, 4.4 Hz, 1H), 2.53–2.41 (m, 2H).</div></div><div id="sec5_4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-Azido-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one (<b>39</b>)</h3><div class="NLM_p last">To a solution of 2-bromo-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one (5.71 g, 22.4 mmol) in acetone (40 mL) was added a solution of sodium azide (2.184 g, 33.6 mmol) in water (10 mL) dropwise, and the mixture was stirred at room temp for 3 h. The reaction mixture was diluted with ethyl acetate and washed with water twice and then brine. The combined aqueous layers were back-extracted with ethyl acetate. The organic layers were combined and dried over sodium sulfate and evaporated to yield an oily residue. The crude product was purified by flash chromatography (120 g silica gel cartridge, eluting with 5:95 followed by 1:9 and 2:8 EtOAc–hexane). Crystallization from ethyl acetate–hexanes afforded a total of 3.37 g of 2-azido-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one (69.3% yield over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.04 (d, <i>J</i> = 8.8 Hz, 1H), 6.86 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 6.70 (d, <i>J</i> = 2.4 Hz, 1H), 4.19 (dd, <i>J</i> = 11.8, 4.7 Hz, 1H), 3.87 (s, 3H), 3.03 (dd, <i>J</i> = 7.8, 4.5 Hz, 2H), 2.34 (dq, <i>J</i> = 13.2, 4.6 Hz, 1H), 2.16–2.05 (m, 1H).</div></div><div id="sec5_4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-Amino-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one, HCl (<b>40</b>)</h3><div class="NLM_p last">A mixture of 2-azido-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one (4.88 g, 22.47 mmol), 2.0 M HCl in water (33.7 mL, 67.4 mmol), and MeOH (125 mL) under nitrogen was charged with 10% Pd/C (50% wet) and stirred under a 50 psi hydrogen atmosphere for 4 h. The reaction mixture was then filtered through a plug of Celite using methanol. The reaction mixture was concentrated. The residue was suspended in MeOH and treated with EtOAc, and the resulting solids were collected by filtration and dried in vacuo. 2-Amino-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one, HCl (3.8 g, 74.3% yield) was isolated. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.99 (1 H, d, <i>J</i> = 8.80 Hz), 6.95 (1 H, dd, <i>J</i> = 8.80, 2.64 Hz), 6.89 (1 H, d, <i>J</i> = 2.42 Hz), 4.22 (1 H, dd, <i>J</i> = 13.98, 4.95 Hz), 3.89 (3 H, s), 3.20–3.29 (1 H, m), 3.12 (1 H, ddd, <i>J</i> = 17.17, 4.62, 2.64 Hz), 2.46–2.53 (1 H, m, <i>J</i> = 12.30, 4.75, 4.75, 2.64 Hz), 2.17 (1 H, dddd, <i>J</i> = 13.64, 12.87, 12.65, 4.62 Hz).</div></div><div id="sec5_4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(6-Methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxamide (<b>41</b>)</h3><div class="NLM_p last">To a solution of 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (1407 mg, 5.47 mmol) in dichloromethane (12 mL) at 0 °C was added oxalyl chloride (0.878 mL, 10.03 mmol) followed by DMF (0.018 mL, 0.228 mmol), and the cooling bath was removed and the mixture was stirred for 25 min. The reaction mixture was evaporated, and the residue was azeotroped with anhydrous ethylene chloride (3×). The residue was dissolved in 10 mL of dichloromethane and was added to a stirred solution of 2-amino-6-methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one hydrochloride (1038 mg, 4.56 mmol) and dimethyl aminopyridine (55.7 mg, 0.456 mmol) in 5 mL of dichloromethane by a syringe. Then Hunig’s Base (2.389 mL, 13.68 mmol) was added, and the mixture was stirred overnight. The reaction mixture was diluted with ethyl acetate and then washed with saturated sodium bicarbonate followed by brine. It was dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and purified by flash chromatography (80 g redisep cartridge was presaturated with 10%EtOAc–hexanes, the crude was loaded as a solution in dichloromethane, and the he column was eluted with 10% EtOAc–hexanes). <i>N</i>-(6-Methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxamide (0.78 g, 1.812 mmol, 39.8% yield) was obtained. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 431.11, found 431.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.06 (1 H, d, <i>J</i> = 8.80 Hz), 7.82 (1 H, d, <i>J</i> = 4.40 Hz), 7.59–7.64 (2 H, m), 7.49–7.57 (2 H, m), 6.90 (1 H, dd, <i>J</i> = 8.80, 2.42 Hz), 6.75 (1 H, d, <i>J</i> = 2.20 Hz), 4.77 (1 H, dt, <i>J</i> = 13.42, 4.84 Hz), 3.90 (3 H, s), 3.30 (1 H, ddd, <i>J</i> = 17.28, 13.09, 4.62 Hz), 3.05 (1 H, ddd, <i>J</i> = 17.22, 4.24, 2.31 Hz), 2.95–3.02 (2 H, m).</div></div><div id="sec5_4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-(7-Methoxy-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-2-yl)-3-phenyl-4-(trifluoromethyl)isoxazole (<b>42</b>)</h3><div class="NLM_p last">A mixture of the <i>N</i>-(6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxamide (133 mg, 0.309 mmol) and Lawesson’s reagent (187 mg, 0.464 mmol) in THF (3.0 mL) was heated for 30 min at 120 °C in a microwave. The resulting bright-yellow mixture was combined with 14 mg of crude from an earlier run, concentrated in vacuo, and purified by flash chromatography (with 10% followed by 20% ethyl acetate–hexanes). 5-(7-Methoxy-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-2-yl)-3-phenyl-4-(trifluoromethyl)isoxazole (0.088 g, 0.205 mmol, 60.3% yield) was obtained. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 429.08, found 429.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.66 (1 H, s), 7.65 (1 H, d, <i>J</i> = 1.54 Hz), 7.49–7.56 (3 H, m), 7.35 (1 H, d, <i>J</i> = 8.36 Hz), 6.86 (1 H, d, <i>J</i> = 2.42 Hz), 6.83 (1 H, dd, <i>J</i> = 8.36, 2.64 Hz), 3.87 (3 H, s), 3.16–3.21 (2 H, m), 3.09–3.15 (2 H, m).</div></div><div id="sec5_4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-ol (<b>43</b>)</h3><div class="NLM_p last">To a solution of 5-(7-methoxy-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-2-yl)-3-phenyl-4-(trifluoromethyl)isoxazole (0.088 g, 0.205 mmol) in dichloromethane (4 mL) was added 1 M boron tribromide (1.027 mL, 1.027 mmol) in dichloromethane dropwise, and the mixture was stirred at room temperature for 6 h. The reaction was quenched by the slow addition of saturated ammonium chloride, and the product was extracted with ethyl acetate and washed with brine. The combined aqueous layers were back-extracted with ethyl acetate once, and the combined organic layer was dried over sodium sulfate. Evaporation of the solvent gave an oily residue. It was purified by flash chromatography (40 g redisep cartridge eluting with 2:8 followed by 3:7 ethyl acetate–hexanes). 2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-ol (0.085 g, 0.205 mmol, 100% yield) was obtained. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 415.06, found 415.16. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.65 (1 H, s), 7.63 (1 H, d, <i>J</i> = 1.54 Hz), 7.47–7.57 (3 H, m), 7.29 (1 H, d, <i>J</i> = 8.14 Hz), 6.78 (1 H, d, <i>J</i> = 2.42 Hz), 6.75 (1 H, dd, <i>J</i> = 8.14, 2.64 Hz), 3.14–3.21 (2 H, m), 3.05–3.12 (2 H, m).</div></div><div id="sec5_4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-yl trifluoromethanesulfonate (<b>44</b>)</h3><div class="NLM_p last">To a solution of 2-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-ol (0.085g, 0.205 mmol) in pyridine (5.0 mL) at 0 °C was added trifluoromethanesulfonic anhydride (0.042 mL, 0.246 mmol). After 30 min, the cooling bath was removed. After 2 h the reaction mixture was concentrated under reduced pressure. The residue was partitioned between ether and 1 N HCl. The organic layer was washed with saturated sodium bicarbonate, brine, dried over anhyd sodium sulfate, and concentrated to yield a tan solid which were washed with hexanes. The mother liquor was purified by silica gel flash chromatography (with 10% ethyl acetate–hexanes). The desired product was combined with the solid obtained earlier. 2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-yl trifluoromethanesulfonate (0.1 g, 0.183 mmol, 89% yield) was obtained. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>12</sub>F<sub>6</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> 547.01, found 546.84. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.64–7.68 (2 H, m, 7.50–7.59 (3 H, m), 7.47 (1 H, d, <i>J</i> = 8.36 Hz), 7.24 (1 H, d, <i>J</i> = 2.42 Hz), 7.21 (1 H, dd, <i>J</i> = 8.14, 2.42 Hz), 3.23–3.28 (2 H, m), 3.17–3.23 (2 H, m).</div></div><div id="sec5_4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-Phenyl-4-(trifluoromethyl)-5-(7-vinyl-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-2-yl)isoxazole (<b>45</b>)</h3><div class="NLM_p last">A mixture of 2-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-yl trifluoromethanesulfonate (0.1 g, 0.183 mmol), tributyl(vinyl)tin (0.059 mL, 0.201 mmol), and lithium chloride (0.023 g, 0.549 mmol) in dioxane (2.5 mL) were added to a microwave reaction vessel. To this was then added the tetrakis(triphenylphosphine)palladium(0) (0.021 g, 0.018 mmol), and argon was bubbled through the reaction mixture for 3 min. The vessel was capped, and the reddish-brown mixture was immersed in a 100 °C oil bath. After overnight stirring, the reaction mixture was cooled and diluted with ethyl acetate. It was filtered through Celite. The filter cake was washed with ethyl acetate (3 times). The ethyl acetate layers were combined and concentrated under reduced pressure, and the residue was stirred in diethyl ether for 30 min. It was then filtered through Celite and washed with diethyl ether. The ether layer was evaporated, and the residue was purified by flash silica gel chromatography. The crude product was used as such for the subsequent step without further purification. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>OS [M + H]<sup>+</sup> 425.09, found 424.96.</div></div><div id="sec5_4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazole-7-carbaldehyde (<b>46</b>)</h3><div class="NLM_p last">To a solution of 3-phenyl-4-(trifluoromethyl)-5-(7-vinyl-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-2-yl)isoxazole (0.066 g, 0.155 mmol) in THF (1.0 mL) at rt was added a solution of NMO (0.040 g, 0.342 mmol) in water (1 mL) followed by addition of osmium tetroxide (2.5% in butanol (0.32 mL, 3.11 μmol). The reaction was stirred at room temperature for 3 h when the diol formation was found to be over as per LC/MS ((M + H) = 458.96). To the reaction was then added the sodium periodate (0.050 g, 0.233 mmol) in 1 mL of water. Stirring was continued for 90 min, and the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with brine, dried over magnesium sulfate, concentrated, and purified by flash silica gel chromatography. 2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazole-7-carbaldehyde (31 mg, 0.073 mmol, 46.8% yield over two steps) was obtained. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 427.06, found 426.95. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.02 (1 H, s), 7.83 (1 H, s), 7.81 (1 H, dd, <i>J</i> = 7.92, 1.54 Hz), 7.64–7.68 (2 H, m), 7.50–7.59 (4 H, m), 3.23–3.29 (4 H, m).</div></div><div id="sec5_4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-((2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-yl)methyl)azetidine-3-carboxylic Acid, TFA (<b>47</b>)</h3><div class="NLM_p last">To a stirring solution of 2-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazole-7-carbaldehyde (0.031 g, 0.073 mmol) and azetidine-3-carboxylic acid (8.82 mg, 0.087 mmol) in methanol (1.5 mL) and 1,2-dichloroethane (1.5 mL) was added at room temperature about 3–4 drops of acetic acid. The reaction mixture was immersed in an oil bath heated at 80 °C for 1 h. It was then cooled to room temperature and treated with sodium cyanoborohydride (5.48 mg, 0.087 mmol). The reaction mixture was stirred at room temperature for 1 h, concentrated, and purified by reverse phase prep HPLC (HPLC conditions: Phenomenex Luna C18 5 μm column (250 mm × 30 mm); 25–100% CH<sub>3</sub>CN/water (0.1% TFA); 25 min gradient; 30 mL/min). 1-((2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]thiazol-7-yl)methyl)azetidine-3-carboxylic acid, TFA (12 mg, 0.018 mmol, 25.3% yield), was obtained. HPLC <i>t</i><sub>r</sub> = 9.084 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 512.12, found 511.97. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.53–7.66 (6 H, m), 7.46 (1 H, s), 7.42 (1 H, dd, <i>J</i> = 7.81, 1.65 Hz), 4.43 (2 H, s), 4.29–4.41 (4 H, m), 3.65–3.75 (1 H, m), 3.16–3.25 (4 H, m).</div></div><div id="sec5_4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>48</b>)</h3><div class="NLM_p last">This compound was prepared starting from methyl 5-phenyl-4-(trifluoromethyl)isoxazole-3-carboxylate<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> using the sequence outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. HPLC <i>t</i><sub>r</sub> = 7.70 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 496.15, found 496.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ ppm 8.06 (1 H, d, <i>J</i> = 7.9 Hz), 7.77 (2 H, d, <i>J</i> = 7.3 Hz), 7.59–7.71 (3 H, m), 7.51 (1 H, s), 7.48 (1 H, d, <i>J</i> = 7.7 Hz), 4.42 (2 H, s), 4.25–4.34 (4 H, m), 3.55–3.65 (1 H, m), 3.14 (4 H, s).</div></div><div id="sec5_4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-((3-(3-Phenyl-4-(trifluoromethyl)isothiazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>49</b>)</h3><div class="NLM_p last">This compound was prepared starting from methyl 3-phenyl-4-(trifluoromethyl)isothiazole-5-carboxylate<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> using the sequence outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. HPLC <i>t</i><sub>r</sub> = 9.16 min (method B). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 512.13, found 512.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.84 (1 H, d, <i>J</i> = 7.8 Hz), 7.60–7.65 (2 H, m), 7.53–7.58 (3 H, m), 7.35 (1 H, s), 7.32 (1 H, d, <i>J</i> = 7.8 Hz), 3.59 (2 H, s), 3.42 (2 H, s), 3.16–3.25 (3 H, m), 3.02 (2 H, t, <i>J</i> = 6.9 Hz), 2.93 (2 H, t, <i>J</i> = 6.9 Hz).</div></div><div id="sec5_4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-((3-(5-Phenyl-4-(trifluoromethyl)isothiazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (TFA Salt) (<b>50</b>)</h3><div class="NLM_p last">This compound was prepared starting from methyl 5-phenyl-4-(trifluoromethyl)isothiazole-3-carboxylate<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> using the sequence outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. HPLC 93.6%; <i>t</i><sub>r</sub> = 9.05 min (method B). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 512.13, found 512.1. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.05 (1 H, d, <i>J</i> = 7.9 Hz), 7.55–7.63 (5 H, m), 7.53 (1 H, s), 7.49 (1 H, dd, <i>J</i> = 7.9, 1.8 Hz), 4.47 (2 H, s), 4.32–4.43 (4 H, m), 3.67–3.78 (1 H, m), 3.11 (4 H, s).</div></div><div id="sec5_4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-((3-(3-(Pyridin-2-yl)-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>51</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 6.89 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 497.1, found 497.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.07 (dd, <i>J</i> = 12.54, 5.50 Hz, 3H), 3.42 (br s, 2H) 3.60 (s, 2H), 7.33 (d, <i>J</i> = 7.92 Hz, 1H), 7.37 (s, 1H), 7.65 (dd, <i>J</i> = 6.71, 4.95 Hz, 1H), 7.85 (d, <i>J</i> = 7.92 Hz, 1H), 7.95 (d, <i>J</i> = 7.70 Hz, 1H), 8.07 (td, <i>J</i> = 7.65, 1.43 Hz, 1H), and 8.81 (d, <i>J</i> = 4.40 Hz, 1H).</div></div><div id="sec5_4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-((3-(5-Isobutyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>52</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.36 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>24</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 476.2, found 476.3. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.95 (d, <i>J</i> = 7.96 Hz, 1H), 7.43 (dd, 2H), 7.39 (d, <i>J</i> = 7.92 Hz, 1H), 4.37 (s, 2H), 4.14–4.30 (m, 4H), 3.56–3.77 (m, 1H), 2.92–3.11 (m, 4H), 2.87 (d, <i>J</i> = 7.37 Hz, 2H), 2.07 (m, 1H), 0.94 (s, 6H).</div></div><div id="sec5_4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-((3-(5-(1-Methylcyclopropyl)-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>53</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.25 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>22</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 474.2, found 474.2. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ ppm 7.94 (d, <i>J</i> = 7.63 Hz, 1H), 7.40 (s, 1H), 7.10–7.44 (m, 1H), 4.36 (s, 2H), 4.10–4.32 (m, 4H), 3.50–3.80 (m, 1H), 2.68–3.13 (m, 4H), 1.39 (s, 3H), 1.00–1.23 (m, 2H), 0.63–1.02 (m, 2H).</div></div><div id="sec5_4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-((3-(4-Isopropoxy-3-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (Hydrochloric Acid Salt) (<b>54</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 8.05 min, (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 487.18, found, 487.1. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04–7.93 (m, 3H), 7.58–7.45 (m, 2H), 7.39 (d, <i>J</i> = 8.8 Hz, 1H), 4.51–4.31 (m, 7H), 3.78–3.68 (m, 1H), 3.15–3.04 (m, 4H), 1.40 (d, <i>J</i> = 6.2 Hz, 6H).</div></div><div id="sec5_4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-((3-(3-Cyano-4-isopropoxyphenyl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>55</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 2.69 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 444.19, found 444.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.02–8.07 (2 H, m), 7.97 (1 H, d, <i>J</i> = 7.9 Hz), 7.51 (1 H, s), 7.46 (1 H, dd, <i>J</i> = 7.8, 1.2 Hz), 7.38 (1 H, d), 4.38 (2 H, s), 4.13–4.23 (5 H, m), 3.40–3.50 (1 H, m), 3.04–3.13 (4 H, m), 1.44 (6 H, d, <i>J</i> = 5.9 Hz).</div></div><div id="sec5_4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1-((3-(4-Isopropoxy-2-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (TFA) (<b>56</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.01 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 487.18, found 487.2. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ ppm 8.01 (1 H, d, <i>J</i> = 7.8 Hz), 7.55 (1 H, d, <i>J</i> = 8.6 Hz), 7.50 (1 H, s), 7.48 (1 H, dd, <i>J</i> = 8.0, 1.7 Hz), 7.36 (1 H, d, <i>J</i> = 2.5 Hz), 7.31 (1 H, dd, <i>J</i> = 8.6, 2.5 Hz), 4.79 (1 H, spt, <i>J</i> = 6.1 Hz), 4.46 (2 H, s), 4.32–4.41 (4 H, m), 3.71 (1 H, quin, <i>J</i> = 8.3 Hz), 3.04 (2 H, t, <i>J</i> = 7.1 Hz), 2.77 (2 H, t, <i>J</i> = 7.2 Hz), 1.39 (6 H, d, <i>J</i> = 6.1 Hz).</div></div><div id="sec5_4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1-((3-(4-Isobutyl-3-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (TFA) (<b>57</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.55 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>28</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 485.21, found 485.4. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ ppm 7.83–7.94 (m, 3 H) 7.50 (d, <i>J</i> = 8.32 Hz, 1 H) 7.38 (s, 1 H) 7.34 (dd, <i>J</i> = 8.05, 1.66 Hz, 1 H) 4.33 (s, 2 H) 4.18–4.28 (m, 3 H) 3.58 (qd, <i>J</i> = 8.37, 8.18 Hz, 1 H) 3.15 (1H, hidden under CD<sub>3</sub>OD peak) 2.96–3.01 (m, 4 H) 2.62 (d, <i>J</i> = 6.94 Hz, 2 H) 1.85–1.94 (m, 1 H) 0.84 (d, <i>J</i> = 6.66 Hz, 6 H).</div></div><div id="sec5_4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1-((3-(4-Cyclohexyl-3-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (TFA) (<b>58</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 9.63 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>30</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 511.22, found 511.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.99–8.05 (3 H, m), 7.78 (1 H, d, <i>J</i> = 8.6 Hz), 7.51 (1 H, d, <i>J</i> = 1.1 Hz), 7.47 (1 H, dd, <i>J</i> = 7.9, 1.8 Hz), 4.46 (2 H, s), 4.33–4.38 (4 H, m), 3.63–3.74 (1 H, m), 3.09–3.15 (4 H, m), 3.00 (1 H, t, <i>J</i> = 11.7 Hz), 1.77–1.96 (5 H, m), 1.54–1.67 (2 H, m, <i>J</i> = 12.0, 12.0, 11.9, 2.1 Hz), 1.35–1.53 (3 H, m).</div></div><div id="sec5_4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 1-((3-(3-(Trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (TFA) (<b>59</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.45 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 429.14, found 429.1. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.30–8.24 (m, 2H), 8.20 (d, <i>J</i> = 7.9 Hz, 1H), 8.03–7.94 (m, 2H), 7.71 (d, <i>J</i> = 1.3 Hz, 1H), 7.67 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 4.65 (s, 2H), 4.61–4.50 (m, 4H), 3.95–3.85 (m, 1H), 3.50 (dt, <i>J</i> = 3.3, 1.7 Hz, 2H), two protons under MeOH peak.</div></div><div id="sec5_4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 1-((3-(3,4-Diethoxyphenyl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>60</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 7.93 min (method B). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup> 449.21, found 449. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ ppm 7.96 (1 H, d, <i>J</i> = 7.8 Hz), 7.48 (1 H, s), 7.44 (1 H, dd, <i>J</i> = 7.9, 1.5 Hz), 7.32–7.38 (2 H, m), 7.10 (1 H, d, <i>J</i> = 8.0 Hz), 4.36 (2 H, s), 4.12–4.21 (8 H, m), 3.37–3.46 (1 H, m), 3.01–3.12 (4 H, m), 1.42–1.49 (6 H, m).</div></div><div id="sec5_4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4<i>H</i>-indeno[1,2-<i>c</i>]isoxazol-6-yl)methyl)azetidine-3-carboxylic Acid (TFA) (<b>61</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 7.72 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>19</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 482.13, found 482.4. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.04 (1 H, d, <i>J</i> = 7.9 Hz), 7.75–7.81 (3 H, m), 7.59–7.73 (4 H, m), 4.54 (2 H, s), 4.33–4.44 (4 H, m), 4.10 (2 H, s), 3.72 (1 H, quin, <i>J</i> = 8.3 Hz).</div></div><div id="sec5_4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-((3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>62</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 7.92 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 496.15, found 496.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.72–7.66 (m, 3H), 7.65–7.58 (m, 3H), 7.35 (s, 1H), 7.31 (d, <i>J</i> = 7.5 Hz, 1H), 3.59 (br s, 2H), 3.42 (br s, 2H), 3.23 (br s, 2H), 3.17 (s, 1H), 3.14–3.08 (m, 3H), 3.01–2.95 (m, 2H).</div></div><div id="sec5_4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-5,6-dihydro-4<i>H</i>-benzo[3,4]cyclohepta[1,2-<i>d</i>]isoxazol-8-yl)methyl)azetidine-3-carboxylic Acid (<b>63</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 8.04 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>23</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 510.16, found 510.2.</div></div><div id="sec5_4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 1-((5-Methyl-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydroisoxazolo[4,3-<i>c</i>]quinolin-7-yl)methyl)azetidine-3-carboxylic Acid (<b>64</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.47 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 511.2, found 511.3. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.09 (d, <i>J = 7.92 Hz</i>, 1H), 7.78 (d, <i>J = 7.26</i>, 2H), 7.32–7.77 (m, 5H), 4.44 (s, 2H), 3.47 (s, 2H), 3.09–3.21 (m, 4H), 2.78–3.01 (m, 4H).</div></div><div id="sec5_4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydrobenzo[6,7]oxepino[4,5-<i>d</i>]isoxazol-8-yl)methyl)azetidine-3-carboxylic Acid (<b>65</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 8.00 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 512.1, found 512.5. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.95 (d, <i>J</i> = 7.92 Hz, 1H), 7.80 (d, <i>J</i> = 7.26 Hz, 2H), 7.64–7.76 (m, 3H), 7.17 (dd, <i>J</i> = 8.25, 1.43 Hz, 1H), 7.05 (d, <i>J</i> = 1.10 Hz, 1H), 4.37 (t, <i>J</i> = 4.84 Hz, 2H), 3.58 (s, 2H), 3.16–3.46 (m, 5H), 3.14 (t, <i>J</i> = 4.95 Hz, 2H).</div></div><div id="sec5_4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1-((3-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydro-2<i>H</i>-benzo[g]indazol-7-yl)methyl)azetidine-3-carboxylic Acid (HCl) (<b>66</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 2.89 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>22</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 495.16, found 495.1.</div></div><div id="sec5_4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1-((2-Methyl-3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydro-2<i>H</i>-benzo[<i>g</i>]indazol-7-yl)methyl)azetidine-3-carboxylic Acid, TFA (<b>67</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 2.96 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>24</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 509.18, found 509.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.90 (1 H, d, <i>J</i> = 8.1 Hz), 7.82–7.87 (2 H, m), 7.61–7.72 (3 H, m), 7.40 (2 H, dd, <i>J</i> = 4.1, 2.3 Hz), 4.41 (2 H, s), 4.30–4.38 (4 H, m), 3.91 (3 H, s), 3.71 (1 H, quin, <i>J</i> = 8.4 Hz), 3.02 (2 H, t, <i>J</i> = 7.3 Hz), 2.76 (2 H, t, <i>J</i> = 7.3 Hz).</div></div><div id="sec5_4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 1-((1-Methyl-3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydro-1<i>H</i>-benzo[<i>g</i>]indazol-7-yl)methyl)azetidine-3-carboxylic Acid, TFA (<b>68</b>)</h3><div class="NLM_p last">LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>24</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 509.18, found 509.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.35–7.85 (m, 8 H) 4.3–4.6 (hidden under broad CD<sub>3</sub>OD peak, 9H) 3.7–3.9 (m, 1 H) 2.85–3.2 (m, 4 H).</div></div><div id="sec5_4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 1-((2-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[2,1-<i>d</i>]oxazol-7-yl)methyl)azetidine-3-carboxylic Acid, TFA (<b>69</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 7.54 min (method B). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 496.14, found 496.06. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.67–7.62 (m, 3H), 7.61–7.53 (m, 3H), 7.45 (d, <i>J</i> = 4.6 Hz, 2H), 4.40 (s, 2H), 4.32–4.27 (m, 4H), 3.65–3.55 (m, 1H), 3.29–3.23 (m, 2H), 3.08–3.03 (m, 2H).</div></div><div id="sec5_4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 1-((8-Methyl-3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)azetidine-3-carboxylic Acid (<b>70</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.60 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>22</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 510.2, found 510.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.80 (d, J = 7.26 Hz, 2H), 7.58–7.75 (m, 3H), 7.44 (s, 1H), 4.43 (br s, 2H), 4.21 (br. s, 4H), 3.40–3.63 (m, 1H), 3.10 (s, 4H), 2.51 (s, 3H).</div></div><div id="sec5_4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1-((8-Fluoro-3-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)azetidine-3-carboxylic Acid (<b>71</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 3.54 min (method C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>20</sub>F<sub>4</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 514.14, found 514.07. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.70–7.93 (1H, m), 7.37–7.81 (6H, m), 4.51 (2H, s), 4.31 (4H, br s), 2.92–3.27 (4H, m), and 2.31 (1H, s).</div></div><div id="sec5_4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 1-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydroisoxazolo[5,4-<i>f</i>]quinolin-7-yl)methyl)azetidine-3-carboxylic Acid (<b>72</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 6.89 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 497.1, found 497.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.06 (d, <i>J</i> = 8.05 Hz, 1H), 7.80 (d, <i>J</i> = 7.21 Hz, 2H), 7.70–7.74 (m, 1H), 7.64–7.69 (m, 2H), 7.36 (d, <i>J</i> = 8.05 Hz, 1H), 5.75 (s, 2H), 3.70 (s, 2H), 3.49 (t, <i>J</i> = 7.63 Hz, 2H), 3.16–3.34 (m, 5H), 3.05–3.10 (m, 2H).</div></div><div id="sec5_4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2-((3<i>R</i>)-1-(2-Hydroxy-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)ethyl)piperidin-3-yl)acetic Acid·HCl (<b>73</b> and <b>74</b>)</h3><div class="NLM_p">Chiral separation of <b>73</b> and <b>74</b> was accomplished at the ester stage (ChiralCel OJ-H 25 cm × 3 cm, 5 μm; 40 °C; 140 mL/min; CO<sub>2</sub>/MEOH + 0.1%DEA = 85/15; 256 nm). Peak 1 (<i>t</i><sub>r</sub> = 7.7 min, ester of <b>74</b>) and peak 2 (<i>t</i><sub>r</sub> = 8.8 min, ester of <b>73</b>). Peaks 1 and 2 were hydrolyzed individually to give the corresponding acids <b>74</b> and <b>73</b>.</div><div class="NLM_p"><b>73</b>: HPLC <i>t</i><sub>r</sub> = 7.80 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>29</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 568.21, found 568.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.34 (br s, 1H), 9.89 (br s, 1H), 7.94 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.3 Hz, 2H), 7.76–7.63 (m, 3H), 7.53 (s, 1H), 7.49 (d, <i>J</i> = 8.1 Hz, 1H), 6.35 (br s, 1H), 5.22 (br s, 1H), 3.65 (dd, <i>J</i> = 19.7, 12.2 Hz, 2H), 3.39 (br s, 3H), 3.29–3.20 (m, 2H), 2.97–2.84 (m, 1H), 2.81–2.67 (m, 1H), 2.45–2.18 (m, 3H), 1.94–1.75 (m, 3H), 1.43–1.04 (m, 2H).</div><div class="NLM_p last"><b>74</b>: HPLC <i>t</i><sub>r</sub> = 7.84 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>29</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 568.21, found 568.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.35 (br s, 1H), 9.84 (br s, 1H), 7.94 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.3 Hz, 2H), 7.76–7.64 (m, 3H), 7.53 (s, 1H), 7.50 (d, <i>J</i> = 8.1 Hz, 1H), 6.39 (br s, 1H), 5.22 (br s, 1H), 3.68 (d, <i>J</i> = 10.8 Hz, 1H), 3.58 (d, <i>J</i> = 11.0 Hz, 1H), 3.43–3.18 (m, 5H), 2.96–2.70 (m, 2H), 2.39–2.19 (m, 3H), 1.99–1.71 (m, 3H), 1.34–1.09 (m, 2H).</div></div><div id="sec5_4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (3<i>S</i>)-1-(2-Hydroxy-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)ethyl)piperidine-3-carboxylic Acid·HCl (<b>75</b> and <b>76</b>)</h3><div class="NLM_p">Chiral separation of <b>75</b> and <b>76</b> was accomplished at the ester stage (ChiralCel OJ-H 25 cm × 3 cm, 5 μm; 40 °C; 150 mL/min; CO<sub>2</sub>/MEOH + 0.1%DEA = 75/25; 250 nm). Peak 1 (<i>t</i><sub>r</sub> = 3.4 min, ester of <b>75</b>) and peak 2 (<i>t</i><sub>r</sub> = 4.5 min, ester of <b>76</b>). Peaks 1 and 2 were hydrolyzed individually to give the corresponding acids <b>75</b> and <b>76</b>.</div><div class="NLM_p"><b>75</b>: HPLC <i>t</i><sub>r</sub> = 3.15 min (condition C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>27</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 554.19, found 554.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.0 Hz, 2H), 7.76–7.64 (m, 3H), 7.54 (s, 1H), 7.51 (d, <i>J</i> = 8.1 Hz, 1H), 6.38 (br s, 1H), 5.23 (br s, 1H), 3.83 (br s, 1H), 3.56 (br s, 1H), 3.32 (br s, 4H), 3.06–2.80 (m, 3H), 2.05 (d, <i>J</i> = 12.3 Hz, 1H), 2.00–1.72 (m, 3H), 1.48 (d, <i>J</i> = 10.6 Hz, 1H).</div><div class="NLM_p last"><b>76</b>: HPLC <i>t</i><sub>r</sub> = 3.14 min (condition C). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>27</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 554.19, found 554.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.3 Hz, 2H), 7.76–7.64 (m, 3H), 7.52 (s, 1H), 7.49 (d, <i>J</i> = 7.9 Hz, 1H), 6.39 (br s, 1H), 5.26 (br s, 1H), 3.80 (br s, 1H), 3.67 (d, <i>J</i> = 10.8 Hz, 1H), 3.56–3.36 (m, 1H), 3.35–3.14 (m, 3H), 3.04–2.88 (m, 3H), 2.06 (d, <i>J</i> = 11.7 Hz, 1H), 2.00–1.74 (m, 3H), 1.56–1.39 (m, 1H).</div></div><div id="sec5_4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 2-Hydroxy-<i>N</i>-(2-(methylsulfonyl)ethyl)-2-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)acetamide (<b>77</b> and <b>78</b>)</h3><div class="NLM_p">Chiral separation of <b>77</b> and <b>78</b> was accomplished at the hydroxy acid stage (Chiralcel OJ-H 5 cm × 25 cm, column temperature 20 °C, isocratic elution with mobile phase 35% acetonitrile + 0.1 TFA in CO<sub>2</sub>, 280 mL/min, 250 nm). Peak 1 (<i>t</i><sub>r</sub> = 7.26 min, acid of <b>77</b>) and peak 2 (<i>t</i><sub>r</sub> = 9.88 min, acid of <b>78</b>). Peaks 1 and 2 were coupled individually with 2-(methylsulfonyl)ethanamine using HATU to yield <b>77</b> and <b>78</b>.</div><div class="NLM_p"><b>77</b>: HPLC <i>t</i><sub>r</sub> = 9.25 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>23</sub>F<sub>3</sub>N<sub>3</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 562.13, found 562. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.93 (1 H, d, <i>J</i> = 7.92 Hz), 7.77 (2 H, d, <i>J</i> = 7.48 Hz), 7.59–7.72 (3 H, m), 7.49–7.57 (2 H, m), 5.09 (1 H, s), 3.73 (2 H, q, <i>J</i> = 6.38 Hz), 3.34 (2 H, q, <i>J</i> = 6.38 Hz), 3.08 (4 H, s), 2.97 (3 H, s).</div><div class="NLM_p last"><b>78</b>: HPLC <i>t</i><sub>r</sub> = 9.23 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>23</sub>F<sub>3</sub>N<sub>3</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 562.13, found 562. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.94 (1 H, d, <i>J</i> = 7.92 Hz), 7.78 (2 H, d, <i>J</i> = 7.48 Hz), 7.59–7.71 (3 H, m), 7.49–7.56 (2 H, m), 5.09 (1 H, s), 3.73 (2 H, q, <i>J</i> = 6.24 Hz), 3.34 (2 H, q, <i>J</i> = 6.24 Hz), 3.08 (4 H, s), 2.97 (3 H, s).</div></div><div id="sec5_4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-((3-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-<i>c</i>]isoxazol-7-yl)methyl)-2,5,7-triazaspiro[3.4]octane-6,8-dione (<b>79</b>)</h3><div class="NLM_p last">HPLC <i>t</i><sub>r</sub> = 7.37 min (method A). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>21</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 536.15, found 536.3. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.92 (1 H, d, <i>J</i> = 7.9 Hz), 7.77 (2 H, d, <i>J</i> = 7.3 Hz), 7.58–7.71 (3 H, m), 7.40 (1 H, s), 7.37 (1 H, d, <i>J</i> = 7.7 Hz), 3.78 (2 H, s), 3.75 (2 H, d, <i>J</i> = 8.6 Hz), 3.48 (2 H, d, <i>J</i> = 8.8 Hz), 3.08 (4 H, s).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Receptor [35S] GTPγS Binding Assays</h3><div class="NLM_p">Compounds were loaded in a 384 Falcon V-bottom plate (0.5 μL/well in a 3-fold dilution). Membranes prepared from S1P<sub>1</sub>/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 μL/well, final protein 3 μg/well) with multidrop liquid handler (Thermo Scientific, Waltham, MA). [<sup>35</sup>S]GTP (1250 Ci/mmol, PerkinElmer) was diluted in assay buffer: 20 mM HEPES, pH7.5, 10 mM MgCl<sub>2</sub>, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 μM GDP, 0.1% fatty acid free BSA, and 10 μg/mL saponin to 0.4 nM. Then 40 μL of the [<sup>35</sup>S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to a 384-well FB filter plates via GPCR robot system. The filter plate was washed with water 4 times by using the modified manifold Embla plate washer and dried at 60 °C for 45 min. Then 30 μL of MicroScint 20 scintillation fluid was added to each well for counting at Packard TopCount. EC<sub>50</sub> is defined as the agonist concentration that corresponds to 50% of the Ymax (maximal response) obtained for each individual compound tested.</div><div class="NLM_p last">All procedures involving animals were reviewed and approved by the Institutional Animal Care Use Committee.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Blood Lymphocyte Reduction Assay (BLR) in Rat</h3><div class="NLM_p last">Lewis rats were dosed orally with test article (as a solution or suspension in the vehicle) or vehicle alone (polyethylene glycol 300, “PEG300”). Blood was drawn at 4 h and 24 h by retro-orbital bleeding under isoflurane anesthesia. Blood lymphocyte counts were determined on an ADVIA 120 hematology analyzer (Siemens Healthcare Diagnostics). The results were expressed as a reduction in the number of circulating lymphocytes as compared to the vehicle treated group at the 4 and 24 h measurement. The results represent the average results of all animals within each treatment group (<i>n</i> = 3–4).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Rat Adjuvant Induced Arthritis Assay (AA)</h3><div class="NLM_p last">Male Lewis rats (200–225 g; Harlan, <i>n</i> = 8 treatment group) were immunized at the base of the tail with 100 μL of 10 mg/mL freshly ground <i>Mycobacterium butyricum</i> (Difco Laboratories) in incomplete Freund’s Adjuvant (Sigma). Animals were dosed once daily with the test article (as a solution or suspension in the vehicle) or vehicle alone (PEG300) starting from the day of immunization. The volumes of their hind paws were measured in a water displacement plethysmometer (Ugo Basile, Italy). The baseline paw measurements were taken before onset of the disease (day 7). The paw measurements were then taken three times a week until the end of the study on day 21.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01099">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01099" class="ext-link">10.1021/acs.jmedchem.6b01099</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Single-crystal X-ray structure of compounds <b>3</b> and <b>10</b> along with the parameters like crystal system, space group, unit cell parameters, temperature of data collection etc. (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_001.csv">jm6b01099_si_001.csv (3.52 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_002.pdf">jm6b01099_si_002.pdf (505.12 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01099" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">T. G. Murali Dhar</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bdd0c8cfdcd1d493d9d5dccffddfd0ce93ded2d0"><span class="__cf_email__" data-cfemail="0a677f786b6663246e626b784a68677924696567">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Yun Xiao</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott H. Watterson</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles M. Langevine</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anurag S. Srivastava</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Soo S. Ko</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanlei Zhang</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Cherney</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei-Wei Guo</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John L. Gilmore</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James E. Sheppeck</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dauh-Rurng Wu</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peng Li</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duraisamy Ramasamy</span> - <span class="hlFld-Affiliation affiliation">BMS
Biocon Research Center, Bangalore 560099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piramanayagam Arunachalam</span> - <span class="hlFld-Affiliation affiliation">BMS
Biocon Research Center, Bangalore 560099, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arvind Mathur</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracy L. Taylor</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Shuster</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim W. McIntyre</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ding-Ren Shen</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Yarde</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ellen Cvijic</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony M. Marino</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Praveen V. Balimane</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Yang</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dana M. Banas</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georgia Cornelius</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia J. D’Arienzo</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bethanne M. Warrack</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lois Lehman-McKeeman</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luisa M. Salter-Cid</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Xie</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Percy H. Carter</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alaric J. Dyckman</span> - <span class="hlFld-Affiliation affiliation">Research
and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript contains contributions from all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i94" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i94"> Abbreviations Used</h2><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate</p></td></tr><tr><td class="NLM_term">S1P1–5</td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate receptors 1–5</p></td></tr><tr><td class="NLM_term">GTPγS</td><td class="NLM_def"><p class="first last">guanosine-5′-<i>O</i>-[gamma-thio]triphosphate</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1038/nature02284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1038%2Fnature02284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=14737169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=G.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1&doi=10.1038%2Fnature02284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span></div><div class="casAuthors">Matloubian, Mehrdad; Lo, Charles G.; Cinamon, Guy; Lesneski, Matthew J.; Xu, Ying; Brinkmann, Volker; Allende, Maria L.; Proia, Richard L.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">6972</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adaptive immunity depends on T-cell exit from the thymus and T and B cells traveling between secondary lymphoid organs to survey for antigens.  After activation in lymphoid organs, T cells must again return to circulation to reach sites of infection; however, the mechanisms regulating lymphoid organ exit are unknown.  An immunosuppressant drug, FTY720, inhibits lymphocyte emigration from lymphoid organs, and phosphorylated FTY720 binds and activates four of the five known sphingosine-1-phosphate (S1P) receptors.  However, the role of S1P receptors in normal immune cell trafficking is unclear.  Here we show that in mice whose hematopoietic cells lack a single S1P receptor (S1P1; also known as Edg1) there are no T cells in the periphery because mature T cells are unable to exit the thymus.  Although B cells are present in peripheral lymphoid organs, they are severely deficient in blood and lymph.  Adoptive cell transfer expts. establish an intrinsic requirement for S1P1 in T and B cells for lymphoid organ egress.  Furthermore, S1P1-dependent chemotactic responsiveness is strongly upregulated in T-cell development before exit from the thymus, whereas S1P1 is downregulated during peripheral lymphocyte activation, and this is assocd. with retention in lymphoid organs.  We find that FTY720 treatment downregulates S1P1, creating a temporary pharmacol. S1P1-null state in lymphocytes, providing an explanation for the mechanism of FTY720-induced lymphocyte sequestration.  These findings establish that S1P1 is essential for lymphocyte recirculation and that it regulates egress from both thymus and peripheral lymphoid organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mWA73kFtwbVg90H21EOLACvtfcHk0lgbdIoYwvlh2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D&md5=0dd84e9cca37ec30894497ff4477d0d8</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnature02284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02284%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DG.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360%26doi%3D10.1038%2Fnature02284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sykes, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddy, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuiness, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattikar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaenzel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S.</span><span> </span><span class="NLM_article-title">Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">4797</span><span class="NLM_x">–</span> <span class="NLM_lpage">4807</span><span class="refDoi"> DOI: 10.1111/bph.12620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1111%2Fbph.12620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=24641481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=4797-4807&author=D.+A.+Sykesauthor=D.+M.+Riddyauthor=C.+Stampauthor=M.+E.+Bradleyauthor=N.+McGuinessauthor=A.+Sattikarauthor=D.+Gueriniauthor=I.+Rodriguesauthor=A.+Glaenzelauthor=M.+R.+Dowlingauthor=F.+Mullershausenauthor=S.+Charlton&title=Investigating+the+molecular+mechanisms+through+which+FTY720-P+causes+persistent+S1P1+receptor+internalization&doi=10.1111%2Fbph.12620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization</span></div><div class="casAuthors">Sykes, David A.; Riddy, Darren M.; Stamp, Craig; Bradley, Michelle E.; McGuiness, Neil; Sattikar, Afrah; Guerini, Danilo; Rodrigues, Ines; Glaenzel, Albrecht; Dowling, Mark R.; Mullershausen, Florian; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4797-4807</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The mol. mechanism underlying the clin. efficacy of FTY720-P is thought to involve persistent internalization and enhanced degrdn. of the S1P1 receptor subtype (S1P1R).  We have investigated whether receptor binding kinetics and β-arrestin recruitment could play a role in the persistent internalization of the S1P1R by FTY720-P.  [3H]-FTY720-P and [33P]-S1P were used to label CHO-S1P1/3Rs for binding studies.  Ligand efficacy was assessed through [35S]-GTPγS binding and β-arrestin recruitment.  Metabolic stability was evaluated using a bioassay measuring intracellular Ca2+ release.  CHO-S1P1/3R nos. were detd., following FTY720-P treatment using flow cytometry.  The kinetic off-rate of [3H]-FTY720-P from the S1P1R was sixfold slower than from the S1P3R, and comparable to [33P]-S1P dissocn. from S1P1/3Rs.  S1P and FTY720-P stimulated [35S]-GTPγS incorporation to similar degrees, but FTY720-P was over 30-fold less potent at S1P3Rs.  FTY720-P stimulated a higher level of β-arrestin recruitment at S1P1Rs, 132% of the total recruited by S1P.  In contrast, FTY720-P was a weak partial agonist at S1P3R, stimulating just 29% of the total β-arrestin recruited by S1P.  Internalization expts. confirmed that cell surface expression of the S1P1R but not the S1P3R was reduced following a pulse exposure to FTY720-P, which is metabolically stable unlike S1P.  FTY720-P and S1P activation of the S1P1R results in receptor internalization as a consequence of an efficient recruitment of β-arrestin.  The combination of slow off-rate, efficacious β-arrestin recruitment and metabolic stability all contribute to FTY720-P's ability to promote prolonged S1P1R internalization and may be crit. factors in its efficacy in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ExW4g6HHRrVg90H21EOLACvtfcHk0ljJkwAu8OTCsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsb7K&md5=017d19d0eb9abd87ee8b0bf6d46aae25</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fbph.12620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12620%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DRiddy%26aufirst%3DD.%2BM.%26aulast%3DStamp%26aufirst%3DC.%26aulast%3DBradley%26aufirst%3DM.%2BE.%26aulast%3DMcGuiness%26aufirst%3DN.%26aulast%3DSattikar%26aufirst%3DA.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DRodrigues%26aufirst%3DI.%26aulast%3DGlaenzel%26aufirst%3DA.%26aulast%3DDowling%26aufirst%3DM.%2BR.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DCharlton%26aufirst%3DS.%26atitle%3DInvestigating%2520the%2520molecular%2520mechanisms%2520through%2520which%2520FTY720-P%2520causes%2520persistent%2520S1P1%2520receptor%2520internalization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D4797%26epage%3D4807%26doi%3D10.1111%2Fbph.12620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e3181cbf825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1097%2FWNF.0b013e3181cbf825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+sclerosis&doi=10.1097%2FWNF.0b013e3181cbf825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e3181cbf825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e3181cbf825%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FWNF.0b013e3181cbf825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstorm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1126/science.1070238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1126%2Fscience.1070238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=11923495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstormauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists&doi=10.1126%2Fscience.1070238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span></div><div class="casAuthors">Mandala, Suzanne; Hajdu, Richard; Bergstrom, James; Quackenbush, Elizabeth; Xie, Jenny; Milligan, James; Thornton, Rosemary; Shei, Gan-Ju; Card, Deborah; Keohane, Carolann; Rosenbach, Mark; Hale, Jeffrey; Lynch, Christopher L.; Rupprecht, Kathleen; Parsons, William; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5566</span>),
    <span class="NLM_cas:pages">346-349</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Blood lymphocyte nos., essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs.  We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720.  Both species were high-affinity agonists of at least four of the five S1P receptors.  These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen.  S1P receptor agonists induced emptying of lymphoid sinuses by retention of lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph.  Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPvwG_lLsA8LVg90H21EOLACvtfcHk0ljJkwAu8OTCsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D&md5=b57cbcffe41d144e701dbd42459cf38a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070238%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstorm%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349%26doi%3D10.1126%2Fscience.1070238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span><span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0li4z3fyYjmA-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.; Brown, S.; Studer, S. M.; Rosen, H.</span><span> </span><span class="NLM_article-title">S1P signaling: new therapies and opportunities</span>.  <span class="citation_source-journal">F1000Prime Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span> (DOI: <span class="refDoi"> DOI: 10.12703/P6-109</span> ).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.12703%2FP6-109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=25580263" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&author=P.+J.+Gonzalez-Cabrera&author=S.+Brown&author=S.+M.+Studer&author=H.+Rosen&title=S1P+signaling%3A+new+therapies+and+opportunities&doi=10.12703%2FP6-109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.12703%2FP6-109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12703%252FP6-109%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26atitle%3DS1P%2520signaling%253A%2520new%2520therapies%2520and%2520opportunities%26jtitle%3DF1000Prime%2520Rep.%26date%3D2014%26volume%3D6%26doi%3D10.12703%2FP6-109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kunkel, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span><span class="refDoi"> DOI: 10.1038/nrd4099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1038%2Fnrd4099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=23954895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ylu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=688-702&author=G.+T.+Kunkelauthor=M.+Maceykaauthor=S.+Milstienauthor=S.+Spiegel&title=Targeting+the+sphingosine-1-phosphate+axis+in+cancer%2C+inflammation+and+beyond&doi=10.1038%2Fnrd4099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond</span></div><div class="casAuthors">Kunkel, Gregory T.; Maceyka, Michael; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">688-702</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bioactive lipid sphingosine-1-phosphate (S1P) is involved in multiple cellular signalling systems and has a pivotal role in the control of immune cell trafficking.  As such, S1P has been implicated in disorders such as cancer and inflammatory diseases.  This Review discusses the ways in which S1P might be therapeutically targeted - for example, via the development of chem. inhibitors that target the generation, transport and degrdn. of S1P and via the development of specific S1P receptor agonists.  We also highlight recent conflicting results obsd. in preclin. studies targeting S1P and discuss ongoing clin. trials in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm85yKwYpyLbVg90H21EOLACvtfcHk0lj6KRZ_19HOmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ylu7vL&md5=b215517638c25b2b39d7f7233feb2de0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd4099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4099%26sid%3Dliteratum%253Aachs%26aulast%3DKunkel%26aufirst%3DG.%2BT.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520sphingosine-1-phosphate%2520axis%2520in%2520cancer%252C%2520inflammation%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D688%26epage%3D702%26doi%3D10.1038%2Fnrd4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span><span class="refDoi"> DOI: 10.1021/jm0492507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists&doi=10.1021%2Fjm0492507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665%26doi%3D10.1021%2Fjm0492507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Discovery and Development of Sphingosine-1-Phosphate-1 Receptor Agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1016/B978-0-12-396492-2.00013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2FB978-0-12-396492-2.00013-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+Advances+in+the+Discovery+and+Development+of+Sphingosine-1-Phosphate-1+Receptor+Agonists&doi=10.1016%2FB978-0-12-396492-2.00013-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00013-8%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Sphingosine-1-Phosphate-1%2520Receptor%2520Agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1016%2FB978-0-12-396492-2.00013-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldred, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaux, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, G. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smethurst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydropyrazolopyridine as sphingosine 1-phosphate receptor 3 (S1P<sub>3</sub>)-sparing S1P<sub>1</sub> agonists active at low oral doses</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1003</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01512</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1003-1020&author=E.+H.+Demontauthor=J.+M.+Baileyauthor=R.+A.+Bitauthor=J.+A.+Brownauthor=C.+A.+Campbellauthor=N.+Deeksauthor=S.+J.+Dowellauthor=C.+Eldredauthor=P.+Gaskinauthor=J.+R.+J.+Grayauthor=A.+Haynesauthor=D.+J.+Hirstauthor=D.+S.+Holmesauthor=U.+Kumarauthor=M.+A.+Morseauthor=G.+J.+Osborneauthor=J.+F.+Renauxauthor=G.+A.+L.+Sealauthor=C.+A.+Smethurstauthor=S.+Taylorauthor=R.+Watsonauthor=R.+Willisauthor=J.+Witherington&title=Discovery+of+tetrahydropyrazolopyridine+as+sphingosine+1-phosphate+receptor+3+%28S1P3%29-sparing+S1P1+agonists+active+at+low+oral+doses&doi=10.1021%2Facs.jmedchem.5b01512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses</span></div><div class="casAuthors">Demont, Emmanuel H.; Bailey, James M.; Bit, Rino A.; Brown, Jack A.; Campbell, Colin A.; Deeks, Nigel; Dowell, Simon J.; Eldred, Colin; Gaskin, Pam; Gray, James R. J.; Haynes, Andrea; Hirst, David J.; Holmes, Duncan S.; Kumar, Umesh; Morse, Mary A.; Osborne, Greg J.; Renaux, Jessica F.; Seal, Gail A. L.; Smethurst, Chris A.; Taylor, Simon; Watson, Robert; Willis, Robert; Witherington, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1003-1020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FTY720 is the first oral small mol. approved for the treatment of people suffering from relapsing-remitting multiple sclerosis.  It is a potent agonist of the S1P1 receptor, but its lack of selectivity against the S1P3 receptor has been linked to most of the cardiovascular side effects obsd. in the clinic.  These findings have triggered intensive efforts toward the identification of a second generation of S1P3-sparing S1P1 agonists.  The authors have recently disclosed a series of orally active tetrahydroisoquinoline (THIQ) compds. matching these criteria.  The authors defined and implemented a strategy aiming at the discovery of selective structurally distinct follow-up agonists.  This effort culminated with the identification of a series of orally active tetrahydropyrazolopyridines, e.g. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrDxdhn4Vr3bVg90H21EOLACvtfcHk0lgD2wnaq-7tYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslertQ%253D%253D&md5=578a3b903bac10da197a83fa2b766722</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01512%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DBailey%26aufirst%3DJ.%2BM.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCampbell%26aufirst%3DC.%2BA.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DEldred%26aufirst%3DC.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DHirst%26aufirst%3DD.%2BJ.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOsborne%26aufirst%3DG.%2BJ.%26aulast%3DRenaux%26aufirst%3DJ.%2BF.%26aulast%3DSeal%26aufirst%3DG.%2BA.%2BL.%26aulast%3DSmethurst%26aufirst%3DC.%2BA.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520tetrahydropyrazolopyridine%2520as%2520sphingosine%25201-phosphate%2520receptor%25203%2520%2528S1P3%2529-sparing%2520S1P1%2520agonists%2520active%2520at%2520low%2520oral%2520doses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1003%26epage%3D1020%26doi%3D10.1021%2Facs.jmedchem.5b01512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of new trycyclic indoles as potent modulators of the S1P1 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.bmcl.2014.11.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=659-663&author=D.+J.+Buzardauthor=O.+Schraderauthor=X.+Zhuauthor=J.+Lehmannauthor=B.+Johnsonauthor=M.+Kasemauthor=S.-H.+Kimauthor=A.+Kawasakiauthor=L.+Lopezauthor=J.+Moodyauthor=S.+Hanauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=J.+Thatteauthor=J.+Gatlinauthor=R.+M.+Jones&title=Design+and+synthesis+of+new+trycyclic+indoles+as+potent+modulators+of+the+S1P1+receptor&doi=10.1016%2Fj.bmcl.2014.11.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.089%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DSchrader%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520trycyclic%2520indoles%2520as%2520potent%2520modulators%2520of%2520the%2520S1P1%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D659%26epage%3D663%26doi%3D10.1016%2Fj.bmcl.2014.11.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">(7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acids as S1P1 functional agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1334</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/ml500422m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500422m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1334-1339&author=D.+J.+Buzardauthor=L.+Lopezauthor=J.+Moodyauthor=A.+Kawasakiauthor=T.+O.+Schraderauthor=M.+Kasemauthor=B.+Johnsonauthor=X.+Zhuauthor=L.+Thoresenauthor=S.+H.+Kimauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+Krishnanauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=W.+Chenauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=I.+Gaidarovauthor=T.+Anthonyauthor=M.+Leauthor=D.+J.+Unettauthor=S.+Stirnauthor=A.+Blackburnauthor=D.+P.+Behanauthor=R.+M.+Jones&title=%287-Benzyloxy-2%2C3-dihydro-1H-pyrrolo%5B1%2C2-a%5Dindol-1-yl%29acetic+acids+as+S1P1+functional+agonists&doi=10.1021%2Fml500422m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fml500422m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500422m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%2BO.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3D%25287-Benzyloxy-2%252C3-dihydro-1H-pyrrolo%255B1%252C2-a%255Dindol-1-yl%2529acetic%2520acids%2520as%2520S1P1%2520functional%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1334%26epage%3D1339%26doi%3D10.1021%2Fml500422m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Skidmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cridland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">Optimization of Sphingosine-1-phosphate receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamics profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10424</span><span class="NLM_x">–</span> <span class="NLM_lpage">10442</span><span class="refDoi"> DOI: 10.1021/jm5010336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10424-10442&author=J.+Skidmoreauthor=J.+Heerauthor=C.+N.+Johnsonauthor=D.+Nortonauthor=S.+Redshawauthor=J.+Sweetingauthor=D.+Hurstauthor=A.+Cridlandauthor=D.+Veseyauthor=I.+Wallauthor=M.+Ahmedauthor=D.+Riversauthor=J.+Myattauthor=G.+Giblinauthor=K.+Philpottauthor=U.+Kumarauthor=A.+Stevensauthor=R.+A.+Bitauthor=A.+Haynesauthor=S.+Taylorauthor=R.+Watsonauthor=J.+Witheringtonauthor=E.+Demontauthor=T.+D.+Heightman&title=Optimization+of+Sphingosine-1-phosphate+receptor+agonists%3A+effects+of+acidic%2C+basic%2C+and+zwitterionic+chemotypes+on+pharmacokinetic+and+pharmacodynamics+profiles&doi=10.1021%2Fjm5010336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm5010336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010336%26sid%3Dliteratum%253Aachs%26aulast%3DSkidmore%26aufirst%3DJ.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DSweeting%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DD.%26aulast%3DCridland%26aufirst%3DA.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWall%26aufirst%3DI.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DRivers%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DGiblin%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DOptimization%2520of%2520Sphingosine-1-phosphate%2520receptor%2520agonists%253A%2520effects%2520of%2520acidic%252C%2520basic%252C%2520and%2520zwitterionic%2520chemotypes%2520on%2520pharmacokinetic%2520and%2520pharmacodynamics%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10424%26epage%3D10442%26doi%3D10.1021%2Fjm5010336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P1 receptor agonists – Part 3: From thiophenes to pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1021/jm4014696</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014696" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=110-130&author=M.+H.+Bolliauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=C.+Kohlauthor=J.+Grimontauthor=P.+Hessauthor=C.+Lescopauthor=B.+Mathysauthor=C.+Mullerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=G.+Schmidtauthor=J.+Seifertauthor=B.+Steinerauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists+%E2%80%93+Part+3%3A+From+thiophenes+to+pyridines&doi=10.1021%2Fjm4014696"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014696%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DGrimont%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSeifert%26aufirst%3DJ.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520%25E2%2580%2593%2520Part%25203%253A%2520From%2520thiophenes%2520to%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D110%26epage%3D130%26doi%3D10.1021%2Fjm4014696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Novel S1P1 receptor agonists – Part 2: From bicylco[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1021/jm401456d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401456d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=78-97&author=M.+H.+Bolliauthor=J.+Velkerauthor=C.+Mullerauthor=B.+Mathysauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=S.+Meyerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=B.+Steiner&title=Novel+S1P1+receptor+agonists+%E2%80%93+Part+2%3A+From+bicylco%5B3.1.0%5Dhexane-fused+thiophenes+to+isobutyl+substituted+thiophenes&doi=10.1021%2Fjm401456d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fjm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401456d%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520%25E2%2580%2593%2520Part%25202%253A%2520From%2520bicylco%255B3.1.0%255Dhexane-fused%2520thiophenes%2520to%2520isobutyl%2520substituted%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D78%26epage%3D97%26doi%3D10.1021%2Fjm401456d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span> </span><span class="NLM_article-title">Discovery of oxazole and triazole derivatives as potent and selective S1P1 agonists through pharmacophore-guided design</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.ejmech.2014.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=1-15&author=Y.+Tianauthor=J.+Jinauthor=X.+Wangauthor=J.+Huauthor=Q.+Xiaoauthor=W.+Zhouauthor=X.+Chenauthor=D.+Yin&title=Discovery+of+oxazole+and+triazole+derivatives+as+potent+and+selective+S1P1+agonists+through+pharmacophore-guided+design&doi=10.1016%2Fj.ejmech.2014.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520oxazole%2520and%2520triazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520S1P1%2520agonists%2520through%2520pharmacophore-guided%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.ejmech.2014.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill-Drzewi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueneva-Boucheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, R. M.</span><span> </span><span class="NLM_article-title">Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4807</span><span class="NLM_x">–</span> <span class="NLM_lpage">4811</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.bmcl.2014.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4807-4811&author=J.+C.+Horanauthor=S.+Sanyalauthor=Y.+Choiauthor=M.+Hill-Drzewiauthor=L.+Patnaudeauthor=S.+Andersonauthor=S.+Fogalauthor=C.+Maoauthor=B.+N.+Cookauthor=K.+Gueneva-Bouchevaauthor=M.+B.+Fisherauthor=E.+Hickeyauthor=E.+Packauthor=L.+C.+Bannenauthor=D.+S.+Chanauthor=M.+B.+Macauthor=S.+M.+Ngauthor=Y.+Wangauthor=W.+Xuauthor=L.+K.+Modisauthor=R.+M.+Lemieux&title=Piperazinyl-oxadiazoles+as+selective+sphingosine-1-phosphate+receptor+agonists&doi=10.1016%2Fj.bmcl.2014.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DFogal%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DGueneva-Boucheva%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DBannen%26aufirst%3DL.%2BC.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DMac%26aufirst%3DM.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DPiperazinyl-oxadiazoles%2520as%2520selective%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4807%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2014.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin- 4-one derivatives as potent, orally active S1P1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span><span class="refDoi"> DOI: 10.1021/jm100181s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-+4-one+derivatives+as+potent%2C+orally+active+S1P1+receptor+agonists&doi=10.1021%2Fjm100181s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-%25204-one%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520S1P1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211%26doi%3D10.1021%2Fjm100181s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (siponimod), a potent and selective S1P receptor modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1021/ml300396r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28siponimod%29%2C+a+potent+and+selective+S1P+receptor+modulator&doi=10.1021%2Fml300396r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator</span></div><div class="casAuthors">Pan, Shifeng; Gray, Nathanael S.; Gao, Wenqi; Mi, Yuan; Fan, Yi; Wang, Xing; Tuntland, Tove; Che, Jianwei; Lefebvre, Sophie; Chen, Yu; Chu, Alan; Hinterding, Klaus; Gardin, Anne; End, Peter; Heining, Peter; Bruns, Christian; Cooke, Nigel G.; Nuesslein-Hildesheim, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-337</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of alkoxyimino derivs. as S1P1 agonists were discovered through de novo design using FTY720 as the chem. starting point.  Extensive structure-activity relationship studies led to the discovery of (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid (I, BAF312, Siponimod), which has recently completed phase 2 clin. trials in patients with relapsing-remitting multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV0CukK1Qn3bVg90H21EOLACvtfcHk0lhwwiKaIpqWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVynug%253D%253D&md5=a410b8b34f28380a51b3ffb63ae23161</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528siponimod%2529%252C%2520a%2520potent%2520and%2520selective%2520S1P%2520receptor%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337%26doi%3D10.1021%2Fml300396r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bar-Or, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaramozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangavelu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span> </span><span class="NLM_article-title">Effect of Ceralifimod (ONO-4641), a Sphingosine-1-Phosphate Receptor-1 and -5 Agonist, on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis: Interim Results from the Extension of the DreaMS Study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=161&issue=Suppl+3&author=A.+Bar-Orauthor=F.+Zippauthor=M.+Scaramozzaauthor=T.+Vollmerauthor=B.+Dueauthor=K.+Thangaveluauthor=T.+Fischerauthor=K.+Selmaj&title=Effect+of+Ceralifimod+%28ONO-4641%29%2C+a+Sphingosine-1-Phosphate+Receptor-1+and+-5+Agonist%2C+on+Magnetic+Resonance+Imaging+Outcomes+in+Patients+with+Multiple+Sclerosis%3A+Interim+Results+from+the+Extension+of+the+DreaMS+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Or%26aufirst%3DA.%26aulast%3DZipp%26aufirst%3DF.%26aulast%3DScaramozza%26aufirst%3DM.%26aulast%3DVollmer%26aufirst%3DT.%26aulast%3DDue%26aufirst%3DB.%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DFischer%26aufirst%3DT.%26aulast%3DSelmaj%26aufirst%3DK.%26atitle%3DEffect%2520of%2520Ceralifimod%2520%2528ONO-4641%2529%252C%2520a%2520Sphingosine-1-Phosphate%2520Receptor-1%2520and%2520-5%2520Agonist%252C%2520on%2520Magnetic%2520Resonance%2520Imaging%2520Outcomes%2520in%2520Patients%2520with%2520Multiple%2520Sclerosis%253A%2520Interim%2520Results%2520from%2520the%2520Extension%2520of%2520the%2520DreaMS%2520Study%26jtitle%3DNeurology%26date%3D2014%26volume%3D82%26issue%3DSuppl%25203%26spage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Olson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujrathu, S.</span><span> </span><span class="NLM_article-title">Safety and Tolerability of Orally Administered RPC1063, a Novel S1P1 Receptor Modulator, in Healthy Adult Volunteers, Results of a Phase 1 Study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">Meeting Abstracts 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">P01.178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2013&pages=P01.178&issue=Meeting+Abstracts+1&author=A.+Olsonauthor=J.+Hartungauthor=G.+Timonyauthor=R.+Peachauthor=M.+Boehmauthor=H.+Rosenauthor=H.+Smithauthor=C.+Panauthor=J.+Brooksauthor=S.+Gujrathu&title=Safety+and+Tolerability+of+Orally+Administered+RPC1063%2C+a+Novel+S1P1+Receptor+Modulator%2C+in+Healthy+Adult+Volunteers%2C+Results+of+a+Phase+1+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DJ.%26aulast%3DTimony%26aufirst%3DG.%26aulast%3DPeach%26aufirst%3DR.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DC.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DGujrathu%26aufirst%3DS.%26atitle%3DSafety%2520and%2520Tolerability%2520of%2520Orally%2520Administered%2520RPC1063%252C%2520a%2520Novel%2520S1P1%2520Receptor%2520Modulator%252C%2520in%2520Healthy%2520Adult%2520Volunteers%252C%2520Results%2520of%2520a%2520Phase%25201%2520Study%26jtitle%3DNeurology%26date%3D2013%26volume%3D80%26issue%3DMeeting%2520Abstracts%25201%26spage%3DP01.178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. P.</span><span> </span><span class="NLM_article-title">Discovery of APD334: Design of a clinical stage functional antagonist of the sphingosine-1-phosphate-1 receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1021/ml500389m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500389m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1313-1317&author=D.+J.+Buzardauthor=S.+H.+Kimauthor=L.+Lopezauthor=A.+Kawasakiauthor=X.+Zhuauthor=J.+Moodyauthor=T.+Thoresenauthor=I.+Calderonauthor=B.+Ullmanauthor=S.+Hanauthor=J.+Lehmannauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+G.+Montalbanauthor=Y.-A.+Maauthor=C.+Sageauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=W.+Chenauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=D.+Millsauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=I.+Gaidarovauthor=T.+Anthonyauthor=D.+J.+Unettauthor=A.+Blackburnauthor=J.+Rueterauthor=S.+Stirnauthor=D.+P.+Behanauthor=R.+P.+Jones&title=Discovery+of+APD334%3A+Design+of+a+clinical+stage+functional+antagonist+of+the+sphingosine-1-phosphate-1+receptor&doi=10.1021%2Fml500389m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor</span></div><div class="casAuthors">Buzard, Daniel J.; Kim, Sun Hee; Lopez, Luis; Kawasaki, Andrew; Zhu, Xiuwen; Moody, Jeanne; Thoresen, Lars; Calderon, Imelda; Ullman, Brett; Han, Sangdon; Lehmann, Juerg; Gharbaoui, Tawfik; Sengupta, Dipanjan; Calvano, Lorene; Montalban, Antonio Garrido; Ma, You-An; Sage, Carleton; Gao, Yinghong; Semple, Graeme; Edwards, Jeff; Barden, Jeremy; Morgan, Michael; Chen, Weichao; Usmani, Khawja; Chen, Chuan; Sadeque, Abu; Christopher, Ronald J.; Thatte, Jayant; Fu, Lixia; Solomon, Michelle; Mills, David; Whelan, Kevin; Al-Shamma, Hussien; Gatlin, Joel; Le, Minh; Gaidarov, Ibragim; Anthony, Todd; Unett, David J.; Blackburn, Anthony; Rueter, Jaimie; Stirn, Scott; Behan, Dominic P.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">APD334 I was discovered as part of the internal effort to identify potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases.  I is a potent functional antagonist of S1P1 and has a favorable PK/PD profile, producing robust lymphocyte lowering at relatively low plasma concns. in several preclin. species.  This new agent was efficacious in a mouse exptl. autoimmune encephalomyelitis model of MS and a rat collagen induced arthritis model and was found to have appreciable central exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ikF-8Xd3ibVg90H21EOLACvtfcHk0lg4qGaTRJQNvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE&md5=1e44d556d856ea6f87883b3a535e554c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fml500389m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500389m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DThoresen%26aufirst%3DT.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DUllman%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DMontalban%26aufirst%3DA.%2BG.%26aulast%3DMa%26aufirst%3DY.-A.%26aulast%3DSage%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DRueter%26aufirst%3DJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BP.%26atitle%3DDiscovery%2520of%2520APD334%253A%2520Design%2520of%2520a%2520clinical%2520stage%2520functional%2520antagonist%2520of%2520the%2520sphingosine-1-phosphate-1%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1313%26epage%3D1317%26doi%3D10.1021%2Fml500389m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, J.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers</span> <span class="citation_source-journal">Clinical Pharmacology in Drug Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1002/cpdd.98</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1002%2Fcpdd.98" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=170-178&author=J.+Xuauthor=F.+Grayauthor=A.+Hendersonauthor=K.+Hicksauthor=J.+Yangauthor=P.+Thompsonauthor=J.+Oliver&title=Safety%2C+pharmacokinetics%2C+pharmacodynamics%2C+and+bioavailability+of+GSK2018682%2C+a+sphingosine-1-phosphate+receptor+modulator%2C+in+healthy+volunteers&doi=10.1002%2Fcpdd.98"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.98%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DF.%26aulast%3DHenderson%26aufirst%3DA.%26aulast%3DHicks%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DP.%26aulast%3DOliver%26aufirst%3DJ.%26atitle%3DSafety%252C%2520pharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520bioavailability%2520of%2520GSK2018682%252C%2520a%2520sphingosine-1-phosphate%2520receptor%2520modulator%252C%2520in%2520healthy%2520volunteers%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26date%3D2014%26volume%3D3%26spage%3D170%26epage%3D178%26doi%3D10.1002%2Fcpdd.98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1124/jpet.103.062828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes&doi=10.1124%2Fjpet.103.062828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lhI9Q7Ldev3-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768%26doi%3D10.1124%2Fjpet.103.062828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+Crumbauthor=M.+Saltzmanauthor=M.+Rosenbergauthor=E.+Wallstrom&title=The+selective+sphingosine+1-phosphate+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate&doi=10.1111%2Fj.1476-5381.2012.02061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely, P.; Nuesslein-Hildesheim, B.; Guerini, D.; Brinkmann, V.; Traebert, M.; Bruns, C.; Pan, S.; Gray, N. S.; Hinterding, K.; Cooke, N. G.; Groenewegen, A.; Vitaliti, A.; Sing, T.; Luttringer, O.; Yang, J.; Gardin, A.; Wang, N.; Crumb, W. J., Jr.; Saltzman, M.; Rosenberg, M.; Wallstrom, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P1 and S1P5 receptors.  S1P1 receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclin. and human data.  Exptl. Approach BAF312 was tested in a rat exptl. autoimmune encephalomyelitis (EAE) model.  Electrophysiol. recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  Key Results BAF312 effectively suppressed EAE in rats by internalizing S1P1 receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4+ T cells, Tnaive, Tcentral memory and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P3 receptors (assocd. with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  Conclusion and Implications This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42VfW58NMyLVg90H21EOLACvtfcHk0lhI9Q7Ldev3-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE&md5=0034be62fb68b10abefff50f0220be2a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSaltzman%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DThe%2520selective%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047%26doi%3D10.1111%2Fj.1476-5381.2012.02061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Watterson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langevine, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex-Rabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Potent and selective agonists of sphingosine 1-phosphate 1 (S1P1): Discovery and SAR of a novel isoxazole based series</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2820</span><span class="NLM_x">–</span> <span class="NLM_lpage">2840</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2820-2840&author=S.+H.+Wattersonauthor=J.+Guoauthor=S.+H.+Spergelauthor=C.+M.+Langevineauthor=R.+V.+Moquinauthor=D.+R.+Shenauthor=M.+Yardeauthor=M.+E.+Cvijicauthor=D.+Banasauthor=R.+Liuauthor=S.+J.+Suchardauthor=K.+Gilloolyauthor=T.+Taylorauthor=S.+Rex-Rabeauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=G.+Corneliusauthor=C.+D%E2%80%99Arienzoauthor=A.+Marinoauthor=P.+Balimaneauthor=B.+Warrackauthor=L.+Salter-Cidauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=W.+J.+Pittsauthor=J.+Xieauthor=A.+J.+Dyckman&title=Potent+and+selective+agonists+of+sphingosine+1-phosphate+1+%28S1P1%29%3A+Discovery+and+SAR+of+a+novel+isoxazole+based+series&doi=10.1021%2Facs.jmedchem.6b00089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00089%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DBanas%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DTaylor%26aufirst%3DT.%26aulast%3DRex-Rabe%26aufirst%3DS.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DMarino%26aufirst%3DA.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DWarrack%26aufirst%3DB.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520agonists%2520of%2520sphingosine%25201-phosphate%25201%2520%2528S1P1%2529%253A%2520Discovery%2520and%2520SAR%2520of%2520a%2520novel%2520isoxazole%2520based%2520series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2820%26epage%3D2840%26doi%3D10.1021%2Facs.jmedchem.6b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3679</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.bmcl.2006.04.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3679-3683&author=L.+Yanauthor=P.+Huoauthor=G.+Dohertyauthor=L.+Tothauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=E.+Quackenbushauthor=A.+Wickhamauthor=S.+M.+Mandala&title=Discovery+of+3-arylpropionic+acids+as+potent+agonists+of+sphingosine-1-phosphate+receptor-1+%28S1P1%29+with+high+selectivity+against+all+other+known+S1P+receptor+subtypes&doi=10.1016%2Fj.bmcl.2006.04.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.084%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DWickham%26aufirst%3DA.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%25203-arylpropionic%2520acids%2520as%2520potent%2520agonists%2520of%2520sphingosine-1-phosphate%2520receptor-1%2520%2528S1P1%2529%2520with%2520high%2520selectivity%2520against%2520all%2520other%2520known%2520S1P%2520receptor%2520subtypes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3679%26epage%3D3683%26doi%3D10.1016%2Fj.bmcl.2006.04.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dhar, T. G. M.; Xiao, H.-Y.; Watterson, S. H.; Ko, S.; Dyckman, A. J.; Langevine, C. M.; Das, J.; Cherney, R. J.</span><span> </span><span class="NLM_article-title">Tricyclic heterocyclic compounds</span>. Patent application WO2011/059784,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=T.+G.+M.+Dhar&author=H.-Y.+Xiao&author=S.+H.+Watterson&author=S.+Ko&author=A.+J.+Dyckman&author=C.+M.+Langevine&author=J.+Das&author=R.+J.+Cherney&title=Tricyclic+heterocyclic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DTricyclic%2520heterocyclic%2520compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Xiao, H.-X.; Watterson, S. H.; Langevine, C. M.; Srivastava, A. S.; Ko, S. S.; Gilmore, J. L.; Sheppeck, J. E.; Zhang, Y.; Cherney, R. J.; Li, L.; Wu, D.-R.; Ramasamy, D.; Arunachalam, P.; Mathur, A.; Taylor, T. L.; Shuster, D. J.; McIntyre, K. W.; Chen, D.-R.; Yarde, M.; Cvijic, M. E.; Marino, A. M.; Balimane, P. V.; Yang, Z.; Banas, D. M.; Liu, R.; Cornelius, G.; Darienzo, C. J.; Lehman-McKeeman, L.; Salter-Cid, L.; Xie, J.; Barrish, J. C.; Carter, P. H.; Dyckman, A. J.; Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">Novel tricyclic modulators of sphingosine-1-phosphate receptor (S1P<sub>1</sub>)</span>.  <span class="citation_source-book">Abstracts of Papers, 244th National Meeting & Exposition of the American Chemical Society, Indianapolis, IN, U.S., September 8–12, 2013</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span> <span class="NLM_fpage">MEDI-66</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=MEDI-66&author=H.-X.+Xiao&author=S.+H.+Watterson&author=C.+M.+Langevine&author=A.+S.+Srivastava&author=S.+S.+Ko&author=J.+L.+Gilmore&author=J.+E.+Sheppeck&author=Y.+Zhang&author=R.+J.+Cherney&author=L.+Li&author=D.-R.+Wu&author=D.+Ramasamy&author=P.+Arunachalam&author=A.+Mathur&author=T.+L.+Taylor&author=D.+J.+Shuster&author=K.+W.+McIntyre&author=D.-R.+Chen&author=M.+Yarde&author=M.+E.+Cvijic&author=A.+M.+Marino&author=P.+V.+Balimane&author=Z.+Yang&author=D.+M.+Banas&author=R.+Liu&author=G.+Cornelius&author=C.+J.+Darienzo&author=L.+Lehman-McKeeman&author=L.+Salter-Cid&author=J.+Xie&author=J.+C.+Barrish&author=P.+H.+Carter&author=A.+J.+Dyckman&author=T.+G.+M.+Dhar&title=Abstracts+of+Papers%2C+244th+National+Meeting+%26+Exposition+of+the+American+Chemical+Society%2C+Indianapolis%2C+IN%2C+U.S.%2C+September+8%E2%80%9312%2C+2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DH.-X.%26atitle%3DNovel%2520tricyclic%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptor%2520%2528S1P1%2529%26btitle%3DAbstracts%2520of%2520Papers%252C%2520244th%2520National%2520Meeting%2520%2526%2520Exposition%2520of%2520the%2520American%2520Chemical%2520Society%252C%2520Indianapolis%252C%2520IN%252C%2520U.S.%252C%2520September%25208%25E2%2580%259312%252C%25202013%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013%26spage%3DMEDI-66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Beam, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schady, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakkhit, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornsby, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer-Martinez, S. L.</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3391</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span><span class="refDoi"> DOI: 10.1080/00397910008086979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1080%2F00397910008086979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslykurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Beam%2C+C.+F.%3B+Schady%2C+D.+A.%3B+Rose%2C+K.+L.%3B+Kelley%2C+W.%2C+Jr.%3B+Rakkhit%2C+R.%3B+Hornsby%2C+C.+D.%3B+Studer-Martinez%2C+S.+L.Synth.+Commun.+2000%2C+30%2C+3391%E2%80%933404+10.1080%2F00397910008086979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 4,5-dihydro-3-arylnaphth[1,2-c]isoxazoles from dilithiated 1-tetralone oxime and aromatic esters</span></div><div class="casAuthors">Beam, Charles F.; Schady, Deborah A.; Rose, Kelly L.; Kelley, Wayne, Jr.; Rakkhit, Ronjay; Hornsby, Christopher D.; Studer-Martinez, Shannon L.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3391-3404</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Dilithiated 1-tetralone oxime was prepd. in excess lithium diisopropylamide and condensed with a variety of esters, followed by acid cyclization of C-acylated intermediates, to give substituted 4,5-dihydronaphth[1,2-c]isoxazoles [I, R = (un)substituted phenyl].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6wbZf7JdtLVg90H21EOLACvtfcHk0ljA00_gpGoApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslykurg%253D&md5=184bc6c4cca78bd266b3b3a760567b96</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1080%2F00397910008086979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008086979%26sid%3Dliteratum%253Aachs%26aulast%3DBeam%26aufirst%3DC.%2BF.%26aulast%3DSchady%26aufirst%3DD.%2BA.%26aulast%3DRose%26aufirst%3DK.%2BL.%26aulast%3DKelley%26aufirst%3DW.%26aulast%3DRakkhit%26aufirst%3DR.%26aulast%3DHornsby%26aufirst%3DC.%2BD.%26aulast%3DStuder-Martinez%26aufirst%3DS.%2BL.%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D3391%26epage%3D3404%26doi%3D10.1080%2F00397910008086979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ohigashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1021/op0497862</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op0497862" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ohigashi%2C+A.%3B+Kanda%2C+A.%3B+Tsuboi%2C+H.%3B+Hashimoto%2C+N.Org.+Process+Res.+Dev.+2005%2C+9%2C+179%E2%80%93184+10.1021%2Fop0497862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fop0497862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0497862%26sid%3Dliteratum%253Aachs%26aulast%3DOhigashi%26aufirst%3DA.%26aulast%3DKanda%26aufirst%3DA.%26aulast%3DTsuboi%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DN.%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2005%26volume%3D9%26spage%3D179%26epage%3D184%26doi%3D10.1021%2Fop0497862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liaskopoulos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoulika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoungas, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varvounis, G.</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1055/s-2008-1032178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1055%2Fs-2008-1032178" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liaskopoulos%2C+T.%3B+Skoulika%2C+S.%3B+Tsoungas%2C+P.+G.%3B+Varvounis%2C+G.Synthesis+2008%2C+2008%2C+711%E2%80%93718+10.1055%2Fs-2008-1032178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1055%2Fs-2008-1032178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2008-1032178%26sid%3Dliteratum%253Aachs%26aulast%3DLiaskopoulos%26aufirst%3DT.%26aulast%3DSkoulika%26aufirst%3DS.%26aulast%3DTsoungas%26aufirst%3DP.%2BG.%26aulast%3DVarvounis%26aufirst%3DG.%26jtitle%3DSynthesis%26date%3D2008%26volume%3D2008%26spage%3D711%26epage%3D718%26doi%3D10.1055%2Fs-2008-1032178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Nishio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">2347</span><span class="NLM_x">–</span> <span class="NLM_lpage">2354</span><span class="refDoi"> DOI: 10.1002/1522-2675(20010815)84:8<2347::AID-HLCA2347>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nishio%2C+T.%3B+Ori%2C+M.Helv.+Chim.+Acta+2001%2C+84%2C+2347%E2%80%932354+10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1522-2675%252820010815%252984%253A8%253C2347%253A%253AAID-HLCA2347%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DNishio%26aufirst%3DT.%26aulast%3DOri%26aufirst%3DM.%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2001%26volume%3D84%26spage%3D2347%26epage%3D2354%26doi%3D10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gilmore, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppeck, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galella, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship (SAR) of a series of ethanolamine-based direct-acting agonists of sphingosine-1-phosphate (S1P1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6248</span><span class="NLM_x">–</span> <span class="NLM_lpage">6264</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6248-6264&author=J.+L.+Gilmoreauthor=J.+E.+Sheppeckauthor=S.+H.+Wattersonauthor=L.+Haqueauthor=P.+Mukhopadhyayauthor=A.+J.+Tebbenauthor=M.+A.+Galellaauthor=D.+R.+Shenauthor=M.+Yardeauthor=M.+E.+Cvijicauthor=V.+Borowskiauthor=K.+M.+Gilloolyauthor=T.+Taylorauthor=K.+W.+McIntyreauthor=B.+Warrackauthor=P.+C.+Levesqueauthor=J.+P.+Liauthor=G.+Corneliusauthor=C.+J.+D%E2%80%99Arienzoauthor=A.+M.+Marinoauthor=P.+V.+Balimaneauthor=L.+Salter-Cidauthor=J.+C.+Barrishauthor=W.+J.+Pittsauthor=P.+H.+Carterauthor=J.+Xieauthor=A.+J.+Dyckman&title=Discovery+and+structure+activity+relationship+%28SAR%29+of+a+series+of+ethanolamine-based+direct-acting+agonists+of+sphingosine-1-phosphate+%28S1P1%29&doi=10.1021%2Facs.jmedchem.6b00373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00373%26sid%3Dliteratum%253Aachs%26aulast%3DGilmore%26aufirst%3DJ.%2BL.%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DHaque%26aufirst%3DL.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DBorowski%26aufirst%3DV.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DTaylor%26aufirst%3DT.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DWarrack%26aufirst%3DB.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DMarino%26aufirst%3DA.%2BM.%26aulast%3DBalimane%26aufirst%3DP.%2BV.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520%2528SAR%2529%2520of%2520a%2520series%2520of%2520ethanolamine-based%2520direct-acting%2520agonists%2520of%2520sphingosine-1-phosphate%2520%2528S1P1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6248%26epage%3D6264%26doi%3D10.1021%2Facs.jmedchem.6b00373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g','cit7h'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5267-5289. <a href="https://doi.org/10.1021/acs.jmedchem.6b01575" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulators%252Bof%252BSphingosine-1-phosphate%252BPathway%252BBiology%25253A%252BRecent%252BAdvances%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAgonists%252Band%252BFuture%252BPerspectives%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D30032017%26date%3D13072017%26date%3D14032017%26volume%3D60%26issue%3D13%26spage%3D5267%26epage%3D5289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiuhang Henry  Yip</span>, <span class="hlFld-ContribAuthor ">Dauh‐Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">James  Kempson</span>, <span class="hlFld-ContribAuthor ">Andres  Hernandez</span>, <span class="hlFld-ContribAuthor ">Huiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Dawn  Sun</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>. </span><span class="cited-content_cbyCitation_article-title">Large‐scale chiral supercritical fluid chromatography of a key intermediate in the synthesis of two S1P
              1
              final active pharmaceutical ingredients. </span><span class="cited-content_cbyCitation_journal-name">SEPARATION SCIENCE PLUS</span><span> <strong>2019,</strong> <em>2 </em>
                                    (9)
                                     , 343-352. <a href="https://doi.org/10.1002/sscp.201900047" title="DOI URL">https://doi.org/10.1002/sscp.201900047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/sscp.201900047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsscp.201900047%26sid%3Dliteratum%253Aachs%26jtitle%3DSEPARATION%2520SCIENCE%2520PLUS%26atitle%3DLarge%2525E2%252580%252590scale%252Bchiral%252Bsupercritical%252Bfluid%252Bchromatography%252Bof%252Ba%252Bkey%252Bintermediate%252Bin%252Bthe%252Bsynthesis%252Bof%252Btwo%252BS1P%252B1%252Bfinal%252Bactive%252Bpharmaceutical%252Bingredients%26aulast%3DYip%26aufirst%3DShiuhang%2BHenry%26date%3D2019%26date%3D2019%26volume%3D2%26issue%3D9%26spage%3D343%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ambra  Vestri</span>, <span class="hlFld-ContribAuthor ">Federica  Pierucci</span>, <span class="hlFld-ContribAuthor ">Alessia  Frati</span>, <span class="hlFld-ContribAuthor ">Lucia  Monaco</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Meacci</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fphar.2017.00296" title="DOI URL">https://doi.org/10.3389/fphar.2017.00296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2017.00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2017.00296%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DSphingosine%252B1-Phosphate%252BReceptors%25253A%252BDo%252BThey%252BHave%252Ba%252BTherapeutic%252BPotential%252Bin%252BCardiac%252BFibrosis%25253F%26aulast%3DVestri%26aufirst%3DAmbra%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Marcoux</span>, <span class="hlFld-ContribAuthor ">Hai-Yun  Xiao</span>, <span class="hlFld-ContribAuthor ">T. G.  Murali Dhar</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, <span class="hlFld-ContribAuthor ">Lois D.  Lehman-McKeeman</span>, <span class="hlFld-ContribAuthor ">Dauh-Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">Marta  Dabros</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Yang</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Taylor</span>, <span class="hlFld-ContribAuthor ">Xia D.  Zhou</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Heimrich</span>, <span class="hlFld-ContribAuthor ">Rochelle  Thomas</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huadong  Sun</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Marino</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia J.  D'Arienzo</span>, <span class="hlFld-ContribAuthor ">Anuradha  Gupta</span>, <span class="hlFld-ContribAuthor ">Bala  Pragalathan</span>, <span class="hlFld-ContribAuthor ">Richard  Rampulla</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potent tricyclic prodrug S1P
              1
              receptor modulators. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 725-729. <a href="https://doi.org/10.1039/C6MD00539J" title="DOI URL">https://doi.org/10.1039/C6MD00539J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00539J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00539J%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252Bpotent%252Btricyclic%252Bprodrug%252BS1P%252B1%252Breceptor%252Bmodulators%26aulast%3DMarcoux%26aufirst%3DDavid%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D725%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of S1P, fingolimod (FTY720), and its phosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of tricyclic modulators of S1P<sub>1</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) Tf<sub>2</sub>O, Py, 0 °C to RT, 4 h, 94%, (2) tributyl(vinyl)stannane, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 100 °C, 14 h, 80%, (3) NH<sub>2</sub>OH·HCl, NaOAc, MeOH, 80 °C, 1.5 h, 70%; (b) (1) TMS-Cl, DIPEA, THF, 0 °C, (2) LiTMP, THF, methyl 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylate,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> −78 to 0 °C, (3) SOCl<sub>2</sub>, Py, PhMe, RT to 90 °C, 25% for 3 steps; (c) OsO<sub>4</sub>, NMO, THF, overnight then NaIO<sub>4</sub>, H<sub>2</sub>O, 30 min, 100%; (d) (1) <i>tert</i>-butyl azetidine-3-carboxylate, NaBH(OAc)<sub>3</sub>, Ti(OiPr)<sub>4</sub>, MeOH, DCE, 2 h, 79%, (2) TFA, 90%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-chloropropanoic acid, CF<sub>3</sub>-SO<sub>3</sub>H, 80 °C, 75%; (b) 2 M aq NaOH, 5 °C–RT, 6 M aq H<sub>2</sub>SO<sub>4</sub>, 81%; (c) (CF<sub>3</sub>-SO<sub>2</sub>)<sub>2</sub>O, pyridine, 86%; (d) tributyl(vinyl)stannane, lithium chloride, Pd(PhP)<sub>4</sub>, dioxane, 100 °C, 80%; (e) OsO<sub>4</sub>, NMO, THF, 99%; (f) dimethoxypropane, (1<i>R</i>)-(−)-camphorsulfonic acid, 58%; (g) TiCl<sub>4</sub>, morpholine, toluene, 89%; (h) 3-phenyl-4-(trifluoromethyl)isoxazole-5-carbonyl fluoride,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Et<sub>3</sub>N, CH<sub>3</sub>CN:NH<sub>2</sub>OH-HCl, NaOAc, H<sub>2</sub>O, 45 °C, 17%; (i) SOCl<sub>2</sub>, pyridine, toluene, 62%; (j) TFA, 100%; (k) NaIO<sub>4</sub>, THF, H<sub>2</sub>O; (l) <i>tert</i>-butyl azetidine-3-carboxylate, acetic acid salt, AcOH, titantium(IV) isopropoxide, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 64%; (m) TFA, MeOH slurry crystallization, 99%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) i-BuOCOCl, <i>N</i>-methylmorpholine, THF, NaBH<sub>4</sub>, THF–MeOH, 63%; (b) Dess–Martin reagent, CH<sub>2</sub>Cl<sub>2</sub>, 99%%; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, THF, 67%; (d) <i>n</i>-BuLi, THF, paraformaldehyde, 63%; (e) PBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 40–60%; (f) 4-bromo-2-hydroxybenzaldehyde, K<sub>2</sub>CO<sub>3</sub>, DMF, >85%; (g) NH<sub>2</sub>OH-HCl, Et<sub>3</sub>N, MeOH, 97%; (h) NaOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 73%; (i) tributyl(vinyl)stannane, lithium chloride, (PhP)<sub>4</sub>Pd, dioxane, 100 °C, 67%; (j) OsO<sub>4</sub>, NMO, THF, NaIO<sub>4</sub>, THF, H<sub>2</sub>O, 95%; (k) <i>tert</i>-butyl azetidine-3-carboxylate, acetic acid salt, AcOH, titantium(IV) isopropoxide, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 58%; (ll) TFA, neutralization, MeOH, slurry crystallization, 65%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Isomeric Tricyclic S1P<sub>1</sub> Modulator <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, pTsOH, 60 °C, 11 min; (b) NaN<sub>3</sub>, acetone, water, 3 h rt, 69% over two steps; (c) Pd/C, 2 N HCl, MeOH, 50 psi H<sub>2</sub>, rt 4 h, 74%; (d) (1) 3-phenyl-4-trifluoromethyl)isoxazole-5-carboxylic acid,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> oxalyl chloride, DMF, DCM, 0 °C, (2) DMAP, Hunig’s base, DCM, rt overnight, 40%; (e) Lawesson’s reagent, THF, 30 min, 120 °C μ-wave, 60%; (f) BBr<sub>3</sub>, DCM, 6 h, rt, 100%; (g) triflic anhydride, pyridine, 0 °C, 89%; (h) tributyl(vinyl)stannane, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 100 °C, overnight; (i) OsO<sub>4</sub>, NMO, THF, 3 h, rt then NaIO<sub>4</sub>, H<sub>2</sub>O, 90 min, 47% over two steps; (j) (1) azetidine-3-carboxylic acid, AcOH, MeOH, 1,2-dichloroethane, 1 h, 80 °C, (2) NaCNBH<sub>3</sub>, rt, 1 h, 25%.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat lymphocyte reduction of compound <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/medium/jm-2016-01099j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Rat adjuvant arthritis study of compound <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01099/20161104/images/large/jm-2016-01099j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01099&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1038/nature02284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1038%2Fnature02284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=14737169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=G.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1&doi=10.1038%2Fnature02284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span></div><div class="casAuthors">Matloubian, Mehrdad; Lo, Charles G.; Cinamon, Guy; Lesneski, Matthew J.; Xu, Ying; Brinkmann, Volker; Allende, Maria L.; Proia, Richard L.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">6972</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adaptive immunity depends on T-cell exit from the thymus and T and B cells traveling between secondary lymphoid organs to survey for antigens.  After activation in lymphoid organs, T cells must again return to circulation to reach sites of infection; however, the mechanisms regulating lymphoid organ exit are unknown.  An immunosuppressant drug, FTY720, inhibits lymphocyte emigration from lymphoid organs, and phosphorylated FTY720 binds and activates four of the five known sphingosine-1-phosphate (S1P) receptors.  However, the role of S1P receptors in normal immune cell trafficking is unclear.  Here we show that in mice whose hematopoietic cells lack a single S1P receptor (S1P1; also known as Edg1) there are no T cells in the periphery because mature T cells are unable to exit the thymus.  Although B cells are present in peripheral lymphoid organs, they are severely deficient in blood and lymph.  Adoptive cell transfer expts. establish an intrinsic requirement for S1P1 in T and B cells for lymphoid organ egress.  Furthermore, S1P1-dependent chemotactic responsiveness is strongly upregulated in T-cell development before exit from the thymus, whereas S1P1 is downregulated during peripheral lymphocyte activation, and this is assocd. with retention in lymphoid organs.  We find that FTY720 treatment downregulates S1P1, creating a temporary pharmacol. S1P1-null state in lymphocytes, providing an explanation for the mechanism of FTY720-induced lymphocyte sequestration.  These findings establish that S1P1 is essential for lymphocyte recirculation and that it regulates egress from both thymus and peripheral lymphoid organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mWA73kFtwbVg90H21EOLACvtfcHk0lg8D2EXhkYGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D&md5=0dd84e9cca37ec30894497ff4477d0d8</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnature02284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02284%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DG.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360%26doi%3D10.1038%2Fnature02284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sykes, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddy, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuiness, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattikar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaenzel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S.</span><span> </span><span class="NLM_article-title">Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">4797</span><span class="NLM_x">–</span> <span class="NLM_lpage">4807</span><span class="refDoi"> DOI: 10.1111/bph.12620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1111%2Fbph.12620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=24641481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=4797-4807&author=D.+A.+Sykesauthor=D.+M.+Riddyauthor=C.+Stampauthor=M.+E.+Bradleyauthor=N.+McGuinessauthor=A.+Sattikarauthor=D.+Gueriniauthor=I.+Rodriguesauthor=A.+Glaenzelauthor=M.+R.+Dowlingauthor=F.+Mullershausenauthor=S.+Charlton&title=Investigating+the+molecular+mechanisms+through+which+FTY720-P+causes+persistent+S1P1+receptor+internalization&doi=10.1111%2Fbph.12620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization</span></div><div class="casAuthors">Sykes, David A.; Riddy, Darren M.; Stamp, Craig; Bradley, Michelle E.; McGuiness, Neil; Sattikar, Afrah; Guerini, Danilo; Rodrigues, Ines; Glaenzel, Albrecht; Dowling, Mark R.; Mullershausen, Florian; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4797-4807</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The mol. mechanism underlying the clin. efficacy of FTY720-P is thought to involve persistent internalization and enhanced degrdn. of the S1P1 receptor subtype (S1P1R).  We have investigated whether receptor binding kinetics and β-arrestin recruitment could play a role in the persistent internalization of the S1P1R by FTY720-P.  [3H]-FTY720-P and [33P]-S1P were used to label CHO-S1P1/3Rs for binding studies.  Ligand efficacy was assessed through [35S]-GTPγS binding and β-arrestin recruitment.  Metabolic stability was evaluated using a bioassay measuring intracellular Ca2+ release.  CHO-S1P1/3R nos. were detd., following FTY720-P treatment using flow cytometry.  The kinetic off-rate of [3H]-FTY720-P from the S1P1R was sixfold slower than from the S1P3R, and comparable to [33P]-S1P dissocn. from S1P1/3Rs.  S1P and FTY720-P stimulated [35S]-GTPγS incorporation to similar degrees, but FTY720-P was over 30-fold less potent at S1P3Rs.  FTY720-P stimulated a higher level of β-arrestin recruitment at S1P1Rs, 132% of the total recruited by S1P.  In contrast, FTY720-P was a weak partial agonist at S1P3R, stimulating just 29% of the total β-arrestin recruited by S1P.  Internalization expts. confirmed that cell surface expression of the S1P1R but not the S1P3R was reduced following a pulse exposure to FTY720-P, which is metabolically stable unlike S1P.  FTY720-P and S1P activation of the S1P1R results in receptor internalization as a consequence of an efficient recruitment of β-arrestin.  The combination of slow off-rate, efficacious β-arrestin recruitment and metabolic stability all contribute to FTY720-P's ability to promote prolonged S1P1R internalization and may be crit. factors in its efficacy in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ExW4g6HHRrVg90H21EOLACvtfcHk0lg8D2EXhkYGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsb7K&md5=017d19d0eb9abd87ee8b0bf6d46aae25</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fbph.12620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12620%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DRiddy%26aufirst%3DD.%2BM.%26aulast%3DStamp%26aufirst%3DC.%26aulast%3DBradley%26aufirst%3DM.%2BE.%26aulast%3DMcGuiness%26aufirst%3DN.%26aulast%3DSattikar%26aufirst%3DA.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DRodrigues%26aufirst%3DI.%26aulast%3DGlaenzel%26aufirst%3DA.%26aulast%3DDowling%26aufirst%3DM.%2BR.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DCharlton%26aufirst%3DS.%26atitle%3DInvestigating%2520the%2520molecular%2520mechanisms%2520through%2520which%2520FTY720-P%2520causes%2520persistent%2520S1P1%2520receptor%2520internalization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D4797%26epage%3D4807%26doi%3D10.1111%2Fbph.12620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e3181cbf825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1097%2FWNF.0b013e3181cbf825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+sclerosis&doi=10.1097%2FWNF.0b013e3181cbf825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e3181cbf825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e3181cbf825%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FWNF.0b013e3181cbf825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstorm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1126/science.1070238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1126%2Fscience.1070238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=11923495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstormauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists&doi=10.1126%2Fscience.1070238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span></div><div class="casAuthors">Mandala, Suzanne; Hajdu, Richard; Bergstrom, James; Quackenbush, Elizabeth; Xie, Jenny; Milligan, James; Thornton, Rosemary; Shei, Gan-Ju; Card, Deborah; Keohane, Carolann; Rosenbach, Mark; Hale, Jeffrey; Lynch, Christopher L.; Rupprecht, Kathleen; Parsons, William; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5566</span>),
    <span class="NLM_cas:pages">346-349</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Blood lymphocyte nos., essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs.  We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720.  Both species were high-affinity agonists of at least four of the five S1P receptors.  These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen.  S1P receptor agonists induced emptying of lymphoid sinuses by retention of lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph.  Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPvwG_lLsA8LVg90H21EOLACvtfcHk0lipc6AGtbh4IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D&md5=b57cbcffe41d144e701dbd42459cf38a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070238%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstorm%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349%26doi%3D10.1126%2Fscience.1070238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span><span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lipc6AGtbh4IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.; Brown, S.; Studer, S. M.; Rosen, H.</span><span> </span><span class="NLM_article-title">S1P signaling: new therapies and opportunities</span>.  <span class="citation_source-journal">F1000Prime Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span> (DOI: <span class="refDoi"> DOI: 10.12703/P6-109</span> ).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.12703%2FP6-109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=25580263" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&author=P.+J.+Gonzalez-Cabrera&author=S.+Brown&author=S.+M.+Studer&author=H.+Rosen&title=S1P+signaling%3A+new+therapies+and+opportunities&doi=10.12703%2FP6-109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.12703%2FP6-109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12703%252FP6-109%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26atitle%3DS1P%2520signaling%253A%2520new%2520therapies%2520and%2520opportunities%26jtitle%3DF1000Prime%2520Rep.%26date%3D2014%26volume%3D6%26doi%3D10.12703%2FP6-109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kunkel, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span><span class="refDoi"> DOI: 10.1038/nrd4099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1038%2Fnrd4099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=23954895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ylu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=688-702&author=G.+T.+Kunkelauthor=M.+Maceykaauthor=S.+Milstienauthor=S.+Spiegel&title=Targeting+the+sphingosine-1-phosphate+axis+in+cancer%2C+inflammation+and+beyond&doi=10.1038%2Fnrd4099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond</span></div><div class="casAuthors">Kunkel, Gregory T.; Maceyka, Michael; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">688-702</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bioactive lipid sphingosine-1-phosphate (S1P) is involved in multiple cellular signalling systems and has a pivotal role in the control of immune cell trafficking.  As such, S1P has been implicated in disorders such as cancer and inflammatory diseases.  This Review discusses the ways in which S1P might be therapeutically targeted - for example, via the development of chem. inhibitors that target the generation, transport and degrdn. of S1P and via the development of specific S1P receptor agonists.  We also highlight recent conflicting results obsd. in preclin. studies targeting S1P and discuss ongoing clin. trials in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm85yKwYpyLbVg90H21EOLACvtfcHk0ljdJJnkn0-apw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ylu7vL&md5=b215517638c25b2b39d7f7233feb2de0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd4099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4099%26sid%3Dliteratum%253Aachs%26aulast%3DKunkel%26aufirst%3DG.%2BT.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520sphingosine-1-phosphate%2520axis%2520in%2520cancer%252C%2520inflammation%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D688%26epage%3D702%26doi%3D10.1038%2Fnrd4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span><span class="refDoi"> DOI: 10.1021/jm0492507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists&doi=10.1021%2Fjm0492507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665%26doi%3D10.1021%2Fjm0492507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Discovery and Development of Sphingosine-1-Phosphate-1 Receptor Agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1016/B978-0-12-396492-2.00013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2FB978-0-12-396492-2.00013-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+Advances+in+the+Discovery+and+Development+of+Sphingosine-1-Phosphate-1+Receptor+Agonists&doi=10.1016%2FB978-0-12-396492-2.00013-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00013-8%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Sphingosine-1-Phosphate-1%2520Receptor%2520Agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1016%2FB978-0-12-396492-2.00013-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldred, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaux, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, G. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smethurst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydropyrazolopyridine as sphingosine 1-phosphate receptor 3 (S1P<sub>3</sub>)-sparing S1P<sub>1</sub> agonists active at low oral doses</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1003</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01512</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1003-1020&author=E.+H.+Demontauthor=J.+M.+Baileyauthor=R.+A.+Bitauthor=J.+A.+Brownauthor=C.+A.+Campbellauthor=N.+Deeksauthor=S.+J.+Dowellauthor=C.+Eldredauthor=P.+Gaskinauthor=J.+R.+J.+Grayauthor=A.+Haynesauthor=D.+J.+Hirstauthor=D.+S.+Holmesauthor=U.+Kumarauthor=M.+A.+Morseauthor=G.+J.+Osborneauthor=J.+F.+Renauxauthor=G.+A.+L.+Sealauthor=C.+A.+Smethurstauthor=S.+Taylorauthor=R.+Watsonauthor=R.+Willisauthor=J.+Witherington&title=Discovery+of+tetrahydropyrazolopyridine+as+sphingosine+1-phosphate+receptor+3+%28S1P3%29-sparing+S1P1+agonists+active+at+low+oral+doses&doi=10.1021%2Facs.jmedchem.5b01512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses</span></div><div class="casAuthors">Demont, Emmanuel H.; Bailey, James M.; Bit, Rino A.; Brown, Jack A.; Campbell, Colin A.; Deeks, Nigel; Dowell, Simon J.; Eldred, Colin; Gaskin, Pam; Gray, James R. J.; Haynes, Andrea; Hirst, David J.; Holmes, Duncan S.; Kumar, Umesh; Morse, Mary A.; Osborne, Greg J.; Renaux, Jessica F.; Seal, Gail A. L.; Smethurst, Chris A.; Taylor, Simon; Watson, Robert; Willis, Robert; Witherington, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1003-1020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FTY720 is the first oral small mol. approved for the treatment of people suffering from relapsing-remitting multiple sclerosis.  It is a potent agonist of the S1P1 receptor, but its lack of selectivity against the S1P3 receptor has been linked to most of the cardiovascular side effects obsd. in the clinic.  These findings have triggered intensive efforts toward the identification of a second generation of S1P3-sparing S1P1 agonists.  The authors have recently disclosed a series of orally active tetrahydroisoquinoline (THIQ) compds. matching these criteria.  The authors defined and implemented a strategy aiming at the discovery of selective structurally distinct follow-up agonists.  This effort culminated with the identification of a series of orally active tetrahydropyrazolopyridines, e.g. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrDxdhn4Vr3bVg90H21EOLACvtfcHk0ljrokdUuu_OFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslertQ%253D%253D&md5=578a3b903bac10da197a83fa2b766722</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01512%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DBailey%26aufirst%3DJ.%2BM.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCampbell%26aufirst%3DC.%2BA.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DEldred%26aufirst%3DC.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DHirst%26aufirst%3DD.%2BJ.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOsborne%26aufirst%3DG.%2BJ.%26aulast%3DRenaux%26aufirst%3DJ.%2BF.%26aulast%3DSeal%26aufirst%3DG.%2BA.%2BL.%26aulast%3DSmethurst%26aufirst%3DC.%2BA.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520tetrahydropyrazolopyridine%2520as%2520sphingosine%25201-phosphate%2520receptor%25203%2520%2528S1P3%2529-sparing%2520S1P1%2520agonists%2520active%2520at%2520low%2520oral%2520doses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1003%26epage%3D1020%26doi%3D10.1021%2Facs.jmedchem.5b01512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of new trycyclic indoles as potent modulators of the S1P1 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.bmcl.2014.11.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=659-663&author=D.+J.+Buzardauthor=O.+Schraderauthor=X.+Zhuauthor=J.+Lehmannauthor=B.+Johnsonauthor=M.+Kasemauthor=S.-H.+Kimauthor=A.+Kawasakiauthor=L.+Lopezauthor=J.+Moodyauthor=S.+Hanauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=J.+Thatteauthor=J.+Gatlinauthor=R.+M.+Jones&title=Design+and+synthesis+of+new+trycyclic+indoles+as+potent+modulators+of+the+S1P1+receptor&doi=10.1016%2Fj.bmcl.2014.11.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.089%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DSchrader%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520trycyclic%2520indoles%2520as%2520potent%2520modulators%2520of%2520the%2520S1P1%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D659%26epage%3D663%26doi%3D10.1016%2Fj.bmcl.2014.11.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">(7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acids as S1P1 functional agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1334</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/ml500422m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500422m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1334-1339&author=D.+J.+Buzardauthor=L.+Lopezauthor=J.+Moodyauthor=A.+Kawasakiauthor=T.+O.+Schraderauthor=M.+Kasemauthor=B.+Johnsonauthor=X.+Zhuauthor=L.+Thoresenauthor=S.+H.+Kimauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+Krishnanauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=W.+Chenauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=I.+Gaidarovauthor=T.+Anthonyauthor=M.+Leauthor=D.+J.+Unettauthor=S.+Stirnauthor=A.+Blackburnauthor=D.+P.+Behanauthor=R.+M.+Jones&title=%287-Benzyloxy-2%2C3-dihydro-1H-pyrrolo%5B1%2C2-a%5Dindol-1-yl%29acetic+acids+as+S1P1+functional+agonists&doi=10.1021%2Fml500422m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fml500422m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500422m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%2BO.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3D%25287-Benzyloxy-2%252C3-dihydro-1H-pyrrolo%255B1%252C2-a%255Dindol-1-yl%2529acetic%2520acids%2520as%2520S1P1%2520functional%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1334%26epage%3D1339%26doi%3D10.1021%2Fml500422m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Skidmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cridland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">Optimization of Sphingosine-1-phosphate receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamics profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10424</span><span class="NLM_x">–</span> <span class="NLM_lpage">10442</span><span class="refDoi"> DOI: 10.1021/jm5010336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10424-10442&author=J.+Skidmoreauthor=J.+Heerauthor=C.+N.+Johnsonauthor=D.+Nortonauthor=S.+Redshawauthor=J.+Sweetingauthor=D.+Hurstauthor=A.+Cridlandauthor=D.+Veseyauthor=I.+Wallauthor=M.+Ahmedauthor=D.+Riversauthor=J.+Myattauthor=G.+Giblinauthor=K.+Philpottauthor=U.+Kumarauthor=A.+Stevensauthor=R.+A.+Bitauthor=A.+Haynesauthor=S.+Taylorauthor=R.+Watsonauthor=J.+Witheringtonauthor=E.+Demontauthor=T.+D.+Heightman&title=Optimization+of+Sphingosine-1-phosphate+receptor+agonists%3A+effects+of+acidic%2C+basic%2C+and+zwitterionic+chemotypes+on+pharmacokinetic+and+pharmacodynamics+profiles&doi=10.1021%2Fjm5010336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm5010336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010336%26sid%3Dliteratum%253Aachs%26aulast%3DSkidmore%26aufirst%3DJ.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DSweeting%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DD.%26aulast%3DCridland%26aufirst%3DA.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWall%26aufirst%3DI.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DRivers%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DGiblin%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DOptimization%2520of%2520Sphingosine-1-phosphate%2520receptor%2520agonists%253A%2520effects%2520of%2520acidic%252C%2520basic%252C%2520and%2520zwitterionic%2520chemotypes%2520on%2520pharmacokinetic%2520and%2520pharmacodynamics%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10424%26epage%3D10442%26doi%3D10.1021%2Fjm5010336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P1 receptor agonists – Part 3: From thiophenes to pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1021/jm4014696</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014696" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=110-130&author=M.+H.+Bolliauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=C.+Kohlauthor=J.+Grimontauthor=P.+Hessauthor=C.+Lescopauthor=B.+Mathysauthor=C.+Mullerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=G.+Schmidtauthor=J.+Seifertauthor=B.+Steinerauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists+%E2%80%93+Part+3%3A+From+thiophenes+to+pyridines&doi=10.1021%2Fjm4014696"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014696%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DGrimont%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSeifert%26aufirst%3DJ.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520%25E2%2580%2593%2520Part%25203%253A%2520From%2520thiophenes%2520to%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D110%26epage%3D130%26doi%3D10.1021%2Fjm4014696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Novel S1P1 receptor agonists – Part 2: From bicylco[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1021/jm401456d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401456d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=78-97&author=M.+H.+Bolliauthor=J.+Velkerauthor=C.+Mullerauthor=B.+Mathysauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=S.+Meyerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=B.+Steiner&title=Novel+S1P1+receptor+agonists+%E2%80%93+Part+2%3A+From+bicylco%5B3.1.0%5Dhexane-fused+thiophenes+to+isobutyl+substituted+thiophenes&doi=10.1021%2Fjm401456d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fjm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401456d%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520%25E2%2580%2593%2520Part%25202%253A%2520From%2520bicylco%255B3.1.0%255Dhexane-fused%2520thiophenes%2520to%2520isobutyl%2520substituted%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D78%26epage%3D97%26doi%3D10.1021%2Fjm401456d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span> </span><span class="NLM_article-title">Discovery of oxazole and triazole derivatives as potent and selective S1P1 agonists through pharmacophore-guided design</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.ejmech.2014.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=1-15&author=Y.+Tianauthor=J.+Jinauthor=X.+Wangauthor=J.+Huauthor=Q.+Xiaoauthor=W.+Zhouauthor=X.+Chenauthor=D.+Yin&title=Discovery+of+oxazole+and+triazole+derivatives+as+potent+and+selective+S1P1+agonists+through+pharmacophore-guided+design&doi=10.1016%2Fj.ejmech.2014.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520oxazole%2520and%2520triazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520S1P1%2520agonists%2520through%2520pharmacophore-guided%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.ejmech.2014.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill-Drzewi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueneva-Boucheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, R. M.</span><span> </span><span class="NLM_article-title">Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4807</span><span class="NLM_x">–</span> <span class="NLM_lpage">4811</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.bmcl.2014.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4807-4811&author=J.+C.+Horanauthor=S.+Sanyalauthor=Y.+Choiauthor=M.+Hill-Drzewiauthor=L.+Patnaudeauthor=S.+Andersonauthor=S.+Fogalauthor=C.+Maoauthor=B.+N.+Cookauthor=K.+Gueneva-Bouchevaauthor=M.+B.+Fisherauthor=E.+Hickeyauthor=E.+Packauthor=L.+C.+Bannenauthor=D.+S.+Chanauthor=M.+B.+Macauthor=S.+M.+Ngauthor=Y.+Wangauthor=W.+Xuauthor=L.+K.+Modisauthor=R.+M.+Lemieux&title=Piperazinyl-oxadiazoles+as+selective+sphingosine-1-phosphate+receptor+agonists&doi=10.1016%2Fj.bmcl.2014.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DFogal%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DGueneva-Boucheva%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DBannen%26aufirst%3DL.%2BC.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DMac%26aufirst%3DM.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DPiperazinyl-oxadiazoles%2520as%2520selective%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4807%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2014.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin- 4-one derivatives as potent, orally active S1P1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span><span class="refDoi"> DOI: 10.1021/jm100181s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-+4-one+derivatives+as+potent%2C+orally+active+S1P1+receptor+agonists&doi=10.1021%2Fjm100181s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-%25204-one%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520S1P1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211%26doi%3D10.1021%2Fjm100181s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (siponimod), a potent and selective S1P receptor modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span><span class="refDoi"> DOI: 10.1021/ml300396r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28siponimod%29%2C+a+potent+and+selective+S1P+receptor+modulator&doi=10.1021%2Fml300396r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator</span></div><div class="casAuthors">Pan, Shifeng; Gray, Nathanael S.; Gao, Wenqi; Mi, Yuan; Fan, Yi; Wang, Xing; Tuntland, Tove; Che, Jianwei; Lefebvre, Sophie; Chen, Yu; Chu, Alan; Hinterding, Klaus; Gardin, Anne; End, Peter; Heining, Peter; Bruns, Christian; Cooke, Nigel G.; Nuesslein-Hildesheim, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-337</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of alkoxyimino derivs. as S1P1 agonists were discovered through de novo design using FTY720 as the chem. starting point.  Extensive structure-activity relationship studies led to the discovery of (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid (I, BAF312, Siponimod), which has recently completed phase 2 clin. trials in patients with relapsing-remitting multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV0CukK1Qn3bVg90H21EOLACvtfcHk0lijcgMBfDvaLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVynug%253D%253D&md5=a410b8b34f28380a51b3ffb63ae23161</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528siponimod%2529%252C%2520a%2520potent%2520and%2520selective%2520S1P%2520receptor%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337%26doi%3D10.1021%2Fml300396r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bar-Or, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaramozza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Due, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangavelu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span> </span><span class="NLM_article-title">Effect of Ceralifimod (ONO-4641), a Sphingosine-1-Phosphate Receptor-1 and -5 Agonist, on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis: Interim Results from the Extension of the DreaMS Study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=161&issue=Suppl+3&author=A.+Bar-Orauthor=F.+Zippauthor=M.+Scaramozzaauthor=T.+Vollmerauthor=B.+Dueauthor=K.+Thangaveluauthor=T.+Fischerauthor=K.+Selmaj&title=Effect+of+Ceralifimod+%28ONO-4641%29%2C+a+Sphingosine-1-Phosphate+Receptor-1+and+-5+Agonist%2C+on+Magnetic+Resonance+Imaging+Outcomes+in+Patients+with+Multiple+Sclerosis%3A+Interim+Results+from+the+Extension+of+the+DreaMS+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Or%26aufirst%3DA.%26aulast%3DZipp%26aufirst%3DF.%26aulast%3DScaramozza%26aufirst%3DM.%26aulast%3DVollmer%26aufirst%3DT.%26aulast%3DDue%26aufirst%3DB.%26aulast%3DThangavelu%26aufirst%3DK.%26aulast%3DFischer%26aufirst%3DT.%26aulast%3DSelmaj%26aufirst%3DK.%26atitle%3DEffect%2520of%2520Ceralifimod%2520%2528ONO-4641%2529%252C%2520a%2520Sphingosine-1-Phosphate%2520Receptor-1%2520and%2520-5%2520Agonist%252C%2520on%2520Magnetic%2520Resonance%2520Imaging%2520Outcomes%2520in%2520Patients%2520with%2520Multiple%2520Sclerosis%253A%2520Interim%2520Results%2520from%2520the%2520Extension%2520of%2520the%2520DreaMS%2520Study%26jtitle%3DNeurology%26date%3D2014%26volume%3D82%26issue%3DSuppl%25203%26spage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Olson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujrathu, S.</span><span> </span><span class="NLM_article-title">Safety and Tolerability of Orally Administered RPC1063, a Novel S1P1 Receptor Modulator, in Healthy Adult Volunteers, Results of a Phase 1 Study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">Meeting Abstracts 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">P01.178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2013&pages=P01.178&issue=Meeting+Abstracts+1&author=A.+Olsonauthor=J.+Hartungauthor=G.+Timonyauthor=R.+Peachauthor=M.+Boehmauthor=H.+Rosenauthor=H.+Smithauthor=C.+Panauthor=J.+Brooksauthor=S.+Gujrathu&title=Safety+and+Tolerability+of+Orally+Administered+RPC1063%2C+a+Novel+S1P1+Receptor+Modulator%2C+in+Healthy+Adult+Volunteers%2C+Results+of+a+Phase+1+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DJ.%26aulast%3DTimony%26aufirst%3DG.%26aulast%3DPeach%26aufirst%3DR.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DC.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DGujrathu%26aufirst%3DS.%26atitle%3DSafety%2520and%2520Tolerability%2520of%2520Orally%2520Administered%2520RPC1063%252C%2520a%2520Novel%2520S1P1%2520Receptor%2520Modulator%252C%2520in%2520Healthy%2520Adult%2520Volunteers%252C%2520Results%2520of%2520a%2520Phase%25201%2520Study%26jtitle%3DNeurology%26date%3D2013%26volume%3D80%26issue%3DMeeting%2520Abstracts%25201%26spage%3DP01.178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. P.</span><span> </span><span class="NLM_article-title">Discovery of APD334: Design of a clinical stage functional antagonist of the sphingosine-1-phosphate-1 receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1021/ml500389m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500389m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1313-1317&author=D.+J.+Buzardauthor=S.+H.+Kimauthor=L.+Lopezauthor=A.+Kawasakiauthor=X.+Zhuauthor=J.+Moodyauthor=T.+Thoresenauthor=I.+Calderonauthor=B.+Ullmanauthor=S.+Hanauthor=J.+Lehmannauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+G.+Montalbanauthor=Y.-A.+Maauthor=C.+Sageauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=W.+Chenauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=D.+Millsauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=I.+Gaidarovauthor=T.+Anthonyauthor=D.+J.+Unettauthor=A.+Blackburnauthor=J.+Rueterauthor=S.+Stirnauthor=D.+P.+Behanauthor=R.+P.+Jones&title=Discovery+of+APD334%3A+Design+of+a+clinical+stage+functional+antagonist+of+the+sphingosine-1-phosphate-1+receptor&doi=10.1021%2Fml500389m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor</span></div><div class="casAuthors">Buzard, Daniel J.; Kim, Sun Hee; Lopez, Luis; Kawasaki, Andrew; Zhu, Xiuwen; Moody, Jeanne; Thoresen, Lars; Calderon, Imelda; Ullman, Brett; Han, Sangdon; Lehmann, Juerg; Gharbaoui, Tawfik; Sengupta, Dipanjan; Calvano, Lorene; Montalban, Antonio Garrido; Ma, You-An; Sage, Carleton; Gao, Yinghong; Semple, Graeme; Edwards, Jeff; Barden, Jeremy; Morgan, Michael; Chen, Weichao; Usmani, Khawja; Chen, Chuan; Sadeque, Abu; Christopher, Ronald J.; Thatte, Jayant; Fu, Lixia; Solomon, Michelle; Mills, David; Whelan, Kevin; Al-Shamma, Hussien; Gatlin, Joel; Le, Minh; Gaidarov, Ibragim; Anthony, Todd; Unett, David J.; Blackburn, Anthony; Rueter, Jaimie; Stirn, Scott; Behan, Dominic P.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">APD334 I was discovered as part of the internal effort to identify potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases.  I is a potent functional antagonist of S1P1 and has a favorable PK/PD profile, producing robust lymphocyte lowering at relatively low plasma concns. in several preclin. species.  This new agent was efficacious in a mouse exptl. autoimmune encephalomyelitis model of MS and a rat collagen induced arthritis model and was found to have appreciable central exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ikF-8Xd3ibVg90H21EOLACvtfcHk0lgAUKq6mxvVcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE&md5=1e44d556d856ea6f87883b3a535e554c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fml500389m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500389m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DThoresen%26aufirst%3DT.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DUllman%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DMontalban%26aufirst%3DA.%2BG.%26aulast%3DMa%26aufirst%3DY.-A.%26aulast%3DSage%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DRueter%26aufirst%3DJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BP.%26atitle%3DDiscovery%2520of%2520APD334%253A%2520Design%2520of%2520a%2520clinical%2520stage%2520functional%2520antagonist%2520of%2520the%2520sphingosine-1-phosphate-1%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1313%26epage%3D1317%26doi%3D10.1021%2Fml500389m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, J.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers</span> <span class="citation_source-journal">Clinical Pharmacology in Drug Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1002/cpdd.98</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1002%2Fcpdd.98" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=170-178&author=J.+Xuauthor=F.+Grayauthor=A.+Hendersonauthor=K.+Hicksauthor=J.+Yangauthor=P.+Thompsonauthor=J.+Oliver&title=Safety%2C+pharmacokinetics%2C+pharmacodynamics%2C+and+bioavailability+of+GSK2018682%2C+a+sphingosine-1-phosphate+receptor+modulator%2C+in+healthy+volunteers&doi=10.1002%2Fcpdd.98"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.98%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DF.%26aulast%3DHenderson%26aufirst%3DA.%26aulast%3DHicks%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DP.%26aulast%3DOliver%26aufirst%3DJ.%26atitle%3DSafety%252C%2520pharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520bioavailability%2520of%2520GSK2018682%252C%2520a%2520sphingosine-1-phosphate%2520receptor%2520modulator%252C%2520in%2520healthy%2520volunteers%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26date%3D2014%26volume%3D3%26spage%3D170%26epage%3D178%26doi%3D10.1002%2Fcpdd.98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1124/jpet.103.062828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes&doi=10.1124%2Fjpet.103.062828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lgwEHY99LJtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768%26doi%3D10.1124%2Fjpet.103.062828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+Crumbauthor=M.+Saltzmanauthor=M.+Rosenbergauthor=E.+Wallstrom&title=The+selective+sphingosine+1-phosphate+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate&doi=10.1111%2Fj.1476-5381.2012.02061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely, P.; Nuesslein-Hildesheim, B.; Guerini, D.; Brinkmann, V.; Traebert, M.; Bruns, C.; Pan, S.; Gray, N. S.; Hinterding, K.; Cooke, N. G.; Groenewegen, A.; Vitaliti, A.; Sing, T.; Luttringer, O.; Yang, J.; Gardin, A.; Wang, N.; Crumb, W. J., Jr.; Saltzman, M.; Rosenberg, M.; Wallstrom, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P1 and S1P5 receptors.  S1P1 receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclin. and human data.  Exptl. Approach BAF312 was tested in a rat exptl. autoimmune encephalomyelitis (EAE) model.  Electrophysiol. recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  Key Results BAF312 effectively suppressed EAE in rats by internalizing S1P1 receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4+ T cells, Tnaive, Tcentral memory and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P3 receptors (assocd. with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  Conclusion and Implications This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42VfW58NMyLVg90H21EOLACvtfcHk0lgwEHY99LJtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE&md5=0034be62fb68b10abefff50f0220be2a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSaltzman%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DThe%2520selective%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047%26doi%3D10.1111%2Fj.1476-5381.2012.02061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Watterson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langevine, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex-Rabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Potent and selective agonists of sphingosine 1-phosphate 1 (S1P1): Discovery and SAR of a novel isoxazole based series</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2820</span><span class="NLM_x">–</span> <span class="NLM_lpage">2840</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2820-2840&author=S.+H.+Wattersonauthor=J.+Guoauthor=S.+H.+Spergelauthor=C.+M.+Langevineauthor=R.+V.+Moquinauthor=D.+R.+Shenauthor=M.+Yardeauthor=M.+E.+Cvijicauthor=D.+Banasauthor=R.+Liuauthor=S.+J.+Suchardauthor=K.+Gilloolyauthor=T.+Taylorauthor=S.+Rex-Rabeauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=G.+Corneliusauthor=C.+D%E2%80%99Arienzoauthor=A.+Marinoauthor=P.+Balimaneauthor=B.+Warrackauthor=L.+Salter-Cidauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=W.+J.+Pittsauthor=J.+Xieauthor=A.+J.+Dyckman&title=Potent+and+selective+agonists+of+sphingosine+1-phosphate+1+%28S1P1%29%3A+Discovery+and+SAR+of+a+novel+isoxazole+based+series&doi=10.1021%2Facs.jmedchem.6b00089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00089%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DBanas%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DTaylor%26aufirst%3DT.%26aulast%3DRex-Rabe%26aufirst%3DS.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DMarino%26aufirst%3DA.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DWarrack%26aufirst%3DB.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520agonists%2520of%2520sphingosine%25201-phosphate%25201%2520%2528S1P1%2529%253A%2520Discovery%2520and%2520SAR%2520of%2520a%2520novel%2520isoxazole%2520based%2520series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2820%26epage%3D2840%26doi%3D10.1021%2Facs.jmedchem.6b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3679</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1016%2Fj.bmcl.2006.04.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3679-3683&author=L.+Yanauthor=P.+Huoauthor=G.+Dohertyauthor=L.+Tothauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=E.+Quackenbushauthor=A.+Wickhamauthor=S.+M.+Mandala&title=Discovery+of+3-arylpropionic+acids+as+potent+agonists+of+sphingosine-1-phosphate+receptor-1+%28S1P1%29+with+high+selectivity+against+all+other+known+S1P+receptor+subtypes&doi=10.1016%2Fj.bmcl.2006.04.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.084%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DWickham%26aufirst%3DA.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%25203-arylpropionic%2520acids%2520as%2520potent%2520agonists%2520of%2520sphingosine-1-phosphate%2520receptor-1%2520%2528S1P1%2529%2520with%2520high%2520selectivity%2520against%2520all%2520other%2520known%2520S1P%2520receptor%2520subtypes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3679%26epage%3D3683%26doi%3D10.1016%2Fj.bmcl.2006.04.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dhar, T. G. M.; Xiao, H.-Y.; Watterson, S. H.; Ko, S.; Dyckman, A. J.; Langevine, C. M.; Das, J.; Cherney, R. J.</span><span> </span><span class="NLM_article-title">Tricyclic heterocyclic compounds</span>. Patent application WO2011/059784,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=T.+G.+M.+Dhar&author=H.-Y.+Xiao&author=S.+H.+Watterson&author=S.+Ko&author=A.+J.+Dyckman&author=C.+M.+Langevine&author=J.+Das&author=R.+J.+Cherney&title=Tricyclic+heterocyclic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DTricyclic%2520heterocyclic%2520compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Xiao, H.-X.; Watterson, S. H.; Langevine, C. M.; Srivastava, A. S.; Ko, S. S.; Gilmore, J. L.; Sheppeck, J. E.; Zhang, Y.; Cherney, R. J.; Li, L.; Wu, D.-R.; Ramasamy, D.; Arunachalam, P.; Mathur, A.; Taylor, T. L.; Shuster, D. J.; McIntyre, K. W.; Chen, D.-R.; Yarde, M.; Cvijic, M. E.; Marino, A. M.; Balimane, P. V.; Yang, Z.; Banas, D. M.; Liu, R.; Cornelius, G.; Darienzo, C. J.; Lehman-McKeeman, L.; Salter-Cid, L.; Xie, J.; Barrish, J. C.; Carter, P. H.; Dyckman, A. J.; Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">Novel tricyclic modulators of sphingosine-1-phosphate receptor (S1P<sub>1</sub>)</span>.  <span class="citation_source-book">Abstracts of Papers, 244th National Meeting & Exposition of the American Chemical Society, Indianapolis, IN, U.S., September 8–12, 2013</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span> <span class="NLM_fpage">MEDI-66</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=MEDI-66&author=H.-X.+Xiao&author=S.+H.+Watterson&author=C.+M.+Langevine&author=A.+S.+Srivastava&author=S.+S.+Ko&author=J.+L.+Gilmore&author=J.+E.+Sheppeck&author=Y.+Zhang&author=R.+J.+Cherney&author=L.+Li&author=D.-R.+Wu&author=D.+Ramasamy&author=P.+Arunachalam&author=A.+Mathur&author=T.+L.+Taylor&author=D.+J.+Shuster&author=K.+W.+McIntyre&author=D.-R.+Chen&author=M.+Yarde&author=M.+E.+Cvijic&author=A.+M.+Marino&author=P.+V.+Balimane&author=Z.+Yang&author=D.+M.+Banas&author=R.+Liu&author=G.+Cornelius&author=C.+J.+Darienzo&author=L.+Lehman-McKeeman&author=L.+Salter-Cid&author=J.+Xie&author=J.+C.+Barrish&author=P.+H.+Carter&author=A.+J.+Dyckman&author=T.+G.+M.+Dhar&title=Abstracts+of+Papers%2C+244th+National+Meeting+%26+Exposition+of+the+American+Chemical+Society%2C+Indianapolis%2C+IN%2C+U.S.%2C+September+8%E2%80%9312%2C+2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DH.-X.%26atitle%3DNovel%2520tricyclic%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptor%2520%2528S1P1%2529%26btitle%3DAbstracts%2520of%2520Papers%252C%2520244th%2520National%2520Meeting%2520%2526%2520Exposition%2520of%2520the%2520American%2520Chemical%2520Society%252C%2520Indianapolis%252C%2520IN%252C%2520U.S.%252C%2520September%25208%25E2%2580%259312%252C%25202013%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013%26spage%3DMEDI-66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Beam, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schady, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakkhit, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornsby, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer-Martinez, S. L.</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3391</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span><span class="refDoi"> DOI: 10.1080/00397910008086979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1080%2F00397910008086979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslykurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Beam%2C+C.+F.%3B+Schady%2C+D.+A.%3B+Rose%2C+K.+L.%3B+Kelley%2C+W.%2C+Jr.%3B+Rakkhit%2C+R.%3B+Hornsby%2C+C.+D.%3B+Studer-Martinez%2C+S.+L.Synth.+Commun.+2000%2C+30%2C+3391%E2%80%933404+10.1080%2F00397910008086979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 4,5-dihydro-3-arylnaphth[1,2-c]isoxazoles from dilithiated 1-tetralone oxime and aromatic esters</span></div><div class="casAuthors">Beam, Charles F.; Schady, Deborah A.; Rose, Kelly L.; Kelley, Wayne, Jr.; Rakkhit, Ronjay; Hornsby, Christopher D.; Studer-Martinez, Shannon L.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3391-3404</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Dilithiated 1-tetralone oxime was prepd. in excess lithium diisopropylamide and condensed with a variety of esters, followed by acid cyclization of C-acylated intermediates, to give substituted 4,5-dihydronaphth[1,2-c]isoxazoles [I, R = (un)substituted phenyl].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6wbZf7JdtLVg90H21EOLACvtfcHk0liMwoYf6XLA7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslykurg%253D&md5=184bc6c4cca78bd266b3b3a760567b96</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1080%2F00397910008086979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008086979%26sid%3Dliteratum%253Aachs%26aulast%3DBeam%26aufirst%3DC.%2BF.%26aulast%3DSchady%26aufirst%3DD.%2BA.%26aulast%3DRose%26aufirst%3DK.%2BL.%26aulast%3DKelley%26aufirst%3DW.%26aulast%3DRakkhit%26aufirst%3DR.%26aulast%3DHornsby%26aufirst%3DC.%2BD.%26aulast%3DStuder-Martinez%26aufirst%3DS.%2BL.%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D3391%26epage%3D3404%26doi%3D10.1080%2F00397910008086979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ohigashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1021/op0497862</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op0497862" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ohigashi%2C+A.%3B+Kanda%2C+A.%3B+Tsuboi%2C+H.%3B+Hashimoto%2C+N.Org.+Process+Res.+Dev.+2005%2C+9%2C+179%E2%80%93184+10.1021%2Fop0497862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fop0497862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0497862%26sid%3Dliteratum%253Aachs%26aulast%3DOhigashi%26aufirst%3DA.%26aulast%3DKanda%26aufirst%3DA.%26aulast%3DTsuboi%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DN.%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2005%26volume%3D9%26spage%3D179%26epage%3D184%26doi%3D10.1021%2Fop0497862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liaskopoulos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoulika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoungas, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varvounis, G.</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1055/s-2008-1032178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1055%2Fs-2008-1032178" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liaskopoulos%2C+T.%3B+Skoulika%2C+S.%3B+Tsoungas%2C+P.+G.%3B+Varvounis%2C+G.Synthesis+2008%2C+2008%2C+711%E2%80%93718+10.1055%2Fs-2008-1032178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1055%2Fs-2008-1032178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2008-1032178%26sid%3Dliteratum%253Aachs%26aulast%3DLiaskopoulos%26aufirst%3DT.%26aulast%3DSkoulika%26aufirst%3DS.%26aulast%3DTsoungas%26aufirst%3DP.%2BG.%26aulast%3DVarvounis%26aufirst%3DG.%26jtitle%3DSynthesis%26date%3D2008%26volume%3D2008%26spage%3D711%26epage%3D718%26doi%3D10.1055%2Fs-2008-1032178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Nishio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">2347</span><span class="NLM_x">–</span> <span class="NLM_lpage">2354</span><span class="refDoi"> DOI: 10.1002/1522-2675(20010815)84:8<2347::AID-HLCA2347>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;key=10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nishio%2C+T.%3B+Ori%2C+M.Helv.+Chim.+Acta+2001%2C+84%2C+2347%E2%80%932354+10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1522-2675%252820010815%252984%253A8%253C2347%253A%253AAID-HLCA2347%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DNishio%26aufirst%3DT.%26aulast%3DOri%26aufirst%3DM.%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2001%26volume%3D84%26spage%3D2347%26epage%3D2354%26doi%3D10.1002%2F1522-2675%2820010815%2984%3A8%3C2347%3A%3AAID-HLCA2347%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gilmore, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppeck, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galella, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borowski, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship (SAR) of a series of ethanolamine-based direct-acting agonists of sphingosine-1-phosphate (S1P1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6248</span><span class="NLM_x">–</span> <span class="NLM_lpage">6264</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00373</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6248-6264&author=J.+L.+Gilmoreauthor=J.+E.+Sheppeckauthor=S.+H.+Wattersonauthor=L.+Haqueauthor=P.+Mukhopadhyayauthor=A.+J.+Tebbenauthor=M.+A.+Galellaauthor=D.+R.+Shenauthor=M.+Yardeauthor=M.+E.+Cvijicauthor=V.+Borowskiauthor=K.+M.+Gilloolyauthor=T.+Taylorauthor=K.+W.+McIntyreauthor=B.+Warrackauthor=P.+C.+Levesqueauthor=J.+P.+Liauthor=G.+Corneliusauthor=C.+J.+D%E2%80%99Arienzoauthor=A.+M.+Marinoauthor=P.+V.+Balimaneauthor=L.+Salter-Cidauthor=J.+C.+Barrishauthor=W.+J.+Pittsauthor=P.+H.+Carterauthor=J.+Xieauthor=A.+J.+Dyckman&title=Discovery+and+structure+activity+relationship+%28SAR%29+of+a+series+of+ethanolamine-based+direct-acting+agonists+of+sphingosine-1-phosphate+%28S1P1%29&doi=10.1021%2Facs.jmedchem.6b00373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00373%26sid%3Dliteratum%253Aachs%26aulast%3DGilmore%26aufirst%3DJ.%2BL.%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DHaque%26aufirst%3DL.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DBorowski%26aufirst%3DV.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DTaylor%26aufirst%3DT.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DWarrack%26aufirst%3DB.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DMarino%26aufirst%3DA.%2BM.%26aulast%3DBalimane%26aufirst%3DP.%2BV.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520%2528SAR%2529%2520of%2520a%2520series%2520of%2520ethanolamine-based%2520direct-acting%2520agonists%2520of%2520sphingosine-1-phosphate%2520%2528S1P1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6248%26epage%3D6264%26doi%3D10.1021%2Facs.jmedchem.6b00373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i91"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01099">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_60040"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01099">10.1021/acs.jmedchem.6b01099</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Single-crystal X-ray structure of compounds <b>3</b> and <b>10</b> along with the parameters like crystal system, space group, unit cell parameters, temperature of data collection etc. (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_001.csv">jm6b01099_si_001.csv (3.52 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01099/suppl_file/jm6b01099_si_002.pdf">jm6b01099_si_002.pdf (505.12 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01099&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-21%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01099" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01099" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a146adce13cb8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
